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ABSTRACT  
 
Defined as the protein complement of the genome, the proteome is a varied and 
dynamic repertoire of molecules that in many ways dictates the functional form that is 
taken by the genome. The importance of proteomics is a direct consequence of the 
central role that proteins play in establishing the biological phenotype of organisms in 
healthy and diseased states. As proteins are the principal targets of drug discovery, the 
evolution of proteomics techniques is increasingly relevant in the field of medicinal 
chemistry. Proteomics is a promising approach for the comprehension of fundamental 
cell biology, the elucidation of biochemical pathways involved in disease mechanisms, 
and the identification of new protein targets. Accordingly, this technique is gaining 
widespread use in each phase of drug development, including target identification and 
validation, investigations into mechanisms of drug action or toxicity, biomarker 
discovery and also toxicological profil ing in pre-clinical and clinical settings. 
Proteomics concretely underpin the research and the development of both therapeutic 
agents and diagnostic tools. In fact, the achievement of an early diagnosis, especially 
in the field of autoimmune diseases, is a mandatory task of medicinal chemistry, 
equally relevant as the development of new drugs. 
Humoral responses represent a well-established component of several autoimmune 
pathologies where circulating autoantibodies address self-structures, frequently 
provoking severe damages. Some examples of pathogenic autoantibodies are 
represented by anti-myelin antibodies, contributing to the corrosion of the myelin 
sheath of multiple sclerosis patients, anti-nuclear antibodies, involved in the 
glomerulonephritis manifestations of systemic lupus erythematosus, and 
autoantibodies directed to insulin-secreting beta cells of the pancreas in type 1 
diabetes. 
The specific antigenic targets addressed by these autoantibodies are in most cases 
elusive and the underlying etiopathogenetic mechanisms remain largely unknown. 
Thus, unraveling the native antigens responsible for the production of autoantibodies 
endowed with diagnostic or prognostic value might be of invaluable interest, not only 
for a better comprehension of the disease mechanism(s), but also for the design and 
development of effective synthetic antigenic probes to be used to detect autoantibodies 
as diagnostic tools. By monitoring the presence of the autoantibodies, these probes 
can be used for an early detection of the disease, as well as for its follow-up.  
In this context proteomics provides a technology platform able to address these issues 
from several fronts. Indeed beyond the identification of proteins involved in disease 
progression, it is often critical to explore protein post-translational modifications 
(PTMs). Several studies have highlighted the importance of identifying potential 
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modifications as these may be indicative of the disease state and may lead to the 
development of biomarker assays. 
Proteomics is, by definition, an interdisciplinary science and derivatization reactions are 
frequently translated from chemistry to proteomic experiments as tagging reactions for 
proteins and peptides in the context of complex mixture of biological origin. The fields 
of application span from the enrichment and characterization of PTMs to the 
modification of functional groups to improve the mass spectrometric detection or to the 
introduction of labels for quantitative proteomic analysis. As far as quantitative 
proteomics is concerned, studying the change in the abundance of proteins within a 
cell over time or between different cellular states (normal versus diseased states) helps 
in providing further insights into the pathophysiological basis of protein target 
identification and validation for disease intervention and treatment. 
On the whole, proteomics rises as an appropriate tool for a deeper insight into systems, 
be it cells or organisms, and beyond the basic research, the whole field is driven by a 
vision of fundamental amelioration within medicinal chemistry. 
 
In this scenario, the first chapter of this work of thesis describes a project concerning 
the research of possible autoantigens recognized by anti-citrullinated proteins 
antibodies (ACPAs), biomarkers of rheumatoid arthritis (RA). The attention has been 
focused on histones, nuclear proteins whose presence has also been demonstrated in 
the extracellular environment. In particular citrullinated histones have been recognized 
as main actors in the production of neutrophil extracellular traps (NETs) by neutrophils. 
It has been described that NETs are formed in response to infective and inflammatory 
stimuli that bring to the extrusion of proteins with antimicrobial activity. However when 
NETs clearance is not correctly regulated, these structures may persist in the 
extracellular environment, leading to the presentation of antigens to the immune 
system and possibly supporting autoimmune responses toward self-antigens. 
The target of this research was to confirm the reactivity of citrullinated histones from 
nuclear extracts and NETs toward RA patients’ sera. A proteomic approach has been 
followed, based on the employment of gel separations, immunodetection, mass 
spectrometric analysis of trypsin digested bands and subsequent database searches. 
ACPAs are a hallmark of RA patients and their specificity to citrullinated antigens has 
been clearly proved. Citrulline residues are the result of an enzymatic deimination of 
arginine residues and feature a slight mass increase of 0.984 Da for residue. The 
characterization of PTMs is a primary, very challenging task in the proteomic research; 
accordingly, only few approaches have been described for the detection of deimination. 
In this work, a chemical derivatization strategy has been initially employed, using 2,3 
butanedione and antipyrine that selectively tag the ureic group of citrulline residues 
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introducing a 238.11 Da mass increase. MALDI-TOF analyses were performed on the 
trypsin digest to highlight the presence of derivatized citrullinated peptides. 
Subsequently, a LC-MS/MS strategy has been approached, aimed to more extensively 
characterize the deimination pattern of the identified protein by means of a direct 
detection of citrullines, testing two different stationary phases, namely reversed-phase 
and HILIC. LC-MS/MS data were acquired using a nanoHPLC system coupled to a 
LTQ-Orbitrap mass spectrometer equipped with a nanoESI source. 
 
The second chapter reports a research conducted on a reaction of stable isotope 
labeling, aiming at the relative quantification of the differential expression of proteins in 
two or more samples representing various conditions of biological systems. 
In this project a reaction has been taken into account, based on a reductive amination 
with aldehydes and NaCNBH3 and already reported as labeling strategy for quantitative 
experiments. It has been challenged considering that, beside primary amines which are 
the specific target of the reaction, the reactivity of aldehydes to other nucleophilic sites 
may impair the reliability of the reaction for quantitative purposes. 
Side products have been observed using formaldehyde or acetaldehyde and several 
tests were performed using synthetic peptides to both elucidate the chemical nature of 
the rearrangements and to find the conditions to suppress their formation. Among 
different experimental conditions, a specific attention was set aside for the pH of the 
reaction environment in order to highlight its role in the progression of the reaction. 
Upon fixation of general rules for the use of these reagents in stable isotope peptides 
labeling, the occurrence of the side-products was monitored on a single protein digest 
and a mixture of proteins digest. 
LC-MS/MS experiments were performed and quantitative reports were derived using a 
quantitation software able to extrapolate protein light/heavy ratios by processing the 
intensities of differentially labeled peptide precursors. 
 
The third chapter reports a project which has focused on the research of native 
autoantigens recognized by specific autoantibodies detected in Multiple Sclerosis 
(MuS) patients’ sera. Differently from the research of citrullinated histones recognized 
by RA patients’ ACPAs, in this project the research of candidate antigenic proteins was 
guided by autoantibodies recognized by a specific peptide probe called CSF114(Glc). 
In a previous work from this laboratory it was shown that CSF114(Glc) specifically 
identifies serum autoantibodies in a subset of MuS patients, representing 
approximately the 30% of the patient population. A “chemical reverse approach” 
allowed the identification of the N-glucosylated peptide CSF114(Glc) as the most 
efficient antigenic probe in detecting autoantibodies in relapsing remitting MuS patients. 
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Since serum autoantibodies ought to reflect the presence of corresponding antigens, 
peptides recognized by these autoantibodies might mimic structural features of neo-
epitopes. Given this background CSF114(Glc) affinity-purified antibodies from MuS 
patients’ sera were used to back-track CNS antigens implicated in the MuS-related 
autoimmune response. 
Classical proteomic tools were employed starting from gel separation of rat brain 
proteins followed by western blot with anti-CSF114(Glc) antibodies purified from MuS 
patients’ sera by means of an immunoaffinity chromatography. Mass spectrometric 
analyses of immunoreactive bands were performed and a validation of the identified 
proteins was fulfilled in order to confirm their reactivity. 
 
In conclusion, the three chapters of this thesis highlight the versatility of proteomics 
within the biomedical research. The use of different, sophisticated techniques 
contributed to the fine characterization of elusive self-antigens, recognized by 
autoantibodies of diagnostic/prognostic relevance in two different autoimmune disease, 
i.e. AR and MuS. Moreover the relative quantification of the differential expression of 
proteins in various conditions represents a field of growing interest and a correct 
employment of labeling strategies was proved to be essential for providing reliable 
results. 
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1.1 INTRODUCTION 
 
 
1.1.1 Rheumatoid arthrit is 
Rheumatoid arthritis (RA) is a chronic inflammatory disorder with autoimmune features 
that primarily affects the small diarthrodial joints of hands and feet, lately involves the 
large joints and finally spreads systemically.1 It is considered the most common 
autoimmune disease with an incidence range of 0,5-1,0% in the world’s population; it 
affects women more frequently than men and preferentially occurs between the ages of 
25 to 50.2 
Despite several factors are thought to be involved in the etiology of RA, the underlying 
mechanisms had not still been pointed out; however genetic predisposition, 
environmental and autoimmune factors certainly represent a triad with a central role in 
the pathogenesis of the disease.3 
The primary target of RA is the synovium that in physiological conditions is a relatively 
acellular site while in RA patients is interested by a massive recruitment of immuno 
competent cells. In fact T CD4+ lymphocytes, activated B-cells and macrophages 
consistently infiltrate and, in the worst way, organize in lymphoid aggregates with 
germinal centers. At the same time an extensive network of pro-inflammatory autocrine 
and paracrine cytokines (IL-1. IL-6, IL-15, IL-18, TNF-α, GM-CSF) creates a persistent 
inflammatory status. In this situation resident synovial cells are activated to produce 
hydrolytic degradative enzymes such as metalloproteinases, serine proteases, 
collagenases which altogether start the digestion of the extracellular matrix and the 
formation of the synovial pannus. This process triggers a progressive and aggressive 
erosion of the articular structures (both cartilages and bones) that leads patients to 
suffer a substantial loss of mobility because of the joints destruction and the correlated 
pain. 
Disease progression can be, generically, divided into three phases: disease initiation at 
peripheral lymphoid organs that starts the migration of activated immuno cells to the 
joint, disease propagation which leads the release of cytokines and tissue damages 
mediated by resident cells (Figure 1.1). 
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Figure 1.1. Stepwise progression in the development of RA: initiation, propagation and tissue 
damage 
 
The development of RA reminds the progression of other autoimmune diseases for the 
presence of an asymptomatic onset followed by a time-variable subclinical phase that 
lately evolves into a claimed pathology. During the pre-clinical phase there are 
inflammatory changes in the synovium without any clinical sign or symptom; joints 
inflammation dominates the initial clinical phase and erosion phenomena joined to 
systemic manifestations characterize the chronic phase. 
The very beginning symptoms of RA are often undifferentiable from those of other 
arthritis diseases such as systemic lupus erythematosus (SLE), psoriatic arthritis or 
seronegative spondylarthropathies, making difficult its discrimination. Morning stiffness, 
reduced grip strength, symmetric arthritis are only few examples of the most common 
symptoms. Their entity largely depends on the presence and the degree of phlogosis 
so when body tissues are inflamed the disease is active while in absence of 
inflammation the disease is inactive and in remission. In this phase, which can lasts for 
weeks, months or years, symptoms disappear and patients feel better; as soon as the 
symptoms reappear the disease is active again. 
Since RA etiopathogenesis is widely undiscovered the therapeutic treatments are 
focused on controlling patient's signs and symptoms, preventing joints damages and 
maintaining patient’s quality of life and ability to function. Three main classes of drugs 
are used in RA treatment: non-steroidal anti-inflammatory agents (NSAIDs), 
corticosteroids, and disease modifying anti-rheumatic drugs (DMARDs). 
NSAIDs mitigate the pain and the inflammation but unfortunately they do not limit the 
long-term damaging effects of RA on the joints. They need to be taken continuously to 
achieve the effects but side events risk to emerge after a prolonged treatment. 
Corticosteroids are more effective and faster in reducing the main RA symptoms (pain, 
stiffness, joint swelling and tenderness) so they are frequently used to treat the 
severest disabilities caused by RA progression. Contraindications regarding the use of 
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steroids are well-known. DMARDs also work to decrease pain and inflammation by 
suppressing overactive body's immune system; they are not designed to provide 
immediate relief of symptoms because several weeks or months are needed to 
produce the effects. DMARDs include drugs such as methotrexate, 
hydroxychloroquine, sulfasalazine, and leflunomide but also biological agents like some 
recombinant antibodies (adalimumab, infliximab, rituximab as examples) that inhibit 
inflammatory cytokines or transiently deplete mature reactive B-cells. 
It is well established that joint damages start during the asymptomatic phase; around 
the 90% of RA patients exhibit some forms of disability within two decades from the 
onset and early treatments decrease the rate of disease progression. An early 
diagnose is of the greatest importance to allow therapeutic agents to be given as soon 
as possible. Unfortunately it is still a difficult issue to address due to the long 
asymptomatic onset, the plurality of clinical aspects and the absence of clear specific 
RA symptoms.4 
Up to now the diagnosis is performed by combining clinical symptoms with biological 
and radiographic indices which have been standardized by the American College of 
Rheumatology (ACR) and the European League Against Rheumatism (EULAR) (Figure 
1.2). 
 
 
Figure 1.2. Classification criteria for RA according to the ACR/EULAR committee 
 
These criteria have been developed starting from a previous classification criticized for 
its lack of sensitivity toward the early stage of the disease; it was revaluated trying to 
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identify factors that could better correlate with the persistent/erosive features of RA. 
With these new criteria, measured with specific scores, the diagnosis is now based on 
a confirmed presence of synovitis in at least one joint and with no other reliable 
explanations and a total score of 6, summing individual scores of the four groups. 
These groups take into consideration the number and the sites of involved joints, the 
presence of serological abnormalities and consistent acute-phase responses, and, 
finally, symptoms duration. Clinical analyses highlight the presence of an inflammatory 
event in progress however some parameters, such as the presence of acute-phase 
proteins, are not specific for RA if compared with other serological markers such as RF 
and ACPAs. 
RF, Rheumatoid Factor, is an antibody that recognize the Fc portion of 
immunoglobulins G and high titers are, typically, correlated to chronic inflammatory 
conditions. RF is not an hallmark of RA, since its presence is correlated to other 
infective and inflammatory conditions, however it has been demonstrated that, in RA 
patients, occurs many years before the onset of the disease, justifying its inclusion 
within the classification criteria. The discovery of RF and its association to RA have 
been important steps in the investigation of the disease opening the possibility to 
search for biomolecules circulating in the asymptomatic phase of RA to use as early 
diagnostic markers of the disease. 
 
 
1.1.2 Anti-citrullinated peptide antibodies  
Observations made on RF have promoted the search for other antibodies to associate 
with RA and several ones have been found to be more specific and to have a higher 
positive predictive value than RF. The first antibodies described after RF were the anti-
perinuclear factor (APF) and the anti-keratin factor (AKA) which were detected in RA 
patients sera using immunofluorescence techniques.5,6 Both the antibodies recognize 
the same antigen, namely filaggrin, which is a protein involved in the cytokeratin 
filament-aggregation.7 Filaggrin is not a joint-specific protein therefore the recognition is 
supposed to be the consequence of a cross-reaction against un unknown antigen 
expressed in the inflamed sites.  
APF and AKA antibodies are included in the antifilaggrin autoantibodies (AFA) family 
which was proved to be directed against citrullinated epitopes.3,8,9 This discovery 
represented a remarkable breakthrough toward the understanding of the reactivity of 
AFA since citrulline residues constitute the major antigenic determinant recognized by 
antibodies present in RA sera. 
Besides AFA other antibodies were retrieved such as the so called anti-Sa (anti-
Savoie) antibodies that showed a very high specificity (around 95%) for RA, a variable 
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sensitivity according to the stage of the disease and a strong association with the 
disease severity; it was also demonstrated a reactivity toward citrullinated vimentin.10,11 
Antinuclear antibodies have been detected in RA patients such as the anti-A2/anti-
RA33 antibodies directed to the heterogeneous nuclear ribonucleoprotein A2 (hnRNP-
A2) which is overexpressed in synovial membranes, where it may be targeted by 
autoreactive B and T cells.12 During years others autoantibodies with different 
sensitivity and specificity toward RA have been described, all of them able to recognize 
citrullinated proteins. For this reason the acronym ACPAs, anti-citrullinated peptides 
antibodies, has been coined to describe this heterogeneous family of antibodies 
sharing reactivity toward citrullinated epitopes. 
Based on these discoveries enzyme-linked immunosorbent assays (ELISA) have been 
developed using citrullinated antigens as immobilized probes able to specifically elicit 
ACPAs from RA patients’ sera. Cyclic citrullinated peptides (CCPs) are synthetic 
filaggrin peptides developed to act as surrogate target antigens and used in the CCP-
test that represents the gold standard assay for an high specific and sensitive detection 
of ACPAs in RA sera. Three generation of CCP-tests have been developed with 
increasing performances and the antigenic probes have been optimized until a mixture 
of citrullinated peptide sequences have been adopted as the best discriminating. 
Clinical interest on ACPAs has become justified when they were found to be highly 
specific for RA and to have higher predictive value compared to RF since they were 
monitored in the very early stages of the disease.13,14 In other words they represented  
an important biomarker of RA thanks to their presence in patients’ sera several years 
before the symptomatic onset of the disease.  
Biomarkers are measurable characteristic elements whose presence is indicative of a 
pathological status therefore they represent an important tool for the diagnosis or 
prognosis of a disease. In the field of autoimmunity the research of biomarkers is a 
stimulating topic because they are progressive diseases diagnosed only in the late 
phase when tissue damages became sadly evident. Disease outcome varies from mild 
to severe systemic symptoms when joint destruction is accompanied by extra-articular 
manifestations and an early intervention is crucial in preventing irreversible joint 
damages.15 Therefore the availability of molecular markers to be monitored during the 
asymptomatic stage of the disease can improve the effectiveness of the treatments 
promoting, as example, a well-timed use of DMARDs able to produce a favorable effect 
on the course of the pathology.16 
It is not surprising that for RA the biomarkers are represented by autoantibodies since 
autoimmune diseases are characterized by a strong activation of the humoral 
component of the immune system. The development of proper assays able to monitor 
their presence constitutes another topic of great interest that has led to the release in 
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the market of the CCP tests which represent easy to be performed, low cost and not 
invasive tests. 
The presence of ACPAs in the serum is one of the prominent criteria to be considered 
for a correct RA diagnosis but itself it is not sufficient because a small percentage of 
healthy individuals (about 2%) and a more consistent fraction of patients with other 
systemic inflammatory disease (<10%) are ACPAs positive, too. In addition there are 
also ACPAs negative individuals who are affected by RA, that suffer different risk 
factors and have different progression rate of the disease but that share similar clinical 
characteristics with the ACPAs positive ones.17 
The correlation between the presence of ACPAs in RA patients’ sera and a more 
severe and erosive progression of the disease has been demonstrated fueling the 
hypothesis that ACPAs themselves may be involved in the pathophysiology of RA and 
even because their presence is detected before a clear manifestation of disease 
symptoms.18,19 
However ACPA recognition of citrullinated proteins had stimulated a lot of interest 
around these antibodies and several studies had been led in order to disclose the auto-
antigens that can function as real immunogens for the anti-citrulline responses of this 
disease. Many citrullinated proteins have been suggested as candidate autoantigens 
responsible of the induction and/or perpetuation of ACPAs responses but only for few 
of them the pathogenetic mechanism has been confirmed (Figure 1.3). 
 
 
Figure 1.3. Candidate citrullinated (auto)antigens that have been associated with RA18 
 
The synovium has always been considered the principal source of autoantigens 
because it is the primary site of disease manifestations where immuno competent cells 
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massively migrate creating follicular structures that act as a sort of secondary lymphoid 
organ. Since ACPAs are also produced by the local plasma cells of the pannus it is 
presumable that the affinity maturation of the infiltrating B cells is guided by local 
citrullinated proteins.20 Therefore the characterization of potential citrullinated 
autoantigens can help a better understanding of the role of the ACPAs. 
An important point to be clarified is that citrullinated proteins occur in different types of 
joint inflammation, not only in RA, therefore the presence of ACPAs rather than the 
presence of such proteins is a characteristic of this disease. Moreover it has been 
proved that not all citrullinated proteins are specifically recognized by ACPAs so some 
unknown mechanisms are supposed to be responsible for the restriction of the immune 
response toward some citrullinated antigens. 
A first consideration to take is that antibodies responses to proteic antigens require a 
cooperation between B and T lymphocytes. As consequence a citrullinated protein 
recognized by a B cell and containing the correct deiminated B cell epitope but lacking 
an appropriate T cell epitope (deiminated or not) will not provoke the B cell complete 
activation, preventing antibodies’ release. In the anti-citrulline reactivity observed in RA 
autoimmune responses may widely vary between different citrullinated epitopes and 
the presence of specific autoepitopes promoting reciprocal B cell-T cell interactions 
may be the crucial aspect to initiate the ACPA response.  
A second important aspect to take into account is the influence of the genetic 
background that in autoimmunity plays a crucial role since specific poligenic profiles 
enhance the probability to develop the pathology. In particular the MHC class II alleles 
have been found associated with autoantibodies specificity, and involved in the etiology 
and pathogenesis of autoimmune disease according to the “shared epitope 
hypothesis”.21 The better-known HLA-DRB1 alleles include members of the group *04, 
*0101, *0102, *1402 and *1001 which code for variants of the five amino acid sequence 
70–74 of the region of the DRB chain responsible for the peptide binding and T cell 
recognition. It is assumed that structural differences between class II molecules can 
influence this interaction and the higher ACPAs levels found in HLA shared-positive RA 
patients suggest that a specific MHC background may contribute to the antibody 
response restriction. The mentioned HLA alleles showed a higher affinity for 
citrullinated peptides demonstrating the targeted recognition of such epitopes. They 
also proved that a B-cell response directed to citrullines and involving the T cell 
compartment is at the centre of RA pathology. 
As mentioned before, citrullination is typically seen as a symptom of inflammation 
however it is described not only in inflammatory arthritis but also in other autoimmune 
diseases (i.e. Multiple Sclerosis, psoriasis), in neurological pathologies (Alzheimer’s 
disease), in cancer, in glaucoma.22,23 As example citrullinated Myelin Basic Protein 
(MBP) has been associated to Multiple Sclerosis correlating a reduced myelin’s 
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compactness with the secondary structure loss of the protein, as consequence of the 
citrullination. An enhanced digestion by cathepsin D, an increased release of antigenic 
peptides and a propagated autoimmune response were consequences of the 
modification, too.24 This PTM has been also described in some physiological conditions 
such as brain development, female fertil ity, hair formation, plasticity of the central 
nervous system, terminal differentiation of the epidermis and also regulation of gene 
expression.25  
 
 
1.1.3 Deimination and proteomic m ethodologies for the  
characterization of deiminated ant igens  
The research of citrullinated proteins, as possible candidate autoantigens involved in 
the pathological mechanisms of RA, represents an intriguing topic and many articles 
have been published both using classical biochemical approaches and innovative mass 
spectrometric strategies. Such methodologies rely on the specific chemical properties 
of the citrullines which are quite different from the originating arginines. Citrulline is a 
non standard amino acid since there are neither a corresponding mRNA codon nor a 
tRNA. It is not incorporated into proteins during translation but it is the result of a PTM, 
namely citrullination or arginine deimination (Figure 1.4). 
 
  
Figure 1.4. Deimination of arginine into citrulline by means of the PAD 
 
This PTM essentially consists in the conversion of the guanidinium group of the 
arginine’s side chain into an ureic group through an enzymatic reaction catalyzed by 
the peptidylarginine deiminases (PAD), calcium-dependent metalloenzymes that 
belong to the guanidinium-group modifying enzymes superfamily. Five PAD isotypes 
have been described, sharing consistent sequence homology among them (50-55%) 
and mammals (70-95%).2 The main difference concerns their anatomic distribution 
since each of them has a specific tissue localization: PAD1 is mainly expressed in the 
epidermis and uterus, PAD2 is more ubiquitous even if it is more expressed by the 
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neural tissue and the macrophages, PAD3 has an epidermic expression too, PAD4 is 
expressed by the white blood cells, mainly granulocytes, neutrophils and eosinophils 
and PAD6 has been recently identified within mammalian oocytes.26 Among the five 
isotypes PAD4 is the only one that has a nucleic localization, compared to the cytosolic 
distribution of the others, and, together with PAD2, its presence has been 
demonstrated in rheumatoid synovial membranes, synovial fluid cells and extracellular 
synovial fluid.3 
PADs aroused interest within RA research starting from the discovery that RA patients 
owned autoantibodies to citrullinated peptides and that PADs genes conferred 
susceptibility for the disease but it increased once found a strong association between 
a specific PAD4 haplotype and RA.27 Four single nucleotide polymorphisms (SNPs) 
found in the PAD4 gene provoke three amino acid substitutions supposed to be 
responsible for a more stable transcript and an increased activity of the enzymes 
which, ultimately, result into an enhanced production of citrullinated proteins acting as 
autoantigens. Such association has been demonstrated for Japanese and Korean 
population but was not confirmed for Caucasian people probably for the occurrence of 
different polymorphism or haplotypic combinations. 
The hydrolytic deimination activity of PADs depends on several factors including the 
sequence of substrate proteins, the presence of other PTMs and even the type of 
residues flanking the targeted arginine so it seems that some amino acid such as 
tryptophan favor the modification while other such as proline has a negative effect.  
The conversion of an arginine into a citrulline involves some critical chemical 
modifications such as loss of a positive charge, decreased isoelectric point and mass 
increase of 0.984 Da which altogether are responsible for specific modifications on 
proteins (Figure 1.5; on the left). A positive charged arginine side chain converted into 
a neutral group produces relevant effects on the protein structure because the 
hydrogen bonding properties are lost changing the overall conformation (Figure 1.5; on 
the right).2 
 
 
Figure 1.5. Possible modifications induced by citrullination (on the left); as example the change of 
the tertiary structure is shown (on the right) 
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Taking into account these features during years several methods have been developed 
for the detection of citrullinated proteins and peptides in mixture: immunodetection, 
mass spectrometric (MS) analyses with modifications and MS analyses without 
modifications. 
The most classical approach regards 2D-SDS-PAGE followed by specific 
immunodetection of citrullinated proteins, as originally described by Senshuo et al.28 
Basically, proteins transferred into a membrane are incubated at low pH with 2,3-
butanedione and antipyrine which selectively tag citrulline residues; then the 
immunodetection step is performed using commercially available antibodies able to 
recognize citrulline modified with such reaction. The method is sensitive and specific 
thanks to the use of antibodies and is exploitable for in vivo samples citrulline detection 
but it does not provide information neither about the citrulline-bearing proteins nor 
about the exact location of the modification. 
Preliminary information can be extrapolated by a 2D-gel carefully observing the 
migration of the proteins: since PTMs can provoke changing at mass and/or isoelectric 
point, trains’ of spots on the gel are presumably formed by multiple versions of the 
same protein. Citrullination do not provoke a consistent change in the mass but in the 
isoelectric point greater the greater is the number of deiminated arginine therefore an 
horizontal cluster of spots with highest immunoreactivity at the more acidic side of the 
train is typical of proteins bearing an increased status of citrullination. According to 
previous considerations it is evident that the primary purpose of this technique is the 
identification of citrullinated proteins in a target tissue and other proteomic strategies 
have to be used in order to provide more detailed molecular information. 
Different strategies based on specific modifications of citrulline residues have been 
developed, using chemical tags which facilitate its MS detection or its enrichment from 
a protein digest.29 
Derived from the original reaction developed by Senshuo et al a labeling strategy with 
2,3-butanedione and antipyrine can be applied directly to a protein digest, selectively 
introducing into citrullines a chemical tag that produces a mass increase of 238.11 
Da.30 Such citrulline adduct can be detected by MS analysis and, in particular, using 
MALDI-TOF-MS it can be also easily recognized thanks to a characteristic isotopic 
pattern; moreover it acquires chromophoric features that allow a specific UV-absorption 
at 464 nm. The potential of this strategy has been further enhanced after the discovery 
that citrulline-modified peptides exhibit a specific 201.1 Da loss after collision induced 
dissociation (CID) on LC-MS/MS analysis, representing an important signature ion.31 
Due to the difficulty of identifying derivatized citrullinated peptides by CID spectra, the 
employment of a different fragmentation technology has been proposed, namely 
electron transfer dissociation (ETD). It showed a nearly complete coverage with all 
fragment ions shifted of 238.11 Da indicating that a soft fragmentation can preserve the 
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adduct in the peptide. This labeling strategy was proved to be selective for citrullines 
and highly efficacious but such results came from standard peptides or standard 
protein deiminated in vitro, both samples available in large amount. The efficacy on real 
samples containing a small fraction of citrullinated peptides is not known. Even ETD is 
not a routinely technology nor it is widely available on the most common mass 
spectrometers. 
A variation of the described method has been proposed without the use of antipyrine 
and increasing the incubation time with 2,3-butanedione; LC-MS data were processed 
using an in-house search application that performed comparison of the peptide mass 
fingerprinting.32 In this case no complex MS instrumentation was required but an 
hinged sample pre cleaning and fractioning was necessary, with evident difficulties if 
applied to low concentrated samples. 
Another labeling strategy based on the specific reaction of glyoxal derivatives with the 
citrulline ureido group under acidic conditions was proposed using derivatized beads 
exposing 4-hydroxyphenylglyoxal to react with citrulline.33 This way only citrullinated 
peptides were stopped on the beads and, after a proper washing step and a strongly 
basic cleavage, citrullinated peptides were released carrying a modified ureido group. 
In a recently published paper it was proposed the use of a citrulline-specific chemical 
probe, namely rhodamine-phenylglyoxal, to selectively tag citrulline residues and 
furthermore allowing a fluorescent detection on SDS-page thanks to the presence of 
the linked rhodamine dye.34 This methods are all very specific and contribute to a 
reduction of the sample complexity but they require a large amount of sample. 
It is interesting to note that all the labeling strategies that have been developed start 
from considering the reactivity of arginine with dicarbonyl compounds including α-α’-
diketones, such as 2,3-butanedione, and α-keto aldehydes, such as glyoxal and 
substituted glyoxals, which are known to react with an amidine group to form an 
addiction product.35 The breakthrough has been represented by the use of acidic 
conditions that prevent the reactants to attack the protonated guanidinium group of 
arginines and instead promote the selectively addition to the ureic group of citrullines. 
Additionally a stable isotope labeling strategy has been proposed based on the 
introduction of the 18O heavy isotope of the oxygen atom by means of PAD in presence 
of H2
18O so that citrullinated peptides acquire a 3 Da mass shift and a characteristic 
isotope distribution different from natural abundance.36 The big deal of this strategy is 
its exclusive employment for the detection of proteins citrullinated in vitro. 
Unlike the strategies based on labeling reactions the approaches that rely on the direct 
detection of citrullines do not use any tagging reaction but exploit the both chemical 
and mass spectrometric properties of this residue, starting from the 0.984 Da mass 
shift from the unmodified arginine. Methods based only on the detection of such small 
difference anticipate several problems: the presence of the unmodified peptides, the 
Chapter 1                                                                                                                                                       Introduction                                                                                                                 
  
 
 
   18  
difficulty to discriminate arginine deimination from the isobaric asparagine/glutamine 
deamidation, the incomplete fragmentation of citrulline-bearing peptides, the 
controversy regarding trypsin ability to cleave citrullines or not, and the need for an 
high performing LC-MS/MS instrumentation. 
Two interesting approaches have been described: one based on both the accurate 
mass and retention times of specific citrullinated peptides and the other based on a 
diagnostic mass loss from citrullinated peptides submitted to CID. In the first case 
some citrullinated peptides from fibrinogen deiminated in vivo were used as reference 
(in terms of mass and retention times) for the identification of the corresponding in vivo 
citrullinated fibrinogen obtained from synovial tissue samples. It is evident that the 
analysis of the biological sample is limited to the peptides which can be detected in the 
analysis of the in vitro citrullinated protein.37 Instead in the second approach MS/MS 
analysis of citrullinated peptides highlighted a specific neutral loss of 43 Da, 
representing the detachment of isocyanic acid from the ureido group.38 This mass 
signature is very interesting but, once again, it was proved on standard abundant 
peptides and no information regarding a low concentration range are available. 
An integrated strategy has been proposed combining the diagnostic isocyanic acid 
departure obtainable from CID with the higher identification power of ETD; basically 
ETD is performed only on those peptides that after CID fragmentation exhibited the 
typical neutral loss of 43 Da.39 The need for an MS instrument able to perform both of 
the fragmentations in a single analysis is evident therefore the real applicability is 
limited. 
A very recent and pioneering approach has been proposed for the MS detection of 
citrullines; it compares the experimental isotopic pattern of a mono charged citrullinated 
peptide with its expected theoretical one.40 If the corresponding unmodified peptide is 
present, the citrullinated peptide would exhibit a skewed isotopic distribution, due to the 
partial overlapping between the two forms. Using statistical models to calculate the 
deviation it is possible to quantify citrullinated peptides. However the decisive 
confirmation regarding the presence of citrullines is fulfi lled by means of labeling 
strategies since a deamidated asparagine/glutamine provokes an analogues mass shift 
of 0.984 Da. 
The major consideration that emerges from the overview of the MS currently available 
methods for the detection of citrullines is that the great part of them has been proved 
only on standard peptides or at least on standard proteins deiminated in vitro. Both 
cases represent ideal conditions for the low complexity and the large amount available 
for the analysis; only few methods have been tested on biological samples. In addition 
some strategies rely on complex instrumentations and other present limited 
applications. 
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In conclusion the best approach is still not there since each of them presents positive 
and negative aspects. It is also evident the huge demand to improve the sensitivity of 
these methods to be applied to biological samples in order to map the citrullination 
status of in vivo deiminated proteins and do advancing the correlated biomedical 
research. 
 
 
1.1.4 Deiminated histones and neutrophi l ex tracellu lar traps 
Histones are hydrophilic and basic proteins characterized by the presence of several 
positively charged amino acids, namely lysines and arginines; these residues are 
involved in interactions with the negatively charged phosphate groups of DNA. Indeed 
histones participate in the organization of nucleosomes which are the structural core 
units responsible for the chromatin packaging. 
Five canonical histone isotypes, namely H1, H2A, H2B, H3 and H4, are known and 
many other subtypes for each of them have been described. Histones are typically 
nuclear proteins but evidences have been accumulated proving their presence in 
different sub cellular compartments. As example in the cytosol they can form 
complexes with other histones or other proteins.41,42 Additional features have been  
described such as the ability to cross lipid bilayers through an endocytosis-indipendent 
pathway based on a direct translocation and to mediate penetration of macromolecules 
covalently attached to them.43,44 The antimicrobial activity of histones is not a recent 
finding and three histonic peptides have been described to be active against bacteria. 
They are buforin I (39 amino acids),45 parasin I (21 amino acids),46 and hipposin (51 
amino acids),47 all derived from the N-terminus domain of histone H2A. However 
histones themselves have an antimicrobial activity suggesting that they could actively 
take part in the innate immunity responses.48 All these data prove that histonic proteins 
do not exclusively act as scaffold for the nucleosome core but they are possibly 
involved in many other functions, largely unknown. 
Strictly correlated to the mentioned antimicrobial activity of histones is the recent 
finding that they are also involved in a form of innate response carried out by 
neutrophils. In presence of infectious and inflammatory stimuli these cells extrude 
structures named neutrophil extracellular traps (NETs) which exhibit an antibacterial 
activity.49 This mechanism ensures a high local concentration of antimicrobial 
molecules able to disarm and kill bacteria. It is very interesting to note that the key 
event for mediating NETs release is just the histones citrullination mediated by enzyme 
PAD4. This event provoke the chromatin unfolding so that web-like structures form and 
trap granule and nuclear constituents of neutrophils.50 
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Histones bearing citrullinated residues do not represent a novelty because they have 
been already described in the epigenetic regulation of gene transcription where 
deimination antagonize arginine residues methylation. With the discovery of NETs a 
further functionality of deiminated histones has been discovered, that is chromatin 
unfolding for NETs release. The presence of PTMs on histones able to modulate their 
activity is a known event and there are so different occurring PTMs (acetylation, 
phosphorilation, ubiquitination, methylation, ADP-ribosylation, biotinylation etc) that an 
“histone code” hypothesis has been proposed, predicting that a single or a 
combinations of PTMs may work to regulate histones structure and to guide distinct 
biological functions.51 
Histone deimination and the production of reactive oxygen species (ROS) are crucial 
events to initiate the NETosis which is a cell-death program different from the well 
known necrosis and apoptosis mechanisms. Basically, stimulation of neutrophils results 
in the activation of NADPH oxidases and in the formation of ROS. How ROS directly 
promote NETs formation remains unclear but their signaling is required to start the 
subsequent molecular events: disruption of the nuclear membrane, PAD4 activation, 
histones deimination, chromatin decondensation, mixing of nuclear contents with 
cytoplasmic and granular proteins (Figure 1.6). 
 
 
Figure 1.6. Model for the formation of neutrophil extracellular traps52 
 
As a final step, traps formed by DNA fibers trapping antimicrobial components and 
nucleic proteins are released in the extracellular medium thus blocking and killing 
different microbes.53 Elastase, cathepsin G, myeloperoxidase, lactoferrin, gelatinase B, 
pentraxin 3 and even histones are examples of proteins that NETs carry outside the 
cell. 
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A wide panel of proinflammatory stimuli have been proved able to initiate the NETs 
program: bacterial lipopolysaccharide (LPS), the mitogen phorbol myristate acetate 
(PMA), the interleukin 8 (IL-8), hydrogen peroxide and so on. In few cases a direct 
exposure is sufficient to trigger NETs formation like in the case of some pathogens (S. 
aureus, Streptococcus pyogenes, Mycobacterium tuberculosis, Escherichia coli, 
Candida albicans). In other case a priming step must have been done to stimulate 
NETs formation like for the chemotactic complement-derived peptide C5a while no 
such priming step is required for LPS, PMA, or IL-8.  
As evident both infectious and not-infectious stimuli can generate NETs and several 
evidences had accumulated that NETs may be involved in various clinical settings, in 
particular in the autoimmunity field. Indeed the release of PAD4 into the extracellular 
space may generate modified self-antigens with potential immunogenic features. Also 
the exposure of intracellular proteins by means of NETs could plays a role during the 
development of autoimmune diseases. 
An example of NETs occurring in autoimmune disorders is proved by the small-vessel 
vasculitis, a chronic auto inflammatory condition, where it was shown that NETs 
contained two known autoantigens, proteinase-3 and myeloperoxidase, normally 
contained in the neutrophils granules.54 Instead in systemic lupus erythematosus (SLE) 
a subset of patients were found to have an impaired NETs degradation which was 
correlated to an higher anti-NET Abs deposition at kidney level that contributed to the 
renal damages.55 
These last evidences are very interesting because SLE patients own a type of 
autoantibodies called anti-neutrophil cytoplasmic antibodies (ANCA) which are mainly 
directed against DNA, histones, riboproteins and other nucleoproteins. Immuno 
complexes formed by ANCA and relative antigens may be pathogenic in the 
development of gromerulonephritis which is a major organ manifestation of SLE. 
Authors propose that NETs may act as a source of autoantigens by exposing 
chromatin and neutrophil proteins in an immunostimolatory context. Moreover a 
persistent exposure can exacerbate the autoimmune response leading to the formation 
of immuno complexes. 
The role of NETs in the etiopathogenesis of autoimmune diseases is largely unknown 
but these preliminary studies demonstrated that they constitute an interesting and 
innovative scenario to explore. 
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1.2 OBJECTIVES 
 
The research of citrullinated proteins with a potential role in the pathogenesis of 
rheumatoid arthritis (RA) started many years ago, when anti-citrullinated proteins 
antibodies (ACPAs) were recognized as biomarkers of the disease. 
It is now accepted that ACPAs represent a family of antibodies with overlapping 
specificities that are directed to a variety of citrullinated substrates, of exogenous or 
endogenous origin. 
In this work of thesis the research of deiminated proteins recognized by ACPAs has 
been conducted focusing the attention toward histone proteins, which have been 
studied in the context of neutrophils extracellular traps (NETs). 
Histones are nuclear proteins described to occur even in other sub cellular 
compartments or extracellularly and the recent discovery that neutrophils extrude 
deiminated histones outside the cell to form NETs has attracted attention.  
Several evidences have proved that NETs exert an antimicrobial function and their 
release occur in case of infections. When NETs clearance is not correctly regulated, 
they may persist in the extracellular environment, leading to the presentation of 
antigens to the immune system and possibly supporting autoimmune responses toward 
self antigens. 
Therefore the aim of this project was to investigate the presence in neutrophils nuclear 
extracts and NETs of deiminated histones recognized by RA sera and to characterize 
their deimination pattern using proteomic strategies. 
In the first part of the research we evaluated the presence of deiminated histones 
within nuclei and NET of purified neutrophils, using a classical approach that employed 
SDS-PAGE followed by immunodetection with RA sera. Mass spectrometric analyses 
have been conducted to identify the proteins present in the bands and a derivatization 
technique has been used to characterize the presence of the deimination. 
In the second part of the work we investigated more in depth the deimination pattern of 
histone H4 by means of an LC-MS/MS strategy based on the direct detection of 
citrulline residues with two different stationary phases, namely reversed-phase and 
HILIC. 
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1.2.1 Scheme of the work  
 
The first part of the project was developed as follows: 
• Neutrophils isolated from healthy blood donors were cultured and incubated 
with or without a calcium ionophore able to activate PAD4-mediated 
deimination. Acid extracted proteins were separated on Tris-Tricine-SDS PAGE 
and subjected to immunodetection with RA sera to check the reactivity. 
Corresponding reactive gel bands were trypsin-digested and submitted to 
MALDI-TOF analysis to achieve protein identification. 
• A derivatization technique with 2,3-butanedione and antipyrine, specific for 
citrulline residues, was optimized on different standard samples including 
citrullinated and not citrullinated peptides combined in binary and more complex 
mixtures. 
• The derivatization technique was applied to the trypsin-digested bands and 
analyzed by MALDI-TOF MS to search for possible deiminated peptides. 
• Neutrophils were used again and activated to produce NETs in presence of 
PMA which is a stimulus known to prime the respiratory burst by enhancing 
superoxide release and promoting the generation of ROS. NETs’ proteins were 
gel separated and immunoblotted to confirm the reactivity toward RA sera. The 
proteolytic digest of the gel band was analyzed by MALDI-TOF MS. The same 
labeling strategy was employed to highlight the presence of deiminated 
peptides. 
 
The second part of the project was developed as follows: 
• A direct detection of citrullines was attempted with the NETs digest trying to 
obtain more detailed information regarding the deimination pattern of the 
identified protein by means of LC-MS/MS analysis. Taking into account all the 
intrinsic critical aspects of this approach reversed-phase and HILIC were 
considered as the most appropriate chromatographic supports. 
• Each stationary phase, equipped on a nanoLC-LTQ-Orbitrap system, was 
tested with standard peptides to verify the selectivity toward a pair of 
deiminated and not deiminated peptides. 
• Tryptic NETs digest was separated on the reverse-phase and MS/MS spectra 
of citrullinated peptides were analyzed in order to deduce the exact deiminated 
position by looking for fragment ions bearing the 0.984 Da increment. 
• Similar analysis were performed on HILIC highlighting the major problems that 
emerged from such technology; a targeted MS/MS analysis was repeated 
focusing the attention on the peptide of interest. 
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1.3 RESULTS AND DISCUSSION 
 
 
1.3.1 Identif ication of antigens expressed in nuclei  of  activated  
neutrophils  
A density gradient fractionation of blood is a common procedure employed to isolate 
mononuclear cells and granulocytes by means of polysucrose media that allow the 
separation of the cells on the basis of their size, shape and density. A density gradient 
is typically created by layering media of different density in a centrifuge tube. When a 
sample is layered on top of this density gradient and centrifuged, the various particles 
move through the gradient at different rates. According to the protocol described by 
English et al centrifugation of heparinized human blood on a discontinuous gradients 
created by sucrose media results in the simultaneous separation of mononuclear 
leukocytes, granulocytes, and erythrocytes. 56 
In this project granulocytes were purified starting from anticoagulated blood of healthy 
subjects which was layered on a double gradient of two different Histopaque® 
solutions. After centrifugation granulocytes were recovered from the ring formed at the 
interphase between the two solutions while PBMCs stopped at the plasma interphase 
and erythrocytes sedimented at the bottom of the tube. Washed granulocytes were 
cultured and activated by A23187 stimulation for 15 min at 37°C. Cells were lysed in 
H2SO4 and acid extracted proteins were precipitated in TCA. After an appropriate re-
suspension proteins were separated on acrylamide gels, transferred to PVDF and 
subjected to Western blotting using RA sera and normal healthy subjects. Blots 
showed a specific reaction of the pathological sera with an antigen of 11 kDa while no 
reactivity was observed with control sera (Figure 1.7). 
 
 
Figure 1.7. RA sera bind to citrullinated H4 from stimulated neutrophils. RA1 and RA2 =sera of two 
RA patients; NHS=sera of a normal blood donor  
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Immunodetection was also performed with a specific anti-histone H4 antibody (anti-
H4), an anti-citrullinated-histone H4 polyclonal antibody (anti-H4cit) and an anti-
modified citrulline antibody (anti-MC); a reaction occurred at the same position in the 
blot. 
Altogether these data suggested that the protein at 11 KDa recognized by RA sera, by 
anti-H4, by anti-H4cit and by anti-MC antibodies might be histone H4, probably carrying 
deimination sites. To confirm such hypothesis an MS analysis of the corresponding gel 
band was performed. 
The band was excised from two lines of the gel where the same protein extract was 
initially loaded so as to have the result in duplicate. The enzymatic in-gel digestion 
protocol was used to convert the protein contained in the bands in peptides that could 
be extracted and analyzed by MS to achieve the identification. The procedure involved 
consecutive washes to remove the Coomassie staining, a step of reduction and 
carbamidomethylation of cysteine residues to destroy disulfide bonds and an overnight 
trypsin digestion. Tryptic peptides were analyzed by MALDI-TOF MS and the 
corresponding peptide mass fingerprintings (PMFs) were acquired (Figure 1.8). 
 
 
Figure 1.8. PMFs from MALDI-TOF spectra obtained from the excised bands from nuclear extracts 
after tryptic digestion. Nuclei 1= digest from lane 1 from the gel of nuclear extract; Nuclei 2= digest 
from lane 2 from the gel of nuclear extract 
 
The spectra were sent to databank search within the Swiss-Prot human proteome 
using Mascot as search engine and, in both cases, two proteins were significantly 
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identified, namely protein S100-A8 and histone H4. For both samples Mascot query 
results are shown (Figure 1.9). 
 
 
Figure 1.9. Databank search of nuclei sample number 1 (above) and number 2 (below) 
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Both proteins returned a score above the threshold set at 56 by the software and a 
sequence coverage higher than the 50% was calculated for all the proteins.  
For nuclei sample number 1, 8 peptides were recognized for protein S100-A8 (Figure 
1.10; on the left) and 7 for histone H4 (Figure 1.10; on the right).  
 
 
Figure 1.10. Protein view of S100-A8 protein (on the left) and histone H4 (on the right), for nuclei 
sample number 1 
 
For nuclei sample number 2, 7 peptides were retrieved for both protein matches 
(Figure 1.11).  
 
 
Figure 1.11. Protein view of S100-A8 protein (on the left) and histone H4 (on the right), for nuclei 
sample number 2 
 
To confirm proteins identification tandem mass spectrometry analyses were performed 
on selected peptides from the two proteins of the two bands and MS/MS spectra 
acquired to achieve the peptide sequencing. As example are reported the MS/MS 
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spectra of two peptides, one for each protein: precursor MH+=1180.600 corresponding 
to the sequence ISGLIYEETR contained between residues 47-56 of histone H4 (Figure 
1.12) and precursor at MH+=1421.700 corresponding to the sequence LLETECPQYIR 
(bearing a carbamidomethylation on the cysteine residue) contained between residues 
37-47 of protein S100-A8 (Figure 1.13). 
 
 
Figure 1.12. Precursor MH+=1180.600 Da corresponding to ISGLIYEETR sequence contained 
between residues 47-56 of histone H4 
 
 
Figure 1.13. Precursor MH+=1421.700 Da corresponding to LLETECPQYIR sequence contained 
between residues 37-47 of protein S100-A8 
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After the identities were confirmed for both samples, the searches were repeated 
including deimination of arginine as variable modification but any citrullinated peptide 
was retrieved. This was not surprising since arginine deimination causes a 0.984 Da 
mass increase and, if both modified and modified peptides are present, MALDI analysis 
is not able to separate them and search engine to discriminate their presence. 
These preliminary results revealed the specific recognition of a protein at around 11 
kDa by the sera of RA patients. Furthermore Western Blots performed with anti-H4 
antibodies suggested that the protein recognized might be histone H4 and the results 
obtained with anti-H4cit and anti-MC strongly supported the hypothesis that not only 
histone H4 was recognized by that it was carrying deimination sites. 
MS analysis confirmed in duplicates the presence of histone H4 but also highlighted 
the presence of protein S100-A8. It is a calcium binding protein endowed with pro-
inflammatory and regulatory properties, highly abundant in cytosol of neutrophils and 
monocytes.57 Although its levels are increased in RA sera, it has never been described 
as target of autoantibodies and it might be assumed that its presence in the band was 
due to a co-migration with histone H4 since they both share a similar molecular 
weight.58 
 
 
1.3.2 Derivatization o f citrullines with 2,3-butanedione and 
antipyrine  
MS analyses performed on a MALDI-TOF instrument clearly identified two proteins but 
no information regarding their deimination status were obtained. Comparing the 
different strategies described in literature for the detection of citrulline residues the 
derivatization technique with 2,3-butanedione and antipyrine was considered the most 
appropriate for our samples. The reaction involves two consecutive steps: first the 2,3-
butanedione reacts with the ureido group to form an intermediate which then, in 
presence of antipyrine, evolves into a final adduct having a mass increase of 238.11 
Da (Figure 1.14). 
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Figure 1.14. Modification of the ureido group of a citrulline residue by 2,3-butanedione and 
antipyrine31  
 
The reaction is extremely specific for citrulline residues when led in acid conditions that 
block the reactivity on the guanidinium group of arginine since in basic conditions the 
reaction is described specific for arginine. In the original work by Holm et al, it was 
observed that no side products were generated except for two signals at minus 1 Da 
and minus 2 Da from the derivatized mass, in the MALDI-TOF spectra of derivatized 
citrullinated peptides.30 Employing LC-ESI-MS analysis it was proved that such signals 
were artifacts generated during the MALDI ionization process since no corresponding 
chromatographic peaks were found, evidence that they were not chemical species 
produced during the reaction. Such signals however contribute to a characteristic 
isotopic peak of a derivatized citrullinated peak serving as an interesting marker.  
In a further study it was demonstrated that citrullinated peptides, derivatized with 2,3-
butanedione and antipyrine, once submitted to CID produce a worst fragmentation that 
impair the quality of the signals in the spectrum. In fact only a major signal is observed 
at 201.1 Da corresponding to an antipyrine fragment detached from the peptide.31 This 
might be another specific ion signature of citrullinated derivatized peptides but its 
generation results in a lack of b- and y-ions, greatly compromising peptide 
identification. 
In this thesis, in order to confirm the efficacy and specificity of the reaction the same 
experimental conditions described by Holm et al were used during an optimization 
phase with three citrullinated and not citrullinated standard peptides.  
Corresponding MALDI-TOF spectra were acquired. For all the citrullinated peptides 
tested, the reaction was proved to be effective and the typical isotope pattern 
previously described was observed. As example is shown a citrullinated peptide with 
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MH+=2218.730 that after derivatization acquired the increment of 238.11 Da showing a 
signal at 2456.590 m/z and a minus 2 Da signal at 2454.570 m/z (Figure 1.15). 
 
 
Figure 1.15. MALDI-TOF spectrum of a derivatized citrullinated peptide with original MH+=2218.730 
 
The reaction was proved to be specific when tested on several not citrullinated 
peptides primary on those containing arginine confirming that the experimental 
conditions were reliable to tag citrulline residues. The reaction was, furthermore, 
performed with decreasing concentrations of peptides from 1 nmol until 10 pmol and 
the MALDI signals were still clearly visible at this final concentration. It was important to 
check the detection limit of the instrument because the in vivo citrullinated peptides are 
supposed to be much less concentrated than 10 pmol and the results suggested that it 
was possible to detect even less concentrated peptides. 
It was interesting to note that the shape of the derivatizated citrullinated peptide slightly 
changed if decreased concentrations were used. The minus 1 and 2 Da signals 
exhibited different intensities, in some cases higher than the plus 238.11 Da signal. As 
example is reported the spectra of a citrullinated peptide that acquires a mass at 2537 
m/z after derivatization, at different concentrations. At 10 or 100 µM the pattern of the 
signals was as expected while at 1 µM it was almost covered by the minus 1 Da signal 
(Figure 1.16). As consequence the isotopic shapes of the same peptide were 
completely different. 
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Figure 1.16. Different shape of the isotopic pattern of a derivatizated citrullinated peptide at 
different concentrations 
 
Several mixtures of citrullinated and not citrullinated peptides at different 
concentrations were also tested confirming that the reaction was effective and specific 
even in more complex conditions.  
Additional optimization experiments were performed spiking 10 pmol of citrullinated 
peptide inside a protein tryptic digest trying to model a situation as much similar as 
possible to the expected in biological samples. Once MALDI spectrum was acquired, 
the low concentrated derivatizated citrullinated peptide became hardly visible, lost in 
the midst of a large amount of different and high intense peptides.  
It was evident that at low concentrations a purification step was necessary before the 
MS analysis. At first a SpeedVac concentration was performed reducing the volume up 
to 10 µl and then a purification step with Ziptip® was done to efficiently remove the 
reagents and concentrate the sample. This time, once the spectrum was acquired, the 
overall intensity of the peptides was enhanced and the signal of the derivatizated 
citrullinated peptide was tri-fold increased. 
All the reactions performed on the standard peptides confirmed the reliability of 2,3-
butanedione and antipyrine as reagents able to selectively and efficiently tag citrulline 
residues. An optimization of the experimental conditions, including a proper sample 
preparation for the subsequent MALDI-TOF analysis, was found to be crucial in order 
to delineate the better conditions for the analysis of the tryptic digests of the neutrophils 
nuclear extracts. 
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1.3.3 Identificat ion o f a citrull inated histone H4 peptide in  
nuclear extracts 
The derivatization technique with 2,3-butanedione and antipyrine was applied to the 
two samples from the reactive bands of neutrophils’ nuclear extracts and MALDI-TOF 
acquisitions were performed for both of them (Figure 1.17). 
 
 
 
Figure 1.17. MALDI-TOF spectrum of the tryptic digest from sample “nuclei 1” (above) and sample 
“nuclei 2” (below) 
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After a careful manual investigation of both the spectra, signals were observed at 
1720.893 m/z for one sample and at 1720.759 m/z for the other, that were absent 
before the derivatization (Figure 1.18). 
 
  
Figure 1.18. MALDI-TOF spectra of the tryptic digest from “nuclei 1” (on the left) and from “nuclei 
2” (on the right). For each sample a comparison is shown between the zoomed spectra in 
correspondence of the signal at 1720 m/z, before(above) and after(below) the derivatization 
 
These signals were compatible with a citrullinated peptide of mass 1482.703 m/z that 
achieves a mass of 1720 m/z after the derivatization step responsible of the 238.11 Da 
mass increase. The signals at 1720 m/z exhibited the typical isotope pattern of a 
derivatized citrullinated peptide with the minus 2 Da signal at 1718.933 m/z and 
1718.794 m/z. 
Through theoretic digestion of histone H4 it was possible to discover the existence of a 
possible citrullinated peptide with sequence DNIQGITKPAIRR and mass of 1482.814 
Da which might bear one deiminated arginine. Unfortunately the very low intensity of 
the signal prevented the precursor to be selected for subsequent fragmentation and 
confirmation of the peptide sequence was not obtained. The peptide sequence showed 
two arginine residues liable to deimination and simply from the mass value of the 
precursor it was not possible to assess which one contained the modification, requiring 
other strategies to be used.  
On the whole these MS data confirmed that H4 was deiminated, as initially highlighted 
by the Western Blot analysis and supported the hypothesis that RA serum had 
recognized this deiminated protein, among the neutrophils’ nuclear proteins. Indeed 
even if protein S100-A8 contains two arginines susceptible of deimination 
corresponding citrullinated peptides were not detected after derivatization. 
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1.3.4 Identifications of de iminated histone H4 contained in NETs 
of activated neutrophils  
After the preliminary results achieved with the nuclear extracts of neutrophils activated 
to produce deiminated histones, the attention was focused on the NETs that are 
structures containing a fraction of all the nuclear proteins. 
Granulocytes were isolated using the same approach previously described based on a 
gradient separation of blood on polysucrose solutions. Granulocytes cultures were in 
vitro stimulated with PMA to induce NETosis; proteins were isolated by DNase I 
digestion that allowed the release of the neutrophils proteins after having minced the 
DNA filaments of NETs. Proteins were acid precipitated, fractionated on TRIS Tricine 
SDS-PAGE and transferred to PVDF to perform the immunodetections with RA and 
control sera and purified IgG from RA and control sera. 
Interestingly, RA immunoglobulins as well as RA sera decorated bands around 11kDa 
and anti-deiminated H4 antibodies recognized a band at the same level; normal subject 
sera and immunoglobulins used as negative control were not reactive (Figure 1.19). 
 
 
Figure 1.19. RA sera and purified RA IgG binding to proteins from NETs of stimulated neutrophils. 
RA1 and RA2=sera from RA patients; NHS=normal healthy subject; RA IgG1 and RA IgG2= IgGs 
purified from RA patient’s blood by means of affinity chromatography on sepharose coupled to 
protein-G 
 
The band of interest was excised from different lines in order to enhance the protein 
quantity available for the trypsin digestion; the derived peptide mixture was analyzed by 
MALDI-TOF MS to acquire the corresponding PMF spectrum (Figure 1.20). 
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Figure 1.20. PMF MALDI-TOF spectrum obtained from the excised pooled bands from NETs after 
tryptic digestion 
 
A databank search was submitted setting the same parameters used in the previous 
search. It clearly returned the identification of histone H4 with a score of 76 which was 
widely superior than the threshold of 56 (Figure 1.21) and 6 peptides were correctly 
identified allowing a protein coverage of 40 % (Figure 1.22). 
 
 
Figure 1.21. Databank search of NETs sample 
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Figure 1.22. Protein view of histone H4, for NETs sample. 
 
Even in this case some peptides have been selected for the fragmentation even if the 
PMF was clearly compatible with histone H4; as example is reported the MS/MS 
spectrum of precursor MH+= 989.700, corresponding to the sequence VFLENVIR 
included between residue 61 and 68 (Figure 1.23). 
 
 
Figure 1.23. Precursor at 989.700 Da corresponding to VFLENVIR sequence contained between 
residues 61-68 of histone H4 
 
In order to clearly demonstrate the presence of deiminations in the histone H4 
recognized among the NETs proteins, the same derivatization strategy with 2,3-
butanedione and antipyrine was applied to the corresponding tryptic digest. 
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The sample, prepared in the proper optimized way, was analyzed through MALDI-TOF 
MS (Figure 1.24). 
 
 
Figure 1.24. MALDI-TOF spectrum of the tryptic digest from NETs sample 
 
Once again a signal at 1720.754 compatible with the peptide of sequence 
DNIQGITKPAIRR was found and the characteristic isotopic pattern with a signal at 
1718.875 was observed (Figure 1.25). 
 
 
Figure 1.25. Comparison of the MALDI-TOF spectra of the tryptic digest from NETs, zoomed at 
1720.754 m/z, before(above) and after(below) the derivatization 
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The MS data confirmed that deiminated histone H4 was the protein contained in the 
band from NETs sample, recognized by RA patients’ sera, purified IgGs from RA sera 
and commercial anti-cit H4 antibodies. In order to validate the reactivity of RA sera with 
H4, human purified H4 was in vitro deiminated by PAD4 and used as an antigen to 
measure IgG antibodies by ELISA assay. The binding of RA sera to deiminated H4 was 
significantly higher than the binding of NHS (p<0.005). On the contrary, no difference 
was observed with unmodified H4 tested with RA and NHS sera. 
Concerning the identification achieved by the processing of mass spectrometry data it 
is interesting to note that with NETs proteins no contamination from protein S100-A8 
was observed. NETs proteins constitute a subgroup of all the nuclear proteins and the 
acid extraction had provided a still more histones-enriched sample, reducing the 
contamination from other proteins. 
It is also noteworthy that the proteins obtained from NETs produced slightly 
Coomassie-stained bands, difficultly able to produce reliable MS spectra; therefore 
several co-localized bands from different lanes of the same sample were needed to be 
pooled, ensuring a better yield of tryptic peptides. 
The detection of citrulline residues by means of the chemical labeling strategy had 
allowed the individuation of a deiminated peptide from both of the samples, nuclei and 
NETs. This peptide had a mass of 1482.8 m/z that resulted compatible with the tryptic 
peptide DNIQGITKPAIRR included in the histone H4 sequence flanked by residues 25 
and 37. The derivatization technique had not distinguished which was the carrier of the 
modification, between the two arginines, therefore other strategies were required to find 
it out.  
 
 
1.3.5 Direct detection o f citrul line residues using LC-MS/MS 
strategies  
Peptide DNIQGITKPAIRR from histone H4 bears two arginines liable of deimination, 
representing the C-terminal of the peptide and its adjacent residue. It would be quite 
easy to discriminate the modification site simply considering the ability of trypsin to 
cleave deiminated arginines. Indeed if the cleavage was not allowed, the C-terminal 
position would be immediately discarded as possible modification site while in the 
contrary case deeper investigations would be necessary. 
Concerning this topic an explorative investigation was led performing a trypsin 
digestion on two couples of standard peptides containing a citrulline residue or not and 
in both cases the modified arginines were not cleaved. 
The signals at 1189.629 m/z and 844.470 m/z (Figure 1.26; top spectra) belonged to 
the two unmodified peptides cleaved at the arginine residue. Signals at 1190.613 m/z 
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and 845.454 m/z, expectable from their corresponding citrulline-containing peptides 
after the trypsin digestion, were not present in the spectra (Figure 1.26; low spectra). 
 
 
Figure 1.26. MALDI spectra of the two pairs of trypsin-digested peptides bearing a citrulline and 
not. Both of the spectra at the top belong to an unmodified peptide and the underlying spectra to 
their corresponding citrullinated form 
 
These results suggested that trypsin does not cleave deiminated arginines therefore C-
terminal citrullines should not exist. However these considerations would require the 
support of more systematic analyses, to be reliable. Unfortunately there is no trace of 
scientific literature systematically facing this topic but there are, on the contrary, 
conflicting opinions regarding it so that this shortcut cannot be used to map the 
citrullination sites and other strategies need to be explored. 
The scenario of the available proteomic technologies developed to highlight the 
presence of citrulline residues has been described in the introduction of this thesis. For 
our purpose LC-MS/MS analyses appeared as the most immediate and the most 
proper approach to characterize the deimination site of a peptide because the peptide 
sequencing allows a direct localization of the expected increment at amino acidic level. 
Anyway also the problematic aspects that could rise from such strategy were 
considered and weighted.  
Firstly, if considering that the two arginines liable of deimination are adjacent residues 
in the peptide sequence, the localization of the 0.984 Da increment at amino acidic 
level appears not so easy because the discrimination is limited on two single fragment 
ions. If position 36 represents the deimination site the b12 ion will be the discriminating 
signal whereas if residue 37 is the citrulline then the y1 ion will be the signal to 
consider.  
The second crucial aspect to be evaluated is the presence of the unmodified peptide 
and its possible interference in the characterization of the deimination. It has to be 
considered that PTMs usually spread into a very narrow fraction of the entire protein 
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population. Also for the deimination, the in vivo incidence of citrullinated proteins can 
be assumed to be low and, consequently, unmodified peptides arising from not 
citrullinated proteins not only are supposed to exist but also to be the widest fraction. 
Having established this aspect it is, now, important to understand if their presence 
could be a problem, above all considering that they are tryptic peptides. Whether 
trypsin proteolysis does not occur at the C-terminal of citrullines, deiminated peptides 
shall be completely different from their unmodified version because they will always be 
longer peptides due to the presence of the missed cleaved deiminated arginine. The 
sequence of unmodified peptide will be different from the citrullinated one, not 
representing a problem. If, instead, the cleavage of citrullines is allowed, two forms of a 
same peptide sequence could be awaited and this constitutes an aspect to be taken 
into account.  
Considering a real situation such as the one offered by the samples of interest in this 
project, namely the tryptic digests of the gel bands of the nuclear extracts and the 
NETs extracts, it became evident that the experimental conditions were even more 
complex than the theoretical ones. 
Indeed MALDI spectra of the samples and databank searches previously performed on 
corresponding PMFs, had disclosed the presence of the unmodified form of the 
deiminated peptide DNIQGITKPAIRR having the exact amino acidic sequence of its 
modified version and a decreased mass of only 0.984 Da. Worthy to note was that the 
unmodified peptide DNIQGITKPAIRR was the result of a missed cleavage of trypsin 
whose under 100% proteolytic efficiency is a well documented feature.  
The presence of the two peptides differing for that slight mass were argued by the 
skewed shape of the corresponding integrated MALDI signal. Indeed the monoisotopic 
peak corresponded to the monoisotopic of the unmodified peptide and the M+1 peak 
was the result of the M+1 peak of the unmodified summed up to the monoisotopic of 
the citrullinated one. According to the natural abundance of the elemental isotopes, 
each peptide isotope pattern is mass-dependent and the deriving peak shape is 
predictable. The peaks observed were symptomatic of overlapped signals because the 
M+1 peak was more intense than the monoisotopic one and this pattern was 
anomalous for that mass range.  
Summing up, in the spectrum of the digested band coming from neutrophils’ nuclear 
extracts the M+1 peak contained contributions from both the monoisotopic peak of the 
citrullinated peptide (1482.8) and the M+1 peak of the unmodified (1481.8 + 1) (Figure 
1.27). In the spectrum of the NETs the situation was even more complicated due to the 
presence of an unexpected signal at 1481.072 that summed up to the other two and 
that did not correspond to any histone H4 theoretical tryptic peptides. 
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Figure 1.27. MALDI spectra zoom around the peak of the peptide of sequence DNIQGITKPAIRR 
from digested band of one of the two samples from the nuclear extract (on the left) and NETs (on 
the right) 
 
These evidences pointed out that a collateral event, trypsin missed cleavages, was 
greatly enhancing the complexity of the topic by having produced peptides with similar 
chemical properties and slight mass difference.  
Such situation imposed new consideration to be formulated while approaching the LC-
MS/MS characterization of citrullines. Firstly a complete chromatographic separation of 
the two peptide forms was mandatory otherwise the mass spectrometer would have 
operated the co-selection of both precursors, for the subsequent fragmentation. Indeed 
the m/z window used for data-dependent analysis is not narrow enough to exclude one 
isotopic pattern from the other.29 Since peptides bearing the citrullination are supposed 
to be a minority fraction compared to the unmodified ones, if no separation is achieved 
the MS/MS spectra of the citrullinated would be contaminated by the presence of 
signals of the unmodified peptide. If there are misleading signals, besides more intense 
and able to cover the citrullinated-peptides' ones, the deimination site's characterization 
by means of a direct detection of the 0.984 Da increment would risk to be heavily 
undermined. Given that the MS/MS spectra represent the final tool to extract the 
information to discriminate the mass increment, the entire procedure would be 
dramatically invalidated. 
Altogether these considerations highlight that the characterization of the modification 
site is a rather challenging issue; an accurate work of spectral interpretation is 
mandatory and a specialized equipment able to ensure high analytical sensitivity and 
high data confidence is fundamental. 
Another topic interesting to be more extensively analyzed in our samples was the 
citrullination pattern of histone H4 in order to discover other possible modification sites 
whom the derivatization techniques did not point out. This aim is of great importance 
because the discovery of other possible deiminated peptides within histone H4 means 
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pointing out other possible citrullinated epitopes within the protein and such information 
can help a better qualification of the interaction with RA antibodies to be delineated.  
LC-MS/MS analyses provide more information than MALDI analyses for what concerns 
the complexity of a sample, by allowing the detection of low abundant proteins or low 
abundant peptides as the citrullinated are, because the methodology itself is more 
sensitive. 
In proteomics there is a huge need to reach a high analytical sensitivity in order to cope 
with quite frequent problematic aspects: limited sample amounts to handle, wide 
concentration variations of the molecules to analyze and specific targets to detect 
among an high complex sample (i.e low abundant deiminated peptides as in this 
context). A nanoLC-nanoESI configuration of the LC-MS/MS analyses is an important 
tool to fulfill this request since the electrospray ionization mechanism is concentration 
dependent.59 This means that reducing flow rates and the dimension of the system 
dramatically improve the sensitivity and, consequently, the detection range, that can be 
pushed up until sub-femtomole concentrations (Figure 1.28).60 
 
 
Figure 1.28. Change in response with incoming sample flow rate for LC/MS interface (on the left);  
flow and sensitivity gap between nano ESI and ESI (on the right)  
 
Indeed the charged droplets produced by the spraying process pander to subsequent 
fission events producing always smaller offspring droplets and the fission goes forward 
until a lowly charged residue is formed.61 At each fission a fraction of the ionizated 
analytes are set free but, unfortunately, another is lost in the residue of the initial 
droplet therefore the total ion yield is heavily affected. Instead in presence of flow rates 
smaller droplets are produced, the number of fission processes required to form mass 
spectral ions is reduced (“predominant fission pathway” theory) and so the loss of 
analytes is eased. Furthermore this process reduces the concentration of salts in the 
primary droplets available for MS analyses thus reducing the ionic suppression effect 
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they are responsible of.62,63 These aspects explain the very higher sensitivity of a nano 
configuration compared to standard analytical experimental conditions. 
Toward the purposes of this project a high performing instrumentation was required 
and an UltiMate® 3000 nanoHPLC system coupled to a LTQ-Orbitrap mass 
spectrometer equipped with a nanoESI source constituted a proper platform. The nano 
flow configuration and the precursors accurate mass detection provided by the Orbitrap 
analyzer ensure the system to be sensitive enough to supplement the information 
gained through the chemical labeling and hopefully deepen the characterization of the 
histone H4 citrullination pattern.  
LC-MS/MS analyses have been performed on a standard sample represented by a 
couple of a citrullinated and an unmodified peptide and on the tryptic digest coming 
from the NETs extracts that constitute the specific biological sample to be investigated. 
Two different set-up have been tested, namely reversed-phase liquid chromatography 
(RP-LC) and hydrophilic interaction liquid chromatography (HILIC), in order to evaluate 
their ability to provide the best experimental conditions to achieve the predetermined 
aims.  
 
 
1.3.5.1 Analysis on standard peptides 
Since a direct detection of deimination using the mentioned instrumental configuration 
strongly recommends a good chromatographic separation of citrullinated peptides from 
the quite similar unmodified versions an optimization of the method is necessary to 
maximize the selectivity. In order to be as much selective as possible several factors 
should be handled such as the nature and the composition of the eluent, the gradient 
used for elution and the temperature.64 However these factors require a systematic 
investigation to reach the ideal experimental conditions and a great amount of sample 
to be kept available for the analyses but enzymatic digestions of bands usually 
provides few tens of sample. 
Nevertheless, the selectivity is largely based on the stationary phases; each phase 
exhibits an own chemistry that makes possible interactions to occur on its surface. 
Since the sort of bond that analytes establish is dependent on both their reactive 
groups and the stationary phase’s ones, different supports can provide significantly 
different chromatographic behaviors by stimulating specific chemical reactivity and 
evoking different mechanisms of separation. These aspects are relevant because they 
finally indicate that a phase can be more selective than others for specific molecules, 
inherently being more proper to separate them.  
Taking into account all these considerations, the separation of deiminated peptides 
from their corresponding unmodified version had firstly implied an evaluation of their 
different chemical properties in order to find the way to amplify them as much as 
Chapter 1                                                                                                                                    Results and discussion
   
 
 
   45  
possible. Since arginine residues exhibit a positively charged guanidinium group that, 
after deimination, becomes a neutral ureido group, the challenge was to find the 
condition to maximize such a slight difference. 
RP-LC and ZIC-HILIC represents two orthogonal chromatographic separation methods 
(Figure 1.29) due to the opposed characteristics of their stationary phases that allow an 
inverted order of elution of hydrophobic/hydrophilic molecules. In RP the more 
hydrophilic components are the first eluted while in HILIC the opposite happens. 
Actually, in RP-LC analytes are separated by means of hydrophobic interactions 
according to combined processes of partitioning and adsorption of the solute molecules 
at the surface of the hydrophobic solid support, in presence of a mobile phase with 
increasing concentrations of organic modifier for the gradient elution.  
HILIC technology, instead, combines a normal-phase type of separation and uses an 
increasing water gradient for the elution. The surface of the HILIC hydrophilic phases, 
in presence of a water-deficient mobile phase, forms a water-rich layer where the 
analytes can absorb; this way a sort of liquid/liquid extraction system is created so that 
analytes are distributed between the two layers. In addition to these partitioning events 
important contributions are constituted by hydrophilic interactions arising from 
hydrogen bonding as well as dipole-dipole attractions and ionic forces. Compound’s 
polarity joined to the degree of solvatation of the surface of the phase constitutes the 
crucial aspects of the retention mechanisms. 
 
 
Figure 1.29. Interactions on RP stationary phase (on the left) compared to HILIC’s ones (on the 
right) 
 
For HILIC separations different types of polar stationary phases are available, each 
chemically bounded with specific polar functionalities which provide various retention 
capacities and selectivity to polar compounds. Basically three groups can be defined: 
neutral, charged and zwitterionic phases. 
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The first type does not engage electrostatic interactions, turning out to be as the less 
selective because of the failed exploitation of such forces that, instead, play an 
important role in the separation by contributing to the retention of polar analytes. 
As opposite, the charged and the zwitterionic phases make use of strong and weak 
electrostatic interactions, respectively. The charged ones require high ionic strength to 
elute the anchored compounds but the presence of high concentration of salt ions 
weakens the following MS detection reducing its sensitivity. Instead zwitterionic phases 
are characterized by the presence of positive and negative charges placed in close 
proximity each other and at a stoichiometric ratio.65 That chemical design allows 
weaker attractions to realize between the groups displayed on the material surface and 
the oppositely charged analytes so that an elution less invasive for the MS analyses is 
possible. Different types of zwitterionic phases exist, bearing distinctive selectivities 
toward polar compounds, according to the type and the spatial arrangements of the 
groups. These factors are responsible for the surface charge distribution on the phase 
and regulate the different interaction toward zwitterionic, neutral and charged 
compounds.  
For our purposes, the attractive feature of HILIC technology was its polar selectivity 
that made it suitable for the separation of molecules differing for the nature of a polar 
group.  
All these premises seemed to well fit with the intent of separation of a peptide from its 
deiminated form, since both the guanidinium and the ureic group had polar 
characteristics. Moreover the guanidinium shows a permanent positive charge that can 
be the anchor to selectively retain the unmodified peptide to the HILIC support through 
a ionic interaction that the citrullinated peptide is, instead, not able to support. This was 
the rationale of having chosen a HILIC stationary phase as alternative to a reversed-
phase, in order to separate citrullinated peptides from the corresponding non-
citrullinated form.  
The zwitterionic HILIC stationary phases appeared as the most appropriate for the aim 
of this project; in particular, ZIC®-HILIC columns, bearing a betaine-sulfonate function 
with a positively charged quaternary ammonium and a negatively charged sulfonic 
group (Figure 1.30), were chosen for the analyses. 
 
 
Figure 1.30. ZIC-HILIC bonded with sulfobetaine group 
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Taking into account all the previous considerations, RP and ZIC-HILIC® stationary 
phases were tested using a pair of a citrullinated and an unmodified peptide, as model 
for evaluating their behavior in presence of chromatographic orthogonal conditions. 
For RP-LC an equimolar mixture of a deiminated peptide (Mr=2297.2088) and the 
corresponding not modified (Mr=2296.2248) was prepared in an aqueous buffer at a 
final concentration of 4.3 pmol/µl for each peptide. The miniaturized configuration of the 
system allowed the injection of just 1 µl of sample which first flowed to a C18 guard 
cartridge for the concentration step and then to the C18 column for the separation in a 
30 minutes gradient. The LTQ-Orbitrap mass spectrometer was set up to work with the 
high resolution (HR) of the Orbitrap analyzer for the full scan acquisition while the 
precursor selection and the detection of the ion fragments were committed to the LTQ 
analyzer. The instrument operated in data-dependent mode performing the 
fragmentation of the three most intense precursors from each full scan. 
The base peak chromatogram of the peptide binary mixture (Figure 1.31) showed a 
consistent chromatographic separation of the two molecules that exhibited retention 
times of 33.24 and 34.06 min. This result highlighted that the hydrophobic selectivity of 
the C18 stationary phase had been able to retain the citrullinated peptide for a 
sufficient time to realize a separation. 
 
 
Figure 1.31. Base peak chromatogram of the two peptides under RP-LC and a zoom around their 
elution time 
 
The HR mass detection of precursors (Figure 1.32) clearly assigned the first peak to 
the unmodified peptide (M3+=766.41 and M2+=1149.12) with the citrullinated one 
(M3+=766.74 and M2+=1149.61) eluted on tail of the other. 
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Figure 1.32. The HR-MS scan of the triple and double charged unmodified peptide (upper spectra) 
and the triple and double charged of the citrullinated (lower spectra) 
 
The elution order agreed with the slightly lower hydrophobicity of arginine-containing 
peptides compared to the citrullinated ones resulting in a weaker interactions with the 
stationary phase and a faster elution from the column. However in the scans of the 
citrullinated peptide there was still a contribution from the unmodified peptide even if at 
a very low intensity, as evident from the presence of the signals at 766.41 Da and 
1149.12 Da in the peak of the M3+ and M2+ of the citrullinated peptide. This indicated 
that the delay of around 40 seconds between the retention times of the two peptides 
was not enough to ensure a complete chromatographic separation. 
Analyzing the CID spectra of two double-charge precursors of the two peptides (Figure 
1.33) it was evident that citrullinated peptide had gone through a minimum backbone 
cleavage, with the major part of fragment signals mingling in the background noise.  
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Figure 1.33 CID spectra of a doubly-charged precursor of the unmodified peptide (above) and of 
the citrullinated one (below) 
 
This behavior aligned with Hao's findings who first observed this phenomenon 
analyzing synthetic peptides by ESI tandem MS, as mentioned in the introduction of 
this thesis.66 
He also discovered a specific rearrangement that takes place within citrullinated 
peptides during CID fragmentation. That rearrangement guides the release of isocyanic 
acid from the side chain of citrullines, through a process that competes with backbone 
fragmentation and that accounts for a specific neutral loss of 43 Da. In accordance to 
this evidence, CID spectra of our standard citrullinated peptide exhibited exclusive 
signals ascribable to b and y fragments with a 43 Da loss but they were really a few. 
 
After RP analysis the same peptides were submitted to the HILIC analysis using a 
different preparation of the sample due to the opposite features of the method. 
Peptides were prepared in organic buffer containing 90% acetonitrile at the same final 
concentration of 4.3 pmol/µl.  
HILIC columns require a quite long conditioning phase with high percentage of organic 
solvents because hydrophilic surfaces are proved to hold the water when exposed to 
mixtures of high concentrated organic solvent and low concentrated water. And the 
creation and maintenance of this water-enriched layer partially immobilized on the 
surface is essential because it constitutes the place where interactions with molecules 
realize and separation happens. Therefore an extended chromatographic method has 
been created including a conditioning phase of 50 min at the end of each run, to re-
establish the initial condition of the column.  
Peptide mixture analyzed this way produced a good separation of the two forms as 
evident from the corresponding base peak chromatogram (Figure 1.34) where the two 
main peaks at 64.86 and 71.10 minutes corresponded to the two forms. 
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Figure 1.34. Base peak chromatogram of the two peptides under HILIC conditions and a zoom 
around their elution time 
 
This stationary phase was able to produce a wider separation compared to the RP, 
with a temporal delay of more than 6 minutes between the first eluting peak that 
belonged to the citrullinated peptide and the second to the unmodified. Both of the 
signals presented a marked peak tailing which is a common drawback of HILIC 
technology probably due to the double mechanism of retention (partitioning and 
electrostatic interactions) which analytes are submitted to and which is responsible for 
a non homogeneous behavior toward the stationary phase. CID spectra of both 
peptides resembled those obtained in RP with the citrullinated ones showing a minimal 
fragmentation, confirming that the loss of the positive charge has a pronounced effect 
on both the ionization and the fragmentation, as already demonstrated by others.66,67  
The analyses performed with RP-LC and HILIC on the couple of a citrullinated and the 
corresponding arginine-containing peptide revealed a good separation, especially on 
the hydrophilic surface, representing an interesting starting point for the analyses of the 
NETS digest. It has to be noticed that standard peptides represent an ideal sample for 
the low complexity and the great amount of the analytes available for the analysis while 
typical proteomic sample present opposite characteristics. 
 
 
1.3.5.2 RP-LC analysis of NETs digest 
The same instrumental set-up used for the analysis of standard peptides was applied 
to the analysis of the NETs digest and the corresponding LC-MS/MS data were 
processed using the software Xcalibur 2.0.7. As previously described the first aim of 
Chapter 1                                                                                                                                    Results and discussion
   
 
 
   51  
the RP-LC analysis on this sample was to achieve a chromatographic separation of the 
citrullinated peptide DNIQGITKPAIRR (MH+=1482.80) from its unmodified version 
(MH+=1481.80), in order to characterize the exact deimination position. MALDI analysis 
had anticipated the presence of a contaminating peptide (MH+=1480.80) having a 
minus 1 Da mass than the unmodified, thus suggesting to take it into account, too. 
Therefore, in order to evaluate the respective retention times of the three peptides, 
three extracted ion chromatograms (XICs) corresponding to the double-charged 
unmodified peptide (M2+=741.42), the citrullinated (M2+=741.92) and the contaminating 
peptide (M2+=740.92) were extrapolated. 
Due to the close proximity of the three mass values, for each XIC a narrow window of 
0.2 Da was selected trying to exclude the contribute coming from the other two 
peptides. Unfortunately the mass differences among them were not wide enough to 
prevent the algorithm to extract the second or third isotopic peak of the others when 
these converged with the monoisotopic peak of the precursor of interest (Figure 1.35). 
 
 
Figure 1.35. XICs of the unmodified peptide with M2+=741.42 (panel A), the citrullinated with 
M2+=741.92 (panel B) and the contaminant with M2+=740.94 (panel C) 
 
Therefore the XIC of the unmodified peptide (Figure 1.35, panel A) contained also the 
contribute coming from the 13C isotopic peak of the contaminant peptide; the XIC of the 
citrullinated peptide (Figure 1.35, panel B) extracted also the second isotopic peak of 
the unmodified peptide and the third peak of the contaminant. The XIC of the 
contaminant peptide (Figure 1.35, panel C) was the only “pure” XIC due to the fact that 
its monoisotopic mass did not overlay to any isotopic peak of the others. 
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Through comparison of the three XICs it was possible to associate the peak with 
retention time 27.91 to the unmodified peptide, the one at 28.32 to the citrullinated and 
that at 28.91 to the contaminant peptide. From the XIC of the citrullinated peptide which 
contained contributes from all the three peptides it was evident the higher amount of 
the unmodified peptide compared to the other, as should be expected. 
From the analysis of the three XICs one major consideration emerged: not only the 
citrullinated peptide was not separated from its unmodified version as good as had 
happened to the standard peptides but it also eluted in the middle of the unmodified 
and the contaminant peptide. MS full scan acquired at the beginning, at the middle and 
at the end of the citrullinated peptide’s peak showed that it never eluted alone but in 
presence of the unmodified until the apex of the chromatographic peak and together 
with the contaminant at the end (Figure 1.36). 
 
 
Figure 1.36. XIC of the citrullinated peptide. Full  scans, zoomed on the mass of interest, acquired at 
the beginning, at the middle and at the end of the peak of the citrullinated peptide 
 
The further step involved the analysis of the MS/MS spectra of the three precursors but 
a really unpredictable situation was unraveled. Indeed there was a complete 
disagreement between the theoretic fragment ions expectable from the peptide 
DNIQGITKPAIRR and the experimental signals observed which, on the contrary, 
perfectly fitted with the peptide RDNIQGITKPAIR (Figure 1.37, above). 
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Figure 1.37. MS/MS spectra fitting with the sequence RDNIQGITKPAIR (above); theoretic b and y 
ion series of the two sequences (below) 
 
It meant that the sequence who had attracted all the attention until now was not 
DNIQGITKPAIRR identified after databank search of the previous MALDI spectra but 
corresponded to the isobaric RDNIQGITKPAIR. 
The two peptides mostly covered the same region within histone H4 except that the 
first was included between residues 25-37 and the second between 24-36. However, 
even if the sequence was almost similar, the resulting fragmentation pattern was 
completely different (Figure 1.37, below), making undoubted the interpretation of the 
MS/MS spectrum. 
Furthermore they were isobaric peptides due to the presence of the same amino acids 
located in a slight different position. Moreover the sequence RDNIQGITKPAIR was not 
a tryptic peptide and thus it could not be predicted through a theoretical trypsin 
digestion of histone H4.  
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Arginine 24 wss preceded by a leucine residue which is not recognized by trypsin but 
by chymotrypsin which mainly recognizes hydrophobic sites. The trypsin preparation 
used for the digestion had an extractive origin since it comes from porcine pancreas 
and residual chymotrypsin is known to occur, acting as a contaminant agent. Therefore 
RDNIQGITKPAIR peptide could be the result of a combined activity of both of the 
enzymes, producing a semitryptic peptide exhibiting C and N-terminal Arginines. The 
presence of non-specific peptides after tryptic digestion seems to be not unusual 68,69 
and a specific bioinformatic tool called FindPept 70 that works on peptide mass 
fingerprinting data to search peptides rising from unspecific cleavages, had been 
developed by Expasy.71,72 
The three peptides shared the same fragment ions indicating they all had the same 
amino acidic sequence; however the contaminant peptide brought a modification 
responsible for the 1 Da mass decrease compared to the mass of the unmodified. Its 
MS/MS spectra (Figure 1.38) showed that all b series ions were 1 Da lower than those 
corresponding to the unmodified while the y series was the same. This behavior 
suggested that the modification responsible for the 1 Da decrease was located at the 
Aspartate residue thus provoking a shift in all the b series but not affecting the y series; 
an amidation of the residue could be an explanation. 
 
 
Figure 1.38. MS/MS spectrum of precursor 740.92 Da. Signal tagged with * are decreased of 1 Da 
 
Whatever the modification this peptide was bringing the point was that it behaved as an 
interfering molecule because its elution time was very close to the citrullinated’s one 
and the negative consequences rising from that situation has been previously depicted. 
In order to face the real purpose of these LC-MS/MS analyses all the MS/MS spectra of 
precursors at 741.9 m/z (namely the citrullinated peptide) were extrapolated and an 
accurate spectral interpretation was led, trying to establish the deimination site. As 
starting point double or triple charged fragment ions were not considered reliable since 
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fractions of 0.984 Da, which was itself a slight variation, may not be well appreciated 
nor distinct from the experimental bias of the low resolution analyzer. For this reason 
only the MS/MS spectra of double-charged precursors were extracted and only mono 
charged ions were evaluated (two spectra corresponding to triple-charged precursors 
were not considered). 
With these restraints only three spectra were available for the analyses probably for the 
close elution of deiminated peptides with the others and for their low concentration, that 
had reduced the probability for such precursors to be selected for the fragmentation. 
Each scan was analyzed in order to find fragment signals to be considered diagnostic 
of the presence of the citrulline. These did not correspond any more to the ones 
anticipated in the introduction since the amino acidic sequence has been proved to be 
different. The sequence RDNIQGITKPAIR brought the arginine residues at opposite 
positions so the presence of citrulline at N-terminus should produce a b-series 
completely shifted 0,984 Da while if present at C-terminus the same shift should 
involve the y-series. For the scan 2161 and 2157 a great part of the b series was 
increased of 0.984 Da and for scan 2097, even if the coverage was slightly lower, a 
similar trend was observed (Figure 1.39). 
 
 
Figure 1.39. MS/MS spectra of the citrullinated peptide. Signal tagged with * represent the 
diagnostic peptides 
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However it should be noted that that for all the spectra the fragment ions presented 
signals of quite low intensity, some of which slightly higher from the background noise. 
This was partly due to the low amount of citrullinated peptides that reflected the low 
sampling rate of the fragment ions by means of the analyzer and partly due to the 
resistance of citrullinated peptide to go under fragmentation. 
More carefully looking at the spectra it was also noticed that there were some b 
fragment ions that did not contain the increment and there were also one or two y ions 
increased of 0.984 Da. In order to find possible explanations for such behavior MS/MS 
spectra of the standard citrullinated peptide (Mr=2297.2088), previously analyzed by 
means of RPLC-MS/MS run, were re-analyzed since they represented a good model to 
extrapolate useful information. The peptide, indeed, contained, two arginines in the 
amino acidic sequence and the deimination site was known therefore the b and y 
fragment ions with the expected increment were predictable. Despite this, it could 
possible to highlight in the spectra both signals with an increment when not expected 
(expected, instead, if the other arginine was deiminated) and few signals without the 
increment when awaited. 
Having found a similar behavior for both the standard citrullinated peptide and the one 
from the NETs tryptic digest was a confirmation that the low concentration and the 
contamination from the unmodified peptide were factors able to create tangible 
complications in the final interpretation of the spectrum. 
Taking into account all the considerations exposed in this discussion it was concluded 
that the RP-LC analysis of the NETs digest had not been able to provide completely 
satisfactory results, concerning the unraveling of the exact deimination site of peptide 
RDNIQGITKPAIR. However in all citrullinated spectra the b series showed the majority 
of signals bearing the 0.984 Da increment, perhaps indicating that the deimination site 
was located on arginine 24. Other analysis were absolutely required, using the HILIC 
stationary phase firstly trying to reduce the negative contribution rising from the 
interfering peptides. 
 
Before approaching other strategies LC-MS/MS data were analyzed to search for other 
possible deiminated peptides; in particular the Xcalibur raw data was processed using 
the software Raw2MSM which creates MGF peak list files, ready to be directly 
submitted to data bank search. This was led within the human proteome of the 
SwissProt database, imposing semitrypsin as enzyme, deamidation (R) and oxidation 
(M) as variable modifications and carbamidomethylation (C) as fixed modification.  
The first result was the identification of histone H4 with 15 peptides as top scoring 
match and then other proteins identified by means of at least 2 peptides such as 
histone H3.1t and S100-protein isoforms. The identification of proteins that had not 
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emerged by the peptide mass fingerprinting strategy is not surprising considering the 
higher analytical sensitivity of the LC-MS/MS system (Table 1-I). 
 
 
Table 1-I. Identified proteins from NETs digest after database search 
 
Histone H4 sequence coverage was elevated but not complete (Figure 1.40). There 
were no information regarding the N-terminal region of the protein, where the close 
presence of arginine and lysine had caused a massive cleavage by trypsin, releasing 
peptides too short to be detected by the instrument. 
 
 
Figure 1.40. Histone H4 sequence coverage. Underlined residues are those identified 
 
Database search of citrullinated peptides confirmed the identification of the citrullinated 
peptide RDNIQGITKPAIR; it is interesting to note that all but one of the MS/MS spectra 
previously extrapolated from the raw data were found by the search algorithm, correctly 
identified and able to address Arg25 (N-terminal of the peptide) as the modification site. 
The exception was the scan 2097 that was identified below the score indicating a 
difficulty of the search engine to correctly assign the modification. Nevertheless the 
scan 2097 had been previously found to be the most problematic for the presence of a 
lower number of b ions signals containing the increment compared to the y ions, 
therefore the underscored identification might be the result of such unclear spectrum. 
Within all the identified proteins the algorithm highlighted the presence of two further 
putative candidates citrullinated peptides: DNIQGITKPAIR (M2+=663.865) from histone 
H4 and KLPFQR (M2+=395.231) from histone H3.1t (Figure 1.41). 
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Figure 1.41. List of peptides identified from Histone H4 (above) and from Histone H3.1t (below); 
deamidated peptides are enclosed. Individual ions scores > 35 indicate identity or extensive 
homology (p<0.05) 
 
These peptides ought to contain the putative citrulline at the C-terminus, thus assuming 
a trypsin cleavage, but in both cases the identifications were below the threshold score 
that meant that they were not completely reliable. Since even for the scan 2097 of the 
peptide RDNIQGITKPAIR there has been an underscored identification of a deiminated 
peptide it was important to check the quality of the MS/MS spectra of these two 
peptides, like it has been done with peptide RDNIQGITKPAIR. Moreover, given that the 
presence of the peptides with a mass increase of 1 Da compared to the unmodified 
forms has been highlighted, it was also very interesting to figure out which other 
modification might be the responsible of such increase, if not the deimination. 
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Mass ranges were extracted around the value of the unmodified peptide 
DNIQGITKPAIR (M2+=663.373) and the peptide bearing the increment (M2+=663.873). 
The chromatographic behavior showed the latter eluting in tail of the unmodified and a 
partial overlap was evident between their isotopic patterns (Figure 1.42). 
 
 
Figure 1.42. XICs of the peptide DNIQGITKPAIR and its modified version, including the 
corresponding integrated mass scans 
 
Peptide DNIQGITKPAIR is included in the sequence 25-36 of histone H4 as result of 
trypsin activity with no missed cleavage and it is a great part of the region covered by 
the peptide RDNIQGITKPAIR. MS/MS spectra of the couple of peptides 
DNIQGITKPAIR highlighted the absence of a great part of the mono charged ions of 
the b series making not possible the detection of eventual amino acidic differences 
within this series (Figure 1.43). 
 
 
Figure 1.43. MS/MS spectra of DNIQGITKPAIR peptide (above) and its modified form (below) 
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Instead the y series presented several signals shared with the unmodified peptide 
whose presence had masked signals rising from the modified peptide. Only the signal 
y10 contained an increment of 0.984 Da but the intensity of the signal was too low to be 
trustable.  
Therefore, even in this case MS/MS spectrum did not provide a final answer 
concerning the exact modification site within the peptide of interest. The incomplete 
chromatographic separation of unmodified and modified peptides heavily impaired the 
interpretation of the MS/MS spectrum of the modified peptide. 
Similar consideration rose from the other peptide KLPFQR (M2+=394.74) whose 
modified version with the mass increment of 1 Da (M2+=395.23) was evident from the 
MS scan extracted by the XIC (Figure 1.44). 
 
 
Figure 1.44. XICs of the peptide KLPFQR and its modified version, including the corresponding 
integrated mass scans 
 
In order to check the presence of the modification at amino acidic level MS/MS spectra 
of unmodified and modified peptides were compared (Figure 1.45).  
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Figure 1.45. MS/MS spectra of KLPFQR peptide (above) and its modified form (below) 
 
In this case looking at the y series it was found the presence of the increment starting 
from ion y2 that was compatible with a glutamine deamidation, which might have been 
the responsible for the 0.984 Da mass increase observed in the precursor. 
Considering the retention times of the peptides with sequence RDNIQGITKPAIR, 
DNIQGITKPAIR and KLPFQR it was clear that they all eluted in the same temporal 
window crowding the full MS scan with a lot of precursors. In particular within the 
retention time of the citrullinated peptide RDNIQGITKPAIR (M2+=741.93) other 
precursor were present such as DNIQGITKPAIR (M2+=663.33) and the majority of them 
showed signals of higher intensity (Figure 1.46). 
 
 
Figure 1.46. XIC of the citrullinated peptide (above) and full MS scan rising from the integration of 
the chromatographic peak of the citrullinated peptide (below) 
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Since the MS method is set to send to the collision cell only the three most intense 
precursor ions and being the citrullinated peptide RDNIQGITKPAIR the less intense 
among them it was sampled few times as evident from the only three MS/MS spectra of 
double-charged precursors selected for the fragmentation. This situation explained well 
which is the essential difficulty in the detection of low abundant peptides. 
In conclusion these LC-MS/MS analyses performed on the NETs digest using a RP 
stationary phase provided very useful information concerning the peptide that had been 
found to be citrullinated with the derivatization technique: 
• MS/MS spectra of the citrullinated peptide revealed that the amino acidic 
sequence was not the one expected (DNIQGITKPAIRR) but it was slightly 
different (RDNIQGITKPAIR) because of a combined trypsin-chymotrypsin 
activity that produced a semi-tryptic peptide. This discovery moved the attention 
from residues 36 and 37 to residues 24 and 36 as possible deimination sites.  
• The contaminant peptide with MH+=1480.072, as shown by MALDI spectrum, 
was proved to be related to the citrullinated and the unmodified peptides 
because sharing the same amino acidic sequence and probably bearing an 
amidated aspartic acid. 
• The three peptides eluted in a narrow temporal window revealing that an 
uncompleted chromatographic separation had realized; moreover several 
peptides eluted together with the citrullinated one thus reducing the probability 
for this to be selected for the fragmentation.  
• Only three useful MS/MS spectra could be extrapolated for the citrullinated 
peptide RDNIQGITKPAIR and a spectral interpretation was approached. 
However the very low intensity signals combined with the contamination from 
the unmodified peptide hindered an undoubted assignment of the deimination 
site. The MS/MS spectra seemed more compatible with the presence of a 
deiminated Arg24 instead of the Arg36 but deepen analyses were required. 
Interesting results came from the processing of the same analyses in order to highlight 
the presence of other citrullinated peptide: 
• The database search confirmed the identification and the assignment of the 
citrullinated peptide RDNIQGITKPAIR, indicating Arg24 as the deimination site; 
for one scan the results were unclear demonstrating that the identification of 
this PTM is very difficult even when performed by bioinformatic tools. 
• Two further peptides (DNIQGITKPAIR from Histone H4 and KLPFQR from 
Histone H3.1t) were found to be possibly deiminated but the underscored 
identifications necessitated a manual analysis of the spectra. Once again the 
partial co-elution of the unmodified peptide from the modified one was the 
biggest hinder for a correct assignment. For peptide KLPFQR partial indications 
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suggested that the modification was not the arginine deimination but the 
isobaric glutamine deamidation. 
An aspect that clearly emerges from these analyses is the real difficulty in the 
characterization of low expressed components such as peptides bearing a 
modification, spread inside a complex sample that provides interfering molecules. LC-
MS/MS analyses had identified few scans for each of the modified peptides 
(deiminated or deamidated). On one hand this proved the high sensitivity of the 
employed system but on the other hand it highlighted the importance to take care of 
this small number of scans and carefully analyzing the spectra to catch all the 
information they bring. 
 
 
1.3.5.3 HILIC analysis of NETs digest 
The rationale behind the use of HILIC standard phase for the separation of citrullinated 
peptides from the unmodified forms had been already described. 
In RP the modified peptide RDNIQGITKPAIR eluted after the unmodified thanks to its 
slightly higher hydrophobicity that resulted in a longer retention by the phase, even if 
not enough to allow a complete chromatographic separation. 
Since the citrullinated and the unmodified peptides share similar polar properties a 
polar phase such as the ZIC-HILIC® ought to be more incisive than an hydrophobic 
phase in their separation. Moreover the orthogonality of the two configurations ensure 
an opposite order of elution of the peptides so that, with HILIC, citrullinated peptides 
elute before the unmodified. This aspect might be advantageous because the very first 
part of the chromatographic peak of the citrullinated peptide should not suffer the 
contamination from the unmodified expected to elute later. So if few citrullinated 
precursors can be isolated for the fragmentation there is the possibility to have “pure” 
MS/MS spectra available for a final certain interpretation of the fragment ions pattern. 
The sample to submit to these analyses needed to be properly prepared in an organic 
medium being water the elution buffer. The tryptic digest contained a saline solution of 
ammonium bicarbonate therefore it was dried and redissolved in 90% MeCN. 
The same instrumental set-up adopted for the standard peptides was used.  
XICs for the three forms of the peptide RDNIQGITKPAIR were extrapolated in order to 
check their chromatographic behavior. The XIC of the peptide containing a putative 
amidated aspartate represented the reference chromatogram because it did not 
contain any contribute coming from the other (Figure 1.47, panel A). From its shape it 
was clear a feature already seen for the standard peptide that was the peak tailing 
even if in this case a general large peak width was observed. 
This was a really unwanted aspect which even other peptides were supposed to suffer.  
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XIC of the unmodified peptide (Figure 1.47, panel B) showed a massive overlapping 
with the previous one but they were not the analytes target of the analyses therefore it 
was not a great problem. XIC (Figure 1.47, panel C) of the citrullinated peptide, 
instead, showed an extra peak before them, as expected. 
 
 
Figure 1.47. XICs of the contaminant peptide with M2+=740.94 (panel A), the unmodified with 
M2+=741.42 (panel B) and the citrullinated with M2+=741.92 (panel C) 
 
At a first glance it clearly emerged that the desired separation between the citrullinated 
peptide and the unmodified version substantially did not take place mainly because of 
the mentioned marked band broadening responsible of an excessive chromatographic 
dispersion of the analytes. To retrieve more detailed information, full MS scans were 
extracted sampling various retention times in correspondence of the peak of the 
citrullinated peptide (Figure 1.48). 
 
 
Figure 1.48. Full MS scan at different retention times, within the peak of the citrullinated peptide 
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Looking at the extracted scans it was clear that the citrullinated peptide did not ever 
eluted alone but there was always a minimum contribution from the other two species. 
At retention time of 48.61 min the citrullinated peptide was flanked by a small amount 
of the unmodified whose intensity increased so that at 49.45 min reached the intensity 
of the citrullinated and at 49.60 passed it. In the mean time even the peptide with 
suspected amidated aspartate grew in intensity from 49.21 min when it was barely 
visible until 49,60 when its amount become relevant. As consequence of this repeated 
incomplete chromatographic separation, the corresponding MS/MS spectra of the 
citrullinated peptide were supposed to be greatly contaminated by the signals of the 
unmodified and contaminant peptides. 
Three MS/MS spectra of double and triple-charged precursors at 741.9 m/z could be 
extracted from the chromatogram and an anomalous situation was observed. 
The interpretation of the extracted MS/MS spectra pointed out that an isobaric peptide 
of the citrullinated RDNIQGITKPAIR was also present, namely the peptide with 
sequence TVTAMDVVYALKR that in presence of an oxidized methionine acquired a 
mass of 1482.798 Da. Since they shared the same mass and eluted in the same 
moment both were selected for the fragmentation and the subsequent MS/MS 
obviously contained contributions from both of them. Moreover the precursor selected 
was a triple-charged one so it was not useful. 
Only one MS/MS spectrum (scan 5328) did not contain signals from the peptide 
TVTAMDVVYALKR but, unfortunately, it corresponded to a retention time of 49.54 min 
which was a critical chromatographic region because of the elution of both the 
unmodified and the contaminant peptide. Accordingly, there were very few signals with 
the increment of 0.984 Da so that it was not possible to extrapolate the exact 
deimination position (Figure 1.49). 
 
 
Figure 1.49. MS/MS spectrum of the precursor at 741.91 Da of the RDNIQGITKPAIR sequence; §=b1 
ion from the peptide at mass 740.9 Da 
 
Chapter 1                                                                                                                                    Results and discussion
   
 
 
   66  
In this case, more than in the previous RP-LC analysis, contaminations from the other 
similar peptides were consistent and masked the incremented signals of the 
citrullinated peptide thus hindering its interpretation. So the same problems pointed out 
with RP-LC-MS/MS analysis, once again, emerged. This time there was a further 
problem created by the peptide TVTAM*DVVYALKR co-eluting with the isobaric 
citrullinated RDNIQGITKPAIR peptide.  
Corresponding MS/MS spectra resulted heavily contaminated. 
It should also be noticed that the sample preparation required for HILIC analysis had 
imposed steps of drying and re-suspension that could have affected peptide recovery. 
In order to check if, after such preparation, the citrullinated peptide was still present in 
the sample in a sufficient amount to be detected, further runs was performed changing 
the MS method, in particular, the scan events cycle. LTQ analyzer was set to work in 
the top 2 configuration that contemplated a data-dependent isolation of the precursors 
to be fragmented in the first two selections and a targeted isolation of the citrullinated 
peptide in the third selection. This kind of setting augments the sensitivity toward the 
precursor of interest and it is particularly useful in presence of low abundant peptides 
that otherwise would be rarely selected in a data-dependent mode. With this analysis a 
large number of MS/MS spectra of precursors of mass 741.9 Da corresponding to the 
citrullinated peptide were extrapolated, thus indicating that the peptide was present and 
with such MS method that had imposed its selection it was possible to highlight its 
presence. However, extracting the XIC of both the citrullinated and the unmodified 
peptides became evident that no separation between the two forms had realized while 
in the previous analysis a minimum separation was observed. 
Full MS scan showed that all the three peptides RDNIQGITKPAIR were eluting at the 
same retention time without any sign of retention by the HILIC stationary phases and 
also the base peak chromatogram was poor of peaks, altogether suggesting that a 
chromatographic trouble had happened. 
This was confirmed by comparing the base peak chromatogram of a standard BSA 
digest that was run twice in the same sample sequence, one at the beginning and one 
at the end, in order to provide information regarding the reproducibility of the method. A 
robust and reliable chromatographic method should provide reproducible results inter- 
and intra-analysis unless some unexpected events took place instead those 
chromatograms showed that something had gone wrong. Indeed the same sample 
showed different retention times not only compared to the previous analysis but also 
within the same sample list (Figure 1.50) indicating that the system was not robust in 
the operative mode it was working. 
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Figure 1.50. Base peak chromatogram of the standard BSA digest at the beginning of the sample 
list (above) and at the end (in the middle) and from the previous analysis (below) 
 
It is known that a chromatographic system based on HILIC stationary phase is a 
sensible system due to the extremely long time of reconditioning of the column required 
to ensure the mechanisms of retention to correctly take place. From the comparison of 
the BSA analysis run at the beginning and at the end of the sample list it was evident 
that in the first case a poor separation of the peptides had realized while at the end it 
was greatly enhanced. 
The missed separation regarded also the other two peptide of interest, namely 
DNIQGITKPAIR and KLPFQR, whose XICs revealed a similar situation. 
In conclusion all the HILIC analysis performed on the NETs digest turned not to be 
equal to the expectation due to the combination of the failed chromatographic 
separation and of collateral issues which prevented the prefigured purposes to be 
achieved.  
The aims of making a direct detection of citrullines by means of LC-MS/MS analysis 
has faced consistent problems, the most important of which was the interfering from 
unmodified peptide. The analysis on the standard peptides demonstrated to be 
successful when HILIC phase was used while, once employed on the real samples, it 
failed. Further evaluations concerning the real applicability of this technology for our 
purposes will be necessary. 
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1.4 CONCLUSIONS 
 
RA sera contain a variety of autoantibodies but those specific for citrullinated antigens 
are of utmost interest, being highly specific for the disease, probably endowed with 
pathogenic potential and possibly related to the basic mechanisms of the disease.  
Several lines of evidence indicate that histone deimination is the result of PAD4 
activity. It has been shown that PAD4 is localized in nuclei73 and can convert multiple 
arginine sites of H3 and H4 into citrulline.74 PAD4 can in fact deiminate Arg2, Arg8, 
Arg17 and Arg26 on histone H375 and Arg3 on the N-terminal sequence shared by H2a 
and H4.76 PAD4 activation and histone deimination is triggered in HL60 cells and blood 
granulocytes by a variety of stimuli, such as Ca2+ ionophore, LPS, TNF, 
chemoattractant peptides and H2O2.
77 Under these stimuli, neutrophils, eosinophils and 
mast cells extrude NETs, undergoing a novel form of cell death that requires reactive 
oxygen species produced by NADPH-oxidase. In neutrophils stimulated with Ca2+-
ionophore, the qualitative and quantitative NETs composition has been analyzed by a 
proteomic approach.78 Core histones are the most abundant proteins, accounting for 
approximately 70% of all NET-associated proteins. H3 and H4 are present in lower 
amounts than H2B and H2A and their molecular weight is reduced when compared 
with nuclear histones, suggesting post-translational modifications. 
In this project citrullinated H4 has been identified as a novel substrate for ACPAs, thus 
showing that NETosis can be the source of this antigen, and establishing a novel 
connection between innate and adaptive immunity in RA. Initially, immunoblotting 
experiments allowed us to detect a reactivity of RA sera with a band whose identity 
with H4 was suggested by specific antibody recognition and demonstrated by MALDI-
TOF analysis. Citrullination of H4 was shown by reactivity with anti-citrulline antibodies 
and proved by MALDI-TOF analysis after peptide derivatization. Subsequently, RA 
sera reactivity with isolated NETs proteins was observed; again, the band was 
identified as deiminated H4 using specific antibodies and, most importantly by MALDI-
TOF analysis of tryptic peptides from the digested band before and after derivatization. 
As confirmation of the specific reactivity of RA sera with H4, further validation results 
were obtained through studies performed by the Clinical Immunology and Allergy Unit 
of the University of Pisa (Prof. Paola Migliorini). ELISA assays using in vitro deiminated 
human purified H4 as antigen and RA sera showed that the binding of patients’ sera 
was significantly higher than the binding of normal blood donors. Altogether these 
observations proved that RA sera react with deiminated H4. 
The presence of deimination was demonstrated on the tryptic digests deriving from 
activated neutrophils using a chemical modification with antipyrine and 2,3-
butanedione, which are the same reagents employed in the Anti-modified Citrulline 
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detection kit, a very frequently used tool to detect deiminated proteins by 
immunoassays.79 The reaction includes a two steps addition of the reagents to the 
ureido group of citrullines gaining a final mass increment of 238.11 Da in the 
citrullinated peptide whose MALDI spectrum also shows a characteristic isotopic 
pattern for the presence of minus 1 and 2 Da signals.30 The experimental conditions 
were optimized on several citrullinated and not citrullinated peptides pairs and on 
mixtures of low concentrated citrullinated peptide spiked into a BSA tryptic digest, thus 
miming a real biological sample.  
When these derivatization experiments were performed on the nuclear and NETs 
samples, a signal at m/z 1720.8, which was absent before, become visible in the 
MALDI spectra of the derivatizated proteolytic digests. This signal was compatible with 
the mass expected for the derivatizated histone H4 peptide DNIQGITKPAI(cit)R with 
MH+=1482.8. The low intensity of the derivatized peptide’s signal prevented the 
precursor to be isolated and fragmented through tandem mass spectrometry and thus 
the deimination was not confirmed by a corresponding MS/MS spectra. 
Moreover the derivatization technique did not provide information regarding the exact 
deimination position since two arginines were available to modification and in the 
literature there are no formal evidences that allow to exclude citrullination of the C-
terminal ones.29 
 
The second part of the research was a deeper investigation conducted on NETs trypsin 
digest to better delineate the deimination pattern of H4 starting from the peptide 
DNIQGITKPAIRR whose modification status has been demonstrated through 
derivatization. In addition we performed a search for possible further citrullinated H4 
peptides, exploiting a different strategy. 
The challenges in the detection of in vivo citrullinated proteins through proteomic 
methods are clearly presented in a recent review from which important considerations 
emerge.29 The majority of the approaches described in the literature to highlight the 
presence of citrulline residues have been tested either on standard peptides, available 
in large amounts, or on standard proteins deiminated in vitro. Only few of these studies 
face the fundamental problem of working with proteins citrullinated in vivo that is the 
very low amount of citrullinated peptides which dare the analytical sensitivity of the 
mass spectrometers. 
Another important consideration is that the combination of more than one approach is 
necessary in order to provide complementary information, difficult to be achieved by a 
single method. 
In the context of this project, considering the issues left unresolved by the derivatization 
approach initially implemented, a direct detection of citrullines residues by means of an 
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LC-MS/MS analysis appeared as the most appropriate, since the direct interpretation of 
citrullinated peptides’ MS/MS spectra could provide the requested sequence. 
This approach is much more troublesome, if compared to the modification strategies, 
and in fact only few articles report its successful implementation.  
We decided to test two different stationary phases since we were aware that the 
chromatographic separation played the most important role in this analysis. The HILIC 
phase was found to be more efficient than the reverse phase in the separation of a pair 
of standard citrullinated and not citrullinated peptides, allowing us to assume that it 
could be successfully applied to the NETs tryptic digest. Both the analyses clearly 
demonstrated that the peptide at MH+=1482.8 did not correspond to the sequence 
DNIQGITKPAIRR but to the isobaric semitryptic peptide RDNIQGITKPAIR, thus 
changing the possible deimination site of H4. However several difficulties were met that 
prevented the establishment of the exact deimination position on that peptide and did 
also not allow to asses which modification was responsible for the 0.984 Da mass 
increase found in two other histone peptides, DNIQGITKPAIR and KLPFQR. 
Regarding the peptide RDNIQGITKPAIR the presence of the higher concentrated 
unmodified form and a form bearing a presumable aspartate amidation severely 
affected the analysis by eluting in close proximity to the citrullinated, thus hampering a 
correct peptide sequencing to be achieved. Moreover the presence of an isobaric 
peptide of the citrullinated contributed to make more complicated the interpretation of 
the results by reducing its sampling by the mass spectrometer. 
Taken together, these observations confirm that a direct detection of citrullinated 
peptides in real samples by interpretation of their MS/MS spectra is a quite challenging 
task because of both their low amount, combined to the presence of unmodified 
peptides that act as interfering agents. Taking into account the complexity of the 
sample, we do believe that to move forward this project it will be necessary to optimize 
the chromatographic method on a tryptic digest of in vitro deiminated histone H4, in 
order to reproduce the conditions of the real sample, but at higher concentrations. 
Moreover, we concluded that the use of HILIC phase, which proved to be more 
efficacious than the reverse phase when applied to standard peptides, requires a still 
longer phase of conditioning in order to create the optimal conditions for the separation 
mechanisms characteristic of these columns. 
 
In conclusion the present research shows two different interesting aspects. 
On one hand the description of autoantibodies reactive with citrullinated histones raises 
important questions on the mechanisms leading to their production. The prevailing idea 
is that neutrophils by NETosis expose autoantigens to immune cells in the presence of 
danger signals, but whether this is sufficient for the induction of autoantibodies in a 
normal or autoimmune background is still to be settled. As neutrophils are the most 
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abundant cells in synovial fluid, NETosis may create targets for ACPAs in rheumatoid 
synovia, where these autoantibodies are produced. The analysis of NETs composition 
in healthy subjects and in RA patients and the study of their immunogenic properties 
may help to unravel the relationship between NETosis, citrullinated histones and 
induction of ACPAs in RA patients. 
On the other hand the need to clearly highlight the presence of deiminated residues in 
the protein target by means of proteomic technologies represents a methodological 
challenge that has been faced both using an already described derivatization strategy 
and trying a different approach, which has been previously barely described. A direct 
detection of citrulline residues still requires considerable efforts, as confirmed by the 
few successful examples reported in the literature. Accordingly, it is worthy to proceed 
with the idea of using different stationary phases that may offer a solution to the still 
unresolved problem of the separation of citrullinated peptides from the corresponding 
unmodified forms. 
Chapter 1                                                                                                                                           Experimental part
   
 
 
   72  
1.5 EXPERIMENTAL PART 
 
 
Neutrophils isolation and stimulation 
Neutrophils were obtained from buffy coat of healthy blood donors and isolated using 
discontinuous gradient centrifugation according to English et al.56  
Purified neutrophils were resuspended at 2x106 cell/ml in Locke’s solution (NaCl 150 
mM, Hepes-HCl 10 mM pH 7.3, CaCl2 2 mM, Glucose 0.1%) and incubated at 37°C for 
15 min with or without A23187 4 µM (Sigma-Aldrich, Saint Louis, MO, USA), followed 
by a further incubation of one hour in serum-free RPMI at 37°C. 
 
NETs preparation 
Neutrophils were seeded in 6 wells plates in RPMI at 2x106 cells/w and activated with 
100 nM phorbol myristate acetate (PMA) for 4 hours at 37°C.80 After removing the 
medium, the wells were washed 2x10 min with D-PBS and incubated for 20 min at 
37°C with 10U/ml DNase I (Sigma) in RPMI. DNase activity was stopped by adding 
EDTA 5 mM (final concentration). The samples were then centrifuged at 3000g to 
remove intact cells and intact nuclei; the supernatants containing NETs proteins were 
processed as described below. 
 
Histone extraction 
Stimulated and unstimulated neutrophils and NETs were incubated overnight in H2SO4 
0.2 M at 4°C with agitation. Acid extracted proteins were then precipitated with 33% 
trichloroacetic acid (TCA) for 2 hours at 4°C, washed twice with acetone and 
suspended in ddH2O. Protein concentrations were determined using BCA Protein 
Assay (Pierce, Rockford, IL, USA). 
 
SDS-PAGE and immunoblotting 
Acid extracted proteins from stimulated and unstimulated neutrophils and from NETs 
were resolved in a 16.5% Tris-Tricine-SDS PAGE (Bio-Rad, Hercules, CA, USA) under 
non reducing conditions and blotted onto PVDF (Mill ipore, Billerica, MA, USA). The 
membrane strips were saturated for 30 min at room temperature in TBS containing 5% 
BSA and 0.05% Tween-20 and incubated overnight at 4°C with human sera diluted 
1:200, purified antibodies 50 µg/ml , anti Histone H4 (Upstate, Mill ipore), and anti 
histone H4 (citrulline 3) (Upstate, Millipore) rabbit antisera diluited 1:500. 
Anti Citrulline (modified) detection kit (Upstate, Millipore) was used to detect 
deiminated proteins, following the manufacturer’s instructions. 
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Peroxidase activity was visualized by means of enhanced chemiluminescence using 
LuminataTM Western HRP Substrate (Millipore). Images were acquired and analyzed 
using the VersaDoc Imaging System and QuantityOne analysis software (Bio-Rad). 
 
In-gel digestion 
The gel bands of interest were chopped into small pieces, washed with water and 
shrinked with acetonitrile. Reduction and alkylation were performed in a solution of 10 
mM DTT (56°C, 45 min) and iodoacetamide 55 mM (room temperature, 30 min, in the 
dark), respectively. Shrinking and rehydratation were carried out with acetonitrile and 
100 mM ammonium bicarbonate in order to completely remove Coomassie staining. 
Proteins were digested by adding a solution of 12 ng/µl of trypsin (type IX-S, from 
porcine pancreas, Sigma Aldrich) in 10 mM ammonium bicarbonate (37°C, overnight). 
Digestions were stopped with 10% TFA and the supernatants were recovered for 
subsequent mass spectrometry analyses.   
 
Chemical modification 
Derivatization of citrulline residues was performed as described previously.30,31 Briefly 
10 µl of proteolytic digest were added to 10 µl of 50 mM antipyrine in presence of 20 µl 
of 10% TFA; 10 µl of freshly prepared 2,3-butanedione 50 mM were, finally, added to 
start the reaction. After 2h of incubation at 37°C, in the dark the samples were 
SpeedVac-concentrated up to 20 µl and desalted by Zip-Tip C18 pipette tips (Millipore). 
 
MALDI-TOF analysis 
MALDI-MS measurements were performed using an Ultraflex II I TOF-TOF instrument 
(Bruker Daltonics, Bremen, Germany), operating in reflectron positive ion mode 
between a mass range of 860-4000 m/z. Ions were formed by a pulsed UV laser (λ = 
337 nm) beam. The instrumental conditions were: UIS1 = 25 kV; UIS2 = 21.65 kV; 
reflectron potential: 26.3 kV; delay time = 0 nsec.  
External mass calibration was done using the Peptide Calibration Standard, basing on 
the monoisotopic values of [M+H]+ of Angiotensin II, Angiotensin I, Substance P, 
Bombesin, ACTH clip (1-17), ACTH clip (18-39), Somatostatin 28 at m/z 1046.542, 
1296.685, 1347.736, 1619.823, 2093.087, 2465.199 and 3147.471, respectively.  
For the analyses of the proteolytic digests the dried droplet deposition method was 
applied using a solution of α-cyano-4-hydroxycinnamic acid spotted in an AnchorChip 
(Bruker Daltonics) target plate. Peptide mass fingerprint data were obtained for each 
sample and MS-MS analyses were performed on selected precursors. MALDI-TOF-
TOF experiments were carried out using the LIFT device. The instrumental parameters 
were: UIS1=8 kV; UIS2=7.2 kV; ULIFT1= 19 kV. 
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Mascot searches were done against the Swiss-Prot database (release 2012_10) 
calculating 2 maximum missed cleavage for trypsin, carbamidomethylation of cysteine 
as fixed modification, oxidation of methionine as variable modification, 30 ppm and 0.6 
Da as precursors and fragments tolerances, respectively. 
For the analyses of the derivatized digests the same instrumental conditions were 
applied. 
 
LC-MS/MS analysis 
Peptide analysis were performed on a nanoLC-nano-ESI-LTQ-Orbitrap system 
(Thermo Scientific, San Jose, CA, USA). 
The nanoLC system used was an UltiMate™ 3000 apparatus (Dionex) which 
comprised a LPG-3600 dual-gradient pump, a FLM-3000-Flow manager module and a 
WPS-3000 thermostatted well plate autosampler (set at 5°C). 
Reversed-phase separations were performed on a Acclaim® PEPMAP100 C18 
nanocolumn (Dionex) (3 µm particle size, 100 Å; column dimension: 75 µm id x 5 cm) 
using the four different eluents. For the loading sample mobile phase A was made of 
0,1% TFA while phase B of acetonitrile in presence of 0,1% TFA; for the gradient 
mobile phase A was made of water:acetonitrile 97:3 with 0,1% of formic acid while 
phase B of water:acetonitrile 3:97 with 0,1% of formic acid. 
1 µl of the standard peptide or 5 µl of tryptic digest were loaded through µlpickup 
injection onto a Acclaim® PEPMAP100 C18 trapping column (Dionex) (5 µm particle 
size, 100 Å; column dimension: 100 µm id x 5 mm) at a flow rate of 20 µl/min. The 60 
min lasting gradient proceeded at 300 nl/min and included the following steps: for the 
first 10 min the phase B increased from 4 to 40 %, from 10 to 30 min it increased until 
the 65%, from 30 to 35 min it remained at 65%, in a minute rapidly reached the 90% 
were it lasted for 4 min until 40 min, in a minute phase B decreased to 4% where it 
remained until 60 min.  
HILIC separations were performed on a ZIC® HILIC columns (Sequant, Umèa, 
Sweden) (5µm particle size, 200 Å; column dimension: 100 µm id × 10 cm) using 
eluents with the same composition of the previously described. 
Since no ZIC® HILIC trapping columns were equipped on the LC system, a direct on-
column loading was performed by injecting 1 µl of sample through a full-loop injection. 
Peptides were separated using a mobile phase gradient of 125 min, at a 300 nl/min 
including the following steps: 10 min of 97% phase B to allow the sample to reach the 
column after the injection, from 10 to 60 min the phase B decreased until the 50% 
where it remained until 70 min, next 5 min it came back to the 97% of B where it lasted 
until 125 min.  
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The LTQ-Orbitrap mass spectrometer was equipped with a nanoESI source through a 
positive ion electrospray ionization with a spray voltage of 3.1 kV being applied to the 
needle. 
The other spectrometer’s tuning parameters were: capillary voltage at 45 V, tube lens 
voltage at 230 V, capillary temperature at 220°C. 
Two different MS method were applied. In the data-dependent acquisition (DDA) the 
cycle consisted in a survay MS scan with 15000 resolving power within 300-2000 Th, 
followed by MS/MS fragmentation of the three most intense precursor ions by collision-
induced dissociation using a normalized collision energy of 30% in the linear trap. In 
top 2 each full mass spectrometric (MS) scan (15000 resolving power) was followed by 
two MS/MS scans performed in DDA modality and one MS/MS scan performed on the 
target m/z value of 741.9 Th ; the collision energy was of 30%.  
Single charge precursors were automatically excluded from MS/MS acquisition and m/z 
of precursors already fragmented was dynamically excluded (repeat count 2, repeat 
duration 15sec, exclusion duration 30sec).  
Calibration of the Orbitrap analyzer was performed by infusion of a Thermo standard 
calibration mixture (caffeine, tetrapeptide MRFA, and Ultramark). 
LC-MS/MS data was controlled by the Chromeleon software integrated with Xcalibur 
2.0.7 (Thermo Fisher Scientific) to manage both the chromatographic and mass 
spectrometric aspects. Each run was converted to .mgf file using RAW2msm utility 
using default parameters (intensity-weighing the parent ion m/z over the LC elution 
profile and keeping top 6 most intense fragment ions per 100 m/z units). 
 
Data Analysis  
Peak lists were searched on a local server using the Mascot 2.2 algorithm (Matrix 
Science Ltd., London, UK), selecting semitrypsin as the proteolytic enzyme and 
allowing two missed cleavages, against SwissProt databank (release: 2012_05). 
Oxidation (Met) and deimination (Arg) were selected as variable modifications while 
carbamidomethylation (Cys) was selected as fixed modification; mass tolerance for 
precursor ions was set at 10 ppm and for fragment ions at 0.6 Da. At least 2 significant 
sequences for each protein were selected as criterion filter to accept identified proteins. 
For MS/MS searches individual ions scores >35 were reported as indicative of identity 
or extensive homology (p<0.05). 
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2.1 INTRODUCTION 
 
 
2.1.1 Quantitat ive proteom ics 
Biological and biomedical research deals with the study of processes and molecular 
mechanisms that take place inside cells at different levels (e.g. genomic, proteomic, 
metabolic) and that support all the cellular functions (e.g. proliferation, communication, 
surviving, development). These cellular processes and functions are influenced and 
regulated by various stimuli and the recognition of the biological changes correlated to 
them is a crucial task.81,82 Toward this aim it is evident the need to set up analytical 
tools capable to measure and quantify these changes; accordingly, proteomics is 
playing an increasingly important role enabling to measure the expression level of 
proteins, as tangible and measurable response to perturbation-induced changes within 
cells. In fact in the biomedical field the possibility to correlate anomalous cellular 
responses, such as increased/decreased expression of specific proteins, with the 
establishment of a pathological condition represents a desirable scenario. 
Proteomic technologies can provide a significant contribution comparing samples from 
healthy and diseased subjects and mapping possible quantitative differences 
associated with specific conditions. The fast development of mass spectrometry by 
both a methodological and an instrumental point of view, together with a contemporary 
improvement in efficiency of HPLC techniques and materials, has provided powerful 
tools. Various approaches have been developed using 2D gels or MS techniques, the 
latter possibly based on chemical derivatization (Figure 2.1).83 
 
 
Figure 2.1. Quantitative proteomics toolbox83  
Chapter 2                                                                                                                                                      Introduction
   
 
 
   80  
Derivatization-free technologies include different strategies which have in common the 
easy sample preparation and the lowest possible limit of quantification.83 However they 
provide less accurate measurements, reason for which efforts are required to keep a 
very good reproducibility at each experimental step. On the other hand development of 
chemical derivatization-based methods complies the need of increasing the throughput 
screening of samples by means of a single experiment. Indeed differential labeling 
allows a simultaneous analysis of different conditions (namely "multiplexed 
quantitation"), thus minimizing the systematic variation. 
A basic concept of all MS-based methods is that MS itself is not a quantitative 
technology because mass spectrometric response, besides analyte amount, is also 
dependent on various other factors such as sample preparation, instrument conditions 
and analyte physicochemical properties. Nevertheless quantitative proteomics is asked 
to compare results coming from different analyses, situation that clearly collides with 
this problem. For derivatization-free methods this standstill has been overtaken by 
using standardized procedures based on highly performing LC-MS instruments, several 
experimental replicates for each condition and statistical analyses in order to ensure 
reproducibility and statistical significance. At variance, in the case of derivatization-
based methods, a single analysis of the two mixed samples is sufficient to overcome 
that problem, since each couple of native and stable isotope-labeled peptides share the 
same chromatographic and mass spectrometric properties.82 
In the last two decades a great effort has been done to develop chemical labeling 
techniques for relative quantitation experiments by employing chemical reagents able 
to specifically react with functional groups of proteins/peptides (e.g. sulfhydryl, amine 
and carboxyl groups) and modify them with labeled tags (Figure 2.2). 
 
Figure 2.2. Stable isotope-bearing chemical reagents target reactive sites on a protein or peptide84  
 
The rational of employing MS strategies based on derivatization methods for 
quantitative analysis relies on the resolution of mass spectrometers, namely their 
power in separating isomers with different stable isotope composition (isotopomers).84 
As a general evaluation, an ideal and reliable isotopic labeling reaction must produce 
the smallest possible increase of sample complexity, thus it should be very selective, 
quantitative, possibly fast, and give no side-products. Labeling reactions with different 
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stable isotope-bearing chemicals lead to the formation of “heavy” and “light” 
isotopomeric peptides coeluting in LC runs, or showing an almost negligible 
chromatographic isotopic effects (Figure 2.3 A). 
 
 
Figure 2.3. Co-elution of differentially labeled peptides (A) and corresponding MS spectrum 
showing the isotopic cluster for each of them (B) 
 
A good separation of the signals of the isotopomers is also mandatory because 
overlapping between peaks corresponding to light and heavy labeled substrates would 
result in distorted ratios and misrepresenting quantitations (Figure 2.3 B). A mass 
difference of 4 Da is sufficient in the mass range below 1900 Da, but for heavier 
molecules a significant overlap between signals occurs and a wider spacing, in terms 
of mass units, is necessary. 
The most commonly employed commercial reagents are designed to fulfill the above 
mentioned requirements and to offer different approaches according to researchers’ 
needs and instrumental equipment, as they all have their advantages and 
disadvantages. Through these kits the quantitation step can be carried out at MS level 
by using isotopic tags as in the case of ICAT™ (isotope-coded affinity tag) and ICPL™ 
(isotope-coded protein labeling) or at MS/MS level by using isobaric tags as iTRAQ™ 
(Isobaric tags for relative and absolute quantitation) and TMT™ (Tandem Mass Tag). 
The ICAT™ reagent, for example, selectively labels cysteine residues at the peptide 
level and quantitation is performed in MS spectra after an avidin-affinity 
chromatographic step.85 This approach has the great advantage of reducing the 
complexity of the sample but sometimes the low abundance of cysteine residues can 
be a crucial drawback as information about cysteine lacking peptides are lost. The 
more recently developed ICPL™ kits ensure a wider coverage of labeled peptides as 
multiplex quantification can be performed at the MS level, with a selective reaction at 
the primary amino groups on proteins, prior to digestion.86 Isobaric reagents, TMT™ and 
iTRAQ™ produce no increase to the sample complexity nevertheless a slight instability 
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of reagents and the quantitation performed on a single MS2 spectrum represent a 
weakness of this strategy.87,88  
The difficult synthesis of these reagents and their good efficiency always reflects into 
high costs, which can be sometimes a considerable problem. Cheaper reagents exist 
and can be also employed but they sometimes suffer of poor selectivity, give unstable 
products, or are selective for low abundant residues. 
In this scenario stable-isotope labeling strategies based on reductive amination of 
peptides with formaldehyde or acetaldehyde as alkylating agents represent interesting 
alternatives. The reaction is simple, fast, specific and undoubtedly inexpensive if 
compared with commercially available kits, an ensemble of features that support its 
employment in quantitation experiments in proteomics. 
 
 
2.1.2 Reductive amination  
Chemical tagging by reductive amination involves any primary amino groups present in 
a peptide or a protein, namely all the N-terminal amino groups and all the ε-amino 
groups of lysine residues. Reaction with aldehydes generates an imine that is reduced 
to secondary amine with NaCNBH3; then a further sequence of addition and reduction 
leads to a tertiary amine as the final product. By working in a reducing environment with 
an excess of formaldehyde or acetaldehyde, dimethylation or diethylation of amino 
groups is respectively obtained. According with the presence or the absence of a C-
terminal lysine, mono or di-derivatized products are expected upon labeling peptides 
generated by digestion with trypsin.  
For a relative quantitative analysis two proteins from samples of different conditions are 
digested by protease then labeled with d(0)-formaldehyde and d(2)-formaldehyde 
respectively, as example, and finally mixed together to be analyzed by LC-MS. The 
differentially labeled peptides are co-eluted in the chromatographic step and a pair of 
signals is detected at the MS level with a mass shift of 28 Da and 32 Da respectively, 
for each derivatized reactive site (Figure 2.4). 
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Figure 2.4. Reductive amination using d(0)-formaldehyde and d(2)-formaldehyde in presence of 
NaCNBH3 
 
With d(0)-acetaldehyde and d(4)-acetaldehyde, instead, we can obtain a mass 
increase of 56 and 64 Da respectively for each derivatized site, thus a mass separation 
between the differentially labeled peptides that grows up to 16 Da for doubly tagged 
substrates. 
The application of dimethylation in stable isotope labeling procedures for quantitative 
purposes has been firstly reported by Hsu et al demonstrating the reaction to be fast (5 
minutes) and quantitative, working at pH 5-6.89 In other papers modifications have been 
made to the protocol, basically changing the reaction buffer and increasing the 
incubation time up to one hour.90,91 Multiplex experiments have been recently reported  
employing also d(2)-13C-formaldehyde and NaCNBD3 without a sensible increase in 
terms of cost.92 Although the mild reducing agent, NaCNBH3, is known to be more 
selective and efficient towards protonated imines, dimethylation has also been 
performed with neutral and slightly basic conditions and little effect of pH change was 
observed in a systematic investigation with formaldehyde, in the range between 3.0 
and 8.2.93  
Moreover it has been described that the conversion of amino groups from primary to 
tertiary increases the proton affinity of the derivatized sites, positively affecting peptides 
coverage in the identification process and improving de novo sequencing.94 Concerning 
this, a further useful aspect is the enhancement of the a1 ion in MS/MS spectra that has 
also been reported to allow quantitation at the protein level.95  
On the other hand the use of diethylation labeling for peptide quantification has found 
less confirmations as evident from a poor literature concerning the use of acetaldehyde 
as labeling agent, except for small molecules.96 Only recently a diethylating labeling 
based on different acetaldehydes isotopomers and 2-picoline borane instead of 
NaCNBH3 has been successfully applied on the proteome analysis of an unicellular 
algae.97  
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The chemistry of both formaldehyde and acetaldehyde in biological systems features 
interesting aspects for proteomics investigations but it has been deeply investigated 
only in few papers. Formaldehyde has been widely used to fix tissues and cells and it is 
known as a cross-linking agent involving a wide set of amino acid residues.98 Besides 
reacting with the N-terminal amino groups and with lysine it is also able to attack 
tryptophan, histidine, arginine and cysteine residues to form a metylol adduct that, only 
in the case of primary amino groups, undergoes rearrangement to imine. A further 
reaction can involve the generated Schiff-base and other residues, like glutamine, 
asparagines, tryptophan, histidine, arginine, cysteine, and tyrosine, in intra or 
intermolecular cross-links. Metz et al reported a systematic investigation on a series of 
synthetic peptides, each one featuring a different residue likely reactive towards 
formaldehyde, in the presence of glycine or a reducing agent.99,100 
Considerations rising from these studies are important to delineate the reactivity of 
formaldehyde toward chemical groups exposed by the proteins and, in a proteomic 
perspective, invite not to underestimate its ease of use as derivatization agent for 
quantitation experiments. 
 
 
2.1.3 Quantitat ion using the Mascot Distill er software  
Whatever the labeling strategy used for quantitative proteomic experiments, proper 
algorithms of analysis are asked to extrapolate the ultimate light/heavy (L/H) ratio. 
Moreover the analysis of proteomic samples requires the employment of LC-MS/MS 
analysis through which the co-eluting isotopomeric couples of peptides could be 
isolated for subsequent fragmentation. Corresponding peaks list containing all the 
precursors and the products related information (mass, charge, intensity) could be 
submitted to data bank search and then processed to get quantitation results. 
Concerning this workflow it is important to note that the quantitation step follows the 
identification step therefore the number of proteins available for quantitation is limited 
to the proteins that are recognized in all the samples that are tested (Figure 2.5). 
Protein abundance and sample complexity are significant factors that affect the 
availability of proteins for mass spectrometric quantitation. 
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Figure 2.5. Protein availability for quantitative proteomic analysis is limited 
 
Different approaches can be followed to achieve protein quantitation using mass 
spectrometry data.101 Measuring the relative intensities of fragment peaks at fixed m/z 
values within an MS/MS spectrum (reporter method) or of sequence ion fragment 
peaks within an MS/MS spectrum (multiplex method) or considering the relative 
intensities of extracted ion chromatograms for precursors within a single data set 
(precursor method) represent few examples. 
The Mascot Distiller software is able to perform quantitation analysis applying some of 
the above mentioned protocols. In particular for reductive amination it makes use of the 
precursor method, since any chemistry that creates a precursor mass shift adopts this 
method. 
The precursor protocol requires information from the raw data file that are not present 
in the peak list, so the quantitation report is generated by Mascot Distiller, which has 
access to both the Mascot search results and the raw data. It processes the raw data 
and submits the search to Mascot Server; when the search is over results are returned 
to Distiller that can generate the quantitation results reporting the final L/H protein 
ratios (Figure 2.6). 
 
 
Figure 2.6. Mascot distiller workflow 
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Quantitation is performed at peptide level but reported at the protein level; the final 
protein ratio will result improved as more peptide measurement data points are 
provided. To accept a peptide ratio Distiller uses three parameters that measure the 
quality of the experimental data:  
• Fraction refers to the fraction of the peak area in the precursor region accounted for 
by the labeled peptide (called component); this is to control the presence of 
interfering peaks in the same area. 
• Correlation coefficient is a measure of the fitting between the predicted and the 
observed precursor isotope distribution. This second parameters tests the shape of 
the distribution to avoid interference from other peptides. 
• Standard error reflects the variability around the reported ratio that is the result of a 
least squares fit to the heavy and light components from the scans in the XIC peak. 
The standard error is a measure of the reliability of the ratio.  
The final protein ratio can be calculated from the set of peptides as: 
• Median if it is the median of the peptides ratio  
• Average if it is the geometric mean of the peptides ratios 
• Weighted if it is calculated from a weighted average of the peptide ratios. The 
weighting factors are the summed intensities of the components. 
In conclusion Mascot Distiller implements quantitation measuring the relative intensities 
of extracted ion chromatograms for precursors in survey scans and uses a quantitation 
method that encapsulates all the settings for searching, processing, and reporting of 
quantitation data. 
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2.2 OBJECTIVES 
 
One of the most crucial issues and growing area of modern proteomics is the relative 
quantification of the differential expression of proteins in two or more samples 
representing different conditions of biological systems.  
Among the most common stable-isotope labeling strategies, the reaction of aldehydes 
with peptides in the presence of NaCNBH3 features many attractive aspects that 
enable its employment in quantitation proteomics experiments.  
The reactivity of aldehydes toward proteins has been deeply investigated only in few 
papers, reporting how the Schiff-base generated in the reaction with primary amino 
groups is sensitive to any nucleophile site of the protein, easily undergoing cyclizations 
and cross-linking. The almost simultaneous addition of a reducing agent should repress 
any other reaction but the dialkylation of primary amines and indeed, only slight 
problems with side-reactions have been reported, however easily overcome by 
reducing reaction time. 
Considering the known predisposition of aldehydes to promote cross-reactions with 
proteins, we estimated appropriate to study more in detail the impact of the reductive 
amination with either formaldehyde and acetaldehyde in proteomic quantitative 
experiments.  
Moreover, considering the limited available literature and the variability in terms of pH 
and reaction times in the reported protocols, we wanted to fix general rules for their 
employment in stable isotope peptides labeling, particularly for the diethylation 
approach. Indeed acetaldehyde and its heavy isotopomers can be used as diethylating 
agents for providing a wider mass separation between the differentially labeled 
peptides, attractive condition when working with multiply charged peaks on low 
resolution mass spectrometers.  
A parallel investigation was performed on synthetic peptides changing reaction 
conditions, in order to evaluate in particular the role of pH, since this was the most 
divergent parameter among the described protocols. Based on preliminary 
observations derived from both the methylation and the ethylation of model peptides, a 
consistent series of tests were performed trying to highlight the nature of unexpected 
collateral signals.  
Before undertaking experiments on complex biological samples, the occurrence of 
unwanted side-products was monitored on a single protein digest and a mixture of 
proteins digest.  
 
 
 
Chapter 2                                                                                                                                                           Objectives
   
 
 
   88  
2.2.1 Scheme of the work  
 
The research was developed as follows: 
• Two commercially available peptides, TDP and ACTH, were labelled with both 
formaldehyde and acetaldehyde, testing buffers at different pH values and 
different reagents concentration. Reactions were monitored by MALDI-TOF MS. 
• Standard tryptic peptides were employed to deeply investigate the nature of a 
signal at minus 2 Da than the expected and whose incidence was found to be 
pH related and more intense for acetylated peptides. ESI-MS acquisitions, LC 
separations combined to peptide sequencing experiments and guanidination 
reactions allowed the situation to be clarified. 
• Synthetic peptides were expressly produced with amino acids substituted in 
critical positions in order to evaluate their role in the occurrence of a signal at 
minus 4 Da than the expected, in MALDI spectra. Their specific behavior in 
reductive amination and guanidination reactions was studied to delineate its 
characteristics and to limit its formation.  
• More complex samples including a single digested protein and a mixture of 
digested proteins were differentially labeled and LC-MS/MS analyzed; a Mascot 
Distiller processing was applied and evaluations concerning the impact of the 
side-products were extrapolated. 
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2.3 RESULTS AND DISCUSSION 
 
 
2.3.1 Dimethylation and diethy lat ion labeling of  standard 
peptides 
Preliminary tests were performed on two commercially available peptides, 
DRVYIHPFHLVIHN (renin substrate tetradecapeptide human, TDP, EM: 1758.9) and 
RPVKVYPNGAEDESAEAFPLEF (adrenocorticothropic hormone fragment 18-39, 
ACTH, EM: 2464.2), featuring respectively one and two reactive sites. Although both 
substrates were not highly representative of a typical tryptic digest, as neither arginine 
or lysine were present at the C-termini, they were thought to be suitable for some initial 
experiments. The reactions were performed with both non-deuterated formaldehyde 
and acetaldehyde employing buffers lacking primary amino groups thus no TRIS or 
ammonium salts were introduced in the reaction environment.  
The behavior of the reaction at different pH value was the first important task to check 
therefore four buffers were prepared: 0.1 M triethylammonium bicarbonate (pH = 8.8), 
0.1 M triethylammonium bicarbonate (pH = 8.0), 0.1 M tetraethylammonium acetate 
(pH = 6.9) and 0.1 M sodium acetate (pH = 5.3). 
The reaction mixtures were analyzed by MALDI-TOF MS to verify the presence of the 
desired products and the complete absence of the starting material.  
For TDP it was observed that increasing the pH a signal at 1785.9 m/z became more 
evident, featuring two mass units less than the expected dimethylated product of TDP 
([M+H]+: 1787.9) with a mass increase of 28 Da (Figure 2.7).  
 
 
Figure 2.7. MALDI spectra of unlabeled TDP at 1759.9 m/z, dimethylated product at 1787.9 m/z and 
side-product at 1785.9 m/z after 10 min reaction with formaldehyde, at increasing pH from 5.3 to 8.8  
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Instead the reaction with acetaldehyde was much slower respect to with formaldehyde. 
This is not surprising due to a reduced electrophilicity of the secondary iminic carbon.  
No side product was observed in acid condition, as well as with formaldehyde, but, on 
increasing pH, a +54 Da product ([M+H]+: 1814.0),  became evident beside the 
expected +56 Da diethylated compound ([M+H]+: 1815.9), being even the most 
abundant observed when triethylammonium bicarbonate at pH = 8.8 was employed as 
reaction buffer (Figure 2.8). 
 
 
 
Figure 2.8. MALDI spectra of unlabeled TDP at 1759.9 m/z, diethylated product at 1815.9 m/z and 
side-product at 1814.0 m/z after 6 h reaction with acetaldehyde, at increasing pH from 5.3 to 8.8 
 
Moreover the ethylation did not reach completeness after 6 h of incubation at 30°C, as 
evident from the presence of the monoethylated product at [M+H]+: 1787.9. 
The presence of signals at +26 or +54 Da for methylation and ethylation, was not 
reported among the dimethyl labeling approaches described in literature for proteomics 
quantitative experiments. Only Li et al. mentioned the occurrence of a side product with 
a mass increase 2 Da lower than expected, in reactions carried on for 15 minutes 
instead of 5.102 
Metz et al., investigating formaldehyde-derived intramolecular cross-links, reported the 
presence of a small amount of peptide adduct with mass increase of 26 Da after the 
addition of the aldehyde and NaCNBH3 to peptides.
99  
The resulting ring structure was found to be an imidazolidinone (Figure 2.9). Moreover 
formaldehyde and acetaldehyde are known to form stable methylene bridge as results 
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of intramolecular rearrangement that leads to the formation of an imidazolidinone 
derivative.103,104,105 
 
 
Figure 2.9. The Schiff-base generated by the reaction between aldehydes and the terminal amino 
group of peptides can be reduced by hydride addiction (workflow on the left) or undergo 
cyclization by nucleophilic addition of the contiguous peptidic nitrogen (workflow on the right) 
 
The same experimental conditions used for the peptide TDP were applied to the 
peptide ACTH and, again, unexpected signals were found. In particular the signal of a 
secondary product with a 52 mass increase ([M+H]+: 2517.3) was observed, beside the 
signal of the tetramethylated peptide ([M+H]+: 2521.3) in the reaction with 
formaldehyde at the very basic pH. No side-products were observed performing the 
derivatization in acidic conditions.  
Interestingly there was no evidence with acetaldehyde of a +108 Da product, 
corresponding to the +52 Da observed with formaldehyde (Figure 2.10). 
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Figure 2.10. ACTH unlabelled; the reaction with formaldehyde and NaCNBH3  yields a considerable 
amount of a side product with 4 mass units less than the expected tetramethylated product. No 
side product in the reaction with acetaldehyde 
 
In the same work by Metz et al  it was, also, described the presence of an adduct with a 
mass increase of 24 Da (instead of 28) in formaldehyde-treated peptides, in presence 
of NaCNBH3.
99 
It was demonstrated that two methylene bridge occurred between the side chains of 
two closed residues, lysine and arginine (Figure 2.11). 
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Figure 2.11. Reactive side of ACTH. The Schiff-base at the lysine residue can undergo cross-link 
with arginine promoting the formation of the peptide adduct with 4 Da minus than the correctly 
tetramethylated (workflow on the left) 
 
The earlier tests performed on two different peptides showed the presence of two 
overlapping signals in the MALDI spectra, corresponding to the expected labeled 
peptides, and to much less abundant products featuring 2 or 4 mass units less.  
The 2 Da minus signal observed for TDP peptide was consistent with a rearrangement 
involving the Schiff-base to generate an imidazolidinone derivative at the N-terminus 
with the formation of a methylene bond that implies the loss of two hydrogen atoms. 
The reactions performed with formaldehyde or acetaldehyde revealed a similar trend, 
with such signals showing a higher intensity, the higher was the pH.  
At variance, for the 4 Da minus signals observed with ACTH peptide, the apparent loss 
of four hydrogens could be ascribed to the formation of two methylene bridges in a 
rearrangement that probably involves the lysine in position 4 and the N-terminal 
arginine in an intramolecular cross-link.  
Considerations rising from the work of Metz et al provided interesting cues, but 
evidences that similar rearrangements and structures were the real responsible for the 
signals observed in our experiments should be more consistently obtained. 
Accordingly, an extensive and systematic investigation was conducted firstly to confirm 
the presence of the mentioned signals using other peptides, secondly to check if they 
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were ionization-derived artifacts or real chemical species and finally to explain their real 
chemical nature. 
 
 
2.3.2 Insights into the observ ed side products  
Four synthetic peptides were employed to better delineate the nature of the side-chains 
modifications observed with TDP and ACTH. These new peptides were more 
representative of a tryptic digest and more closely modeled a real proteomic sample: 
GTFTASQNYLR (1, EM: 1256.6) and EITFTVLASR (2, EM: 1135.6), featuring a single 
reactive site at the N-terminus, and SIHVDIYSFPK (3, EM: 1304.7) and 
SLEVTFTPVIEDIGK (4, EM: 1646.9), containing a C-terminal lysine that provides a 
further derivatizable amino group. Dimethylation and diethylation reactions were 
performed changing different experimental conditions such as the concentration of 
NaCNBH3 and aldehydes that was varied in the range 0.2-2.0 M and 0.5-3.0 M 
respectively. In these conditions where a large excess of reagents were present no 
substantially differences were found. Moreover even changing the matrix and the 
solvent for the crystallization during the sample spotting in the MALDI target plate no 
significant differences were observed. 
Instead, similarly to previous results, when reductive methylation of peptides was 
performed at the four different pH values (5.3; 6.9; 8.0 and 8.8) some differences were 
observed. No traces of the +26 or +54 Da products were observed at the lower pH 
(Figure 2.12) while slightly visible signals at the more basic pH were present. 
 
 
Figure 2.12. MALDI spectra of methylated peptides 1-4 at different pH values 
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Such results downsized previous observations made on methylated TDP peptide 
where the presence of the signal was clearly evident at pH 8.8. 
On the contrary when the four peptides were subjected to ethylation the pH related 
differences in the presence of the minus 2 Da signal became evident, similarly to that 
observed with acetylated TDP. At acid and neutral pH, spectra were almost clear, while 
at the basic pH of 8.0 and 8.8, in the case of peptides 2, 3 and 4, the minus 2 Da 
signals were even higher than the corresponding ethylated products (Figure 2.13). 
 
 
Figure 2.13. MALDI spectra of ethylated peptides 1-4 at different pH values 
 
It was also interesting to note that peptide 1 did not show the presence of this signal 
even at the more basic pH. It was clear that the chemical environment of the primary 
amino groups played a crucial role in regulating the competition between the 
intermolecular addition of hydride and other intramolecular or intermolecular 
nucleophilic attacks to the generated imine. 
All the previous reactions, monitored through MALDI-TOF analyses, confirmed both the 
presence of the minus 2 Da signals and the general trend observed in the early 
experiments with TDP. 
In order to highlight the nature of the minus 2 Da signals several tests were performed. 
Initially, the tetramethylated and tetraethylated peptide 3 formed at basic pH was 
directly infused on an ESI-qTOF Ultima® mass spectrometer to check the presence of 
the minus 2 Da signals using an ESI source. In both cases the double-charged 
precursors at 681.48 and 709.33 m/z were preceded by an intense minus 2 Da signal 
at 680.52 and 708.34 m/z, respectively. 
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If the minus 2 Da signal was an artifact deriving from the ionization process, both 
MALDI and ESI were able to produce it and it was not exclusively correlated to the 
MALDI desorption process (Figure 2.14). 
 
 
Figure 2.14. ESI spectra of tetramethylated double-charged peptide 3 (681.48 Da) (on the left) and 
tetraethylated double-charged peptide 3 (709.33 Da) (on the right), at pH 8.8. Evidences of high 
intense minus 2 Da signals (680.52 Da and 708.34 Da) 
 
To more deeply investigate the nature of the signals a LC separation was performed on 
the tetramethylated peptide 3; products were manually collected and the corresponding 
MS/MS spectra were analyzed. The chromatogram profile showed the presence of two 
peaks, the first eluting corresponding to the tetramethylated peptide and the second 
one to the side product (Figure 2.15). 
 
 
Figure 2.15. The side product of the reaction of peptide 3 with formaldehyde elutes after the 
expected tetramethylated compound in LC run 
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These data confirmed that the signal observed in MALDI and ESI owned to a real 
chemical species rose as side product after the derivatization, and not to an artifact 
produced during the ionization process.  
Moreover fragmentation spectra, holding peptide sequencing information, helped the 
localization of the mass decrement at the amino acid level. In the MS/MS spectrum of 
the first eluted product (1361.7 m/z) the expected enhancement of the a1 ion was 
observed, the y series was completely detected while in the b series the b1 ion missed.  
The y sequence was exactly the same in the spectrum of the second eluted compound 
(1359.7 m/z) whereas all the b ions were shifted by 2 mass units and the a1 ion was 
almost suppressed, providing evidences that the modification between the two 
products was localized at the N-terminus (Figure 2.16). 
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Figure 2.16. MALDI-CID spectrum of the first eluted compound (above) and MALDI-CID spectrum of 
the second eluted compound (below) 
 
Further evidences supporting the imidazolidinone structure proposed by Metz et al 
came from 2MEGA (N-terminal dimethylation after lysine guanidination) and 2ETGA 
(N-terminal ethylation after lysine guanidination) experiments. Basically lysine residues 
were guanidinated with O-methylisourea so that the following dimethylation or 
diethylation could involve only the N-termini of the peptide.  
The 2MEGA experiment at pH 8.8 showed a slightly visible +26 signal in presence of a 
higher abundant expected peptide at 1375.67 m/z; instead with 2ETGA reactions the 
+26 signal at 1401.7 m/z was more intense than the expected at 1403.7 m/z (Figure 
2.17). 
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Figure 2.17. 2MEGA (on the left) and 2ETGA (on the right) reactions on peptide 3, at pH 5.3 (spectra 
above) and 8.8 (spectra below) 
 
These further reactions highlighted the presence of the signal at minus 2 Da in a 
peptide bearing a blocked lysine residue, confirming that the N-terminal was the site 
responsible for the rearrangement, being the only reactive site of this peptide. 
 
The peculiar modifications observed with ACTH were studied more in detail by using 
ad hoc synthesized decapeptides, designed to reproduce the presumed reactive region 
of the peptide. RPVKVYPNGA (5, EM: 1099.6) was synthesized to replicate the same 
sequence of ACTH from the N-terminus to the Ala10 and APVKVYPNGA (6, EM: 
1014.6) to prevent the cross-link by replacing Arg1 with Ala. The corresponding 
acetylated peptides AcRPVKVYPNGA (7, EM: 1141.6) and AcAPVKVYPNGA (8, EM: 
1056.6) featured a protection at the N-terminus with the aim at avoiding its involvement 
in the rearrangement. Finally AcAPVKVAPNGA (9, EM: 964.5) featured the 
replacement of Tyr6 with Ala, eliminating a further possible residue that could be 
involved in a cross-link with the dimethylated Lys4. 
These peptides were derivatized with both formaldehyde and acetaldehyde to explore 
the characteristics of the rearrangement, and analyzed by MALDI-TOF MS. 
Peptide 5 and 7 behaved exactly as ACTH in the reaction with formaldehyde, thus the 
expected +56 Da product ([M+H]+ 1156.6) was observed at pH 5.3 with no evidence of 
side-products; instead in the reaction at pH 8.8 a secondary product with a 52 Da mass 
increment was visible in the MALDI spectrum (Figure 2.18).  
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Figure 2.18. Formaldehyde-derivatized peptide 5, 6, 7 and 9 
 
Peptides 6 and 9, bearing substituted arginine and tyrosine, respectively, lacked that 
signal thus supporting the hypothesis that a cross-link between the side chain of 
arginine and lysine was the responsible for the +52 Da signal. This was confirmed by 
2-MEGA reactions where, lysine was transformed in homoarginine and the expected 
increment of 70 Da was not accompanied by the minus 4 Da signal.  
Interestingly the formation of the 52 Da signal was found to be almost completely 
suppressed when formaldehyde was added after NaCNBH3, namely when the imine is 
formed in a preexistent reducing environment (Figure 2.19). Otherwise, the short time 
elapsed between the addition of formaldehyde and the subsequent introduction of the 
reducing agent is enough to let the cross-link to take place. 
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Figure 2.19. Peptide 5,7 and ACTH derivatized with formaldehyde and NaCNBH3 (above); adding 
formaldehyde after NaCNBH3 greatly reduces the amount of the rearrangement (below) 
 
These results highlighted another aspect that was the presence of a small amount of a 
secondary product featuring 2 mass units less than the expected derivatized peptide, in 
all the MALDI spectra. Similar results derived also from peptide 8 where no side 
products were expected, as arginine was replaced by alanine and the N-terminus was 
protected by acetylation. Instead, once dimethylated, its MALDI spectrum showed a 
+26 signal but no evidence of a corresponding product was found in the ESI-MS 
spectrum (Figure 2.20) or in LC-MS runs. 
 
 
Figure 2.20. MALDI spectrum (on the right) and ESI spectrum (on the left) of peptide 8 
 
These evidences supported the hypothesis that probably the observed signal did not 
correspond to the formation of a secondary product in the reaction, but rather to a 
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rearrangement of the tertiary amine in the respective immonium ion during the matrix 
assisted desorption event. This phenomenon seems to be related to a rearrangement 
that takes place in the MALDI source.106 Laser desorption is known to be “harder” than 
electrospray ionization, so what we observe in this case is probably the product of a 
rearrangement of the tertiary amine that leads to the loss of two hydrogen atoms 
generating of an immonium ion that gives a [M-H]+ signal (Figure 2.21). 
 
 
Figure 2.21. Possible mechanism for the presence of [M-H]+ ion formation for tertiary amines 
 
It is difficult to attribute the minus 2 Da signal to the imidazolidinone or the immonium 
ion, that are real chemical species or a MALDI artifact, respectively. However these 
hypotheses are supported by the observation that formation of these signals is 
forbidden at low pH and in ESI source, respectively. 
In the reaction with acetaldehyde on peptides 5-9 the formation of a cross-link product 
was never observed, even if the reducing agent was added three hours after the 
introduction of acetaldehyde at pH 8.5. Steric hindrance is probably the main reason for 
this difference with dimethylation, together with an evident overall reduced reactivity. 
Taking into account the results obtained from dimethylation and diethylation of the first 
employed peptides, TDP and ACTH, of the tryptic peptides 1-4 and the ACTH-derived 
synthetic peptides 5-9, some considerations raised. 
The behavior of ACTH or its peptide analogues 5-9 toward formaldehyde is 
undoubtedly peculiar and interesting but, fortunately, such rearrangements should be 
very rare when a tryptic digest is subjected to reductive amination. An intramolecular 
cross-link between arginine and lysine can take place only if a missed cleavage occurs 
and both residues are present in the same peptide at a proper distance from each 
other. 
On the other hand, the imidazolidinone rearrangement at the N-terminus showed a 
higher frequency of occurrence, especially with acetaldehyde above pH 7.0, and could 
negatively affect quantitation experiments increasing the complexity of the sample.  
In order to evaluate the real impact of the imidazolidinone formation in dimethyl and 
diethyl labeling procedures for quantitative experiments, more complex samples were 
prepared and a proper quantitation software was employed to extrapolate light/heavy 
ratios. 
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2.3.3 Evaluation of stable-isotope labeling procedures in  
proteomic model samples 
Mixtures of heavy and light peptides labeled with both formaldehyde and acetaldehyde 
were analyzed by MALDI-TOF MS to check the progress of the reactions and to 
monitor the impact of the imidazolidinone on the quantitation. Methylated peptides 
confirmed to suffer a moderate presence of this side product while ethylated peptides 
were substantially covered by the imidazolidinone at the basic pH.  
As example are reported the signals of peptides 2 and 4, bearing one and two reactive 
sites, respectively. At pH 8.8 the signal of the heavy-labeled peptide 2, because of the 
presence of the imidazolidinone and its isotopic pattern, partially overlapped with the 
signal of the corresponding light labelled, covering the spacing of 8 Da between them 
(Figure 2.22). 
 
 
Figure 2.22. Peptide 2 and 4 ethylated at pH 6.9 (above) and at pH 8.8 (below) 
 
For peptide 4, instead, the spacing of 16 Da was sufficient to separate the two groups 
of signals. The comparison with the corresponding reactions performed at neutral pH, 
where a low amount of imidazolidinone was present, clearly highlighted how the 
presence of this rearrangement enhances the complexity of the spectra hampering a 
correct quantitation to be done. 
In addition, it should be mentioned that reactions with both isotopomeric acetaldehydes 
were confirmed to be significantly slower than reactions with formaldehyde, requiring 
subsequent additions of the reagents to be done in order to achieve a complete 
ethylation. This aspect is crucial because a labeling reaction must provide a complete 
conversion of the peptides to be considered reliable for quantitative purposes. 
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For a more comprehensive evaluation of these aspects a differential labeling was 
performed on a BSA digest with formaldehyde and acetaldehyde at both neutral and 
basic pH. Mixtures of differentially methylated or ethylated digest were prepared with a 
theoretic light/heavy ratio of 0.7, 2.5 and 0.5, analyzed through LC-MS/MS runs and 
the data processed using Mascot Distiller software. 
According to the labeling agent the amino acid modification included in the databank 
search were the dimethylation or the diethylation of lysine and the N-term and the 
quantitation methods used for the processing were Dimethylation [MD] and Diethylation 
[MD], both present in the Mascot Server. 
As an example we report the results from the methylated and ethylated samples at pH 
6 with protein light/heavy ratio of 0.7; results obtained from other methylated samples 
at the two pH values at different protein ratio are also discussed. In the quantitation 
report each experimental light/heavy ratio is reported as the geometric mean of the 
peptide ratios with the corresponding geometrical standard deviation. Moreover, for 
each peptide, in addition to the protein ratio the three mentioned quality parameters are 
included so that peptides bearing improper values are automatically excluded.  
The reaction of methylation performed on the BSA digest proved to be reliable since 
the experimental ratio turned to be very close to the theoretic, 0.76 versus 0.70; there 
was also sufficient homogeneity among the 15 peptides used for the quantification 
(Figure 2.23). Outlier peptides, exceeding the standard error threshold or the fraction 
threshold were excluded from the analysis. 
 
 
Figure 2.23. Quantitation report of methylated samples at pH 6 (above) where the theoretic 
light/heavy ratio was 0.7; table of identified sequences (below) 
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The XICs of the two components of one BSA peptide, namely SLHTLFGDELCK, are 
reported as example showing the co-elution of the two differentially labeled peptides 
(Figure 2.24). 
 
 
Figure 2.24. XICs of the two components of peptide SLHTLFGDELCK 
 
The scan markers on the XICs are for survey scans but only the scan included in the 
shady window are integrated to determine the ratios while the darker bands are the 
scans for which have been found Mascot matches. Database matches for both the 
components in a ratio are not required for each pair of peptides because as long as 
there is a match for one component, the "partner" is inferred from its mass and co-
elution. 
The spectrum of the two components allowed to make a visual judgment about their 
relative intensities showing that the intensity of the double-charged light peptide at 
mass 738.373 Da was about 2/3 lower than the heavy peptide at 742.294 Da (Figure 
2.25). 
 
 
Figure 2.25. Observed mass spectrum of the two components of the peptide SLHTLFGDELCK 
 
When data concerning ethylated BSA digest were processed, the protein was 
recognized based on 22 labeled peptides that were correctly identified by means of 
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their fragmentation spectra. Unfortunately the calculated protein ratio was higher than 
the expected with a reported value of 3.3908 (against the theoretic value of 0.7) based 
on highly variable singular peptide ratios. 
As it was previously noted with the mixture of standard peptides the ethylation reaction  
was much more troublesome than the corresponding methylation one. In order to 
achieve a satisfactory labeling yield several additions of acetaldehydes and NaCNBH3 
were required and a constant monitoring of the progress of the reaction had been 
performed. Considering that, it is not unexpected that the ethylation of the BSA digest 
had faced similar problems hampering the reactions to reach the completeness and 
thus provoking a wrong protein light/heavy ratio. Similar results were obtained in 
repeated experiments of ethylation of complex samples indicating that an overall 
optimization of the labeling, including a constant monitoring of the progression of the 
reaction, was essential to achieve an efficient yield of conversion. 
At variance, the positive results obtained in the previous reactions with formaldehyde 
supported its use as reliable labeling agent. In order to provide further evidences the 
BSA digest differently derivatized at pH 6 was prepared in a different light/heavy ratio, 
namely 2.5, and analyzed by means of LC-MS/MS runs. Even in this case, Mascot 
Distiller processing correctly calculated a protein ratio of 2.421 with a deviation of 1.184 
and once again all the quantified peptides exhibited homogeneous ratios. 
Interesting results were obtained with the differential methylation of the protein digest 
performed at pH 8.0 which was a critical value for the formation of the imidazolidinone 
derivative, as observed with standard peptides. Data processed considering the light 
and heavy methylation returned a ratio of 0.5267, very close to the theoretic which was 
0.5. When the same data were analyzed searching for peptide rearranged to form the 
imidazolidinone derivative no corresponding matches were found, indicating that the 
impact of such side product in the methylation approach was limited. It would have 
been very interesting to evaluate the impact of the imidazolidinone also on the 
differentially ethylated digest since the results obtained with the peptides had proved a 
significant incidence of that rearrangement at basic pH. Because of previous 
considerations, it was not possible to evaluate this aspect and quantify the impact on 
proteomic samples. 
Instead, given the results obtained with formaldehyde on the single protein digest other 
experiments were conducted on more complex samples in order to further validate the 
strategy and to insist monitoring its behavior at both the “safe” and “hazardous” pH. 
A sample containing five proteins was prepared including BSA, myoglobin, alcohol 
dehydrogenase, cytochrome C and carbonic anhydrase 2. The proteins were mixed in 
different amounts so to include a wide range of concentrations. Moreover different 
light/heavy ratios were thought for each protein so as to have available a sample that 
could shape as much as possible a proteomic sample. The two mixture of proteins 
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were separately subjected to light and heavy methylation at pH of 6.0 and 8.0, and then 
mixed to be submitted to LC-MS/MS analysis. 
Quantitation processing of reactions led at pH 6.0 allowed proteins to be measured 
with ratios that resulted very close to the theoretic ones (Figure 2.26), confirming the 
results obtained with the single protein experiment. 
 
 
 
Figure 2.26. Theoretic light/heavy ratio (above) and quantitation report (below) of the methylated 
mixture of five proteins, at pH of 6.0 
  
It was also really encouraging to find out that, once again, the peptides pairs belonging 
to the same protein exhibited a light/heavy ratio in a wide agreement with the final 
protein ratio. Moreover single proteins were identified by means of several labelled 
peptides, indicating an high yield of derivatization also in a more complex sample. 
Interestingly, similar results came from the processing of the methylation reaction 
performed at pH 8.0. Experimental ratios followed the theoretical ones (Figure 2.27) 
and the research for imidazolidinone derivatives did not retrieve any significant match. 
 
 
Figure 2.27. Quantitation report of the methylated mixture of five proteins, at pH of 8.0 
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The results obtained with the methylation of increasing complex samples starting from 
mixture of few peptides to mixture of tryptic peptides from different proteins confirmed 
the reliability of the labeling using formaldehyde. Moreover the impact of the 
imidazolidinone product did not appear to be significant, as already observed with 
preliminary experiments, since research algorithm did not find it out.  
Instead with the ethylation labeling the incidence of the imidazolidinone had been 
proved to be significant even at the neutral pH, showing a potential risk of misleading 
quantitative interpretations. However a sound evaluation of the impact in more complex 
samples, like it has been done with methylation, was not achieved for the occurrence of 
other problems. Indeed acetaldehyde labeling strategy was not successful just starting 
from simple peptides mixtures revealing that the same experimental conditions used for 
methylation were not able to reproduce similar satisfactory results with this reaction, 
mainly in terms of derivatization yield.  
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2.4 CONCLUSIONS 
 
Quantitative proteomics is a powerful approach for understanding global protein 
dynamics in a cell, tissue or organism. To achieve this goal an accurate quantitation of 
protein expression is necessary and the development of suitable methods is one of the 
most challenging and rapidly evolving areas of proteomics. Among the mass 
spectrometry-based technologies the use of chemical tags allowing comparative 
quantitation of proteins in different samples has been achieved by means of different 
stable isotope labeling reactions. 
In this work of thesis a reductive amination reaction has been employed using 
aldehydes that, in presence of NaCNBH3, targets all the free amino groups of peptides, 
namely N-termini and lysine residues, leading to their alkylation. A differential isotope 
labeling can be achieved by employing d(0)-formaldehyde and d(2)-formaldehyde or 
d(0)-acetaldehyde and d(4)-acetaldehyde that produce isotopomeric peptides featuring 
a mass difference of 4 or 8 Da for each dimethylated or diethylated derivatization site, 
respectively.  
The chemistry of the reaction between formaldehyde and an amino group is well 
understood despite the lack of a comprehensive scenario regarding the chemistry of 
aldehyde modifications within proteins. However the description of cross-linking with 
some amino acids in formaldehyde-treated protein suggests to watch out for collateral 
unwanted products that may rise from the derivatization of complex proteomic samples. 
In fact the absence of side products is one of the basic requirements for a reaction to 
become a reliable method of stable isotopic labeling of peptides, in order to avoid 
significant error in the quantitative analysis through the mass spectra. 
Given these premises a targeted evaluation on the reductive amination with both 
formaldehyde and acetaldehyde has been initially conducted using standard peptides, 
in order to monitor the progress of the reactions. 
Our experiments have shown that reductive amination on tryptic peptides leads to the 
desired dimethylation, or diethylations, at N-termini and at lysine residues only when 
pH ensures a rapid action of the hydride and reduces the nucleophilicity of other amino 
groups.  
On the contrary, when using basic pH, some rearrangements can take place involving 
peptide N-terminal in an imidazolidinone derivative or involving the arginine side chain 
in a methylene bridge with dimethylated lysine. Several experiments were led to prove 
the nature of such adducts including ESI source mediated acquisitions, guanidination 
reactions, LC separations, MS/MS spectra interpretation and ad hoc designed synthetic 
peptides. 
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We observed that the incidence of the rearrangement was widely different among the 
tested peptides suggesting that the chemical environment of the reactive site greatly 
influences its formation. The adduct between the dimethylated lysine and the arginine 
by means of two methylene bonds can be also suppressed if a reducing environment is 
created, for instance by the addition of the hydride before the introduction of the 
aldehyde.  
Furthermore it was possible to highlight the presence of an immonium ion rising after 
MALDI desorption featuring the same minus 2 Da signal as imidazolidinone but this 
apparent side product could be a problem in a LC-MALDI experiment only. 
The impact of the imidazolidinone in quantitative experiments was monitored using 
mixture of peptides and more complex samples of tryptic digestion of a single or 
various proteins. While the reactions on peptides were MALDI analyzed, these last 
were analyzed by LC-MS/MS and results processed using the Mascot Distiller 
package. In agreement with the situation observed with standard peptides, it was found 
that for methylation the occurrence of the rearrangement was mostly negligible. 
Moreover the quantitation results were in accordance with the theoretic, confirming its 
reliability as isotope labeling reaction.  
The use of acetaldehyde, instead, revealed more problematic aspects; an higher 
incidence of the imidazolidinone was observed starting from neutral pH and became 
the predominant signal at the most basic pH. Moreover experiments conducted on 
standard peptide mixtures proved a slow kinetic of the reaction requiring subsequent 
additions of the reagents to be performed to reach completeness. In the case of more 
complex samples, such as a digested protein, these further additions were not probably 
sufficient to overcome this problem. Indeed a strong disagreement was retrieved 
between the calculated and the theoretic light/heavy ratio. 
Further experiments will be necessary to monitor the imidazolidinone adduct in 
biological complex proteomic samples and a revision of the experimental conditions 
employed in the ethylation strategy will be also fundamental to evaluate its applicability 
in peptide labeling. 
 
In conclusion this project has partially highlighted how diverse can be the scenarios 
when we undertake a derivatization task on a complex ensemble of substrates.  
By a strictly proteomic point of view we can definitely fix, as a general rule, that 
reductive amination for differential isotope labeling must be performed at pH 5-6 to be 
absolutely sure that no undesired side reactions can take place. In these conditions 
reductive amination actually fits with the requirements of a suitable technique for 
isotope coding in relative quantitation of proteins, including a considerable reduction of 
costs. The application of higher pH values, as already reported in the literature, should 
not bring to any significant drawback with formaldehyde, at least as we work below pH 
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8.0. Conversely, when acetaldehyde is used, the incidence of collateral reactions 
recommends not to work above pH 6.0 in order to limit the formation of side products. 
By a chemical point of view we observed side products in reductive amination either 
with formaldehyde and acetaldehyde. Apart from these evidences based on our 
experiments, we cannot describe a comprehensive picture, or make an assessment of 
those residues that are the most likely promoter of a rearrangement at the N-terminus, 
or individuate the lysine residues more prone to be involved in cross-links. Thus a 
further more extensive investigation could be interesting to widen the knowledge on 
aldehyde-induced modification on peptides and proteins. 
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2.5 EXPERIMENTAL PART 
 
 
Instruments and methods 
MALDI experiments were performed on an UltraFlex II I MALDI-TOF/TOF mass 
spectrometer (Bruker-Daltonics, Bremen, Germany). Data were acquired in positive 
reflectron mode. Acquisitions were performed in the mass range 200-3000 Thomson 
(m/z) with voltages of 25 and 21.7 kV for the first and second ion extraction stages, 9 
kV for the lens, 26.3 and 13.8 kV for reflector 1 and 2 respectively. TOF calibration was 
performed using the Peptide Calibration Standard, basing on the monoisotopic mass of 
bradikinin (clip 1-7) [M+H]+=757.3992, angiotensin II [M+H]+=1046.542, angiotensin I 
[M+H]+=1296.685, Substance P [M+H]+=1347.7354, bombesin [M+H]+=1619.823, 
ACTH (clip 1-17) [M+H]+=2093.087, ACTH (clip 18-39) [M+H]+=2465.199, somatostatin 
[M+H]+=3147.471. MS and MS/MS data were processed and analyzed by the Bruker 
FlexAnalysis 3.0 software. 
 
Chromatographic separation of peptide 3 from the corresponding imidazolidinone was 
performed on a Dionex Ultimate capillary-HPLC system equipped with Famos 
autosampler and Switchos microcolumn switching device (LC Packings, Amsterdam, 
The Netherlands). 
5 µL of the reaction mixture were loaded onto a RP in-line precolumn (Dionex/LC 
Packings) and washed with 0.1% formic acid at a flow rate of 0.030 ml/min, for 3min. 
Separation was performed on a C18 RP capillary column (Dionex/LC Packings) whose 
temperature was set at 30°C. A linear gradient elution was applied at a flow rate of 3 
µL/min (eluent A, 0.1% formic acid in 95% water and 5% acetonitrile; eluent B: 0.1% 
formic acid in 95% acetonitrile and 5% water). from 5 to 40% of B within 25 min. 
The Ultimate system was fully controlled by the Dionex™ Chromeleon® software. 
 
LC-MS/MS experiment for quantitation were performed on a Waters nanoAquity UPLC 
system interfaced with a Waters Q-TOF Premier mass spectrometer equipped with a 
nanoESI source. 
Peptides, 2 µL full loop injection, were trapped on a 5 µm Symmetry C18 column (180 
µm × 620 mm) and washed for 3 min at 0.3 µL/min with 0.1% TFA. Peptides were then 
eluted and separated using a 60 min RP gradient at 250 nL/min (35% ACN over 45 
min) on a 1.7 mm BEH 130 C18 NanoEase™ (75 µm × 625 mm) nanoscale LC 
column. Eluent A was 0.1% formic acid and eluent B 0.1% formic acid in ACN. 
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The column temperature was set at 50 °C. Lock mass ([Glu1]-fibrinopeptide B, 250 
fmol/µL) was constantly infused by the NanoAcquity auxiliary pump at a constant flow 
rate of 250 nL/min.  
The Q-Tof Premier™ mass spectrometer was operated in positive mode.  
The Q-TOF was set to perform automated data-dependent acquisition switching from 
MS to MS/MS mode and returning to the MS mode using data dependent criteria. 
Multiply charged precursors were selected and fragmented automatically with the 
collision energy in MS/MS varied according to the m/z and the charge state of the 
precursor ion. MS survey scans were acquired within a mass range of 300–1600 m/z, 
with a 0.8 s duration and an interscan delay of 0.1 s. A dynamic exclusion window was 
set to 30 s.  
All the LC-MS/MS system was under the control of the Water software MassLynx®. 
 
Reductive amination 
As a general procedure for standard peptides methylation, 50 µL of reaction buffer (0,1 
M) were added to 10 µL of peptide solution (1 mg/mL) in a 0.2 mL eppendorf tube. 2.5 
µL of NaCNBH3 (1 M) were added and the solution vortexed for 30 s, then 2.5 µL of 
formaldehyde solution (0.5 M) were added and the mixture vortexed again. After 1 h 
incubation at 25° C, the reaction was quenched with 2 µL of 10% ammonia solution to 
consume the excess of formaldehyde. 
The ethylation labeling procedure followed the same criteria except for the incubation 
time that was prolonged until 6 h at 30°C; after the first 4 h a supplemental addiction of 
both acetaldehydes and NaCNBH3 were performed and allow to react for other 2 h.  
 
Guanidination 
10 µL o-methyl isourea solution (0.5 M) were added to 10 µL of a solution of peptide (1 
mg/mL) in a 0.2 mL eppendorf tube at 60°C and pH was adjusted to 11 with 1 µL of 2 
M NaOH. The reaction was kept at 60° C for 1 h and quenched with 1 µL of TFA 10%.  
 
Sample preparation 
Before MALDI analysis all the samples have been desalted by  ZipTipµ-C18 treatment 
and spotted with a solution of α-cyano-4-hydroxycinnamic acid (5 mg/mL in 50% 
acetonitrile, 0,1% TFA).  
 
Peptides synthesis  
Peptides from 5 to 9 were synthesized on an automatic batch synthesizer (APEX 396, 
Advanced ChemTech) equipped with a 40-well reaction block, following the 
fluorenylmethoxycarbonyl (Fmoc)/tert-butyl (tBu) solid-phase peptide synthesis (SPPS) 
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strategy. Fmoc amino acids and resins were purchased from Calbiochem–
Novabiochem.  
Fmoc deprotections were performed in 30 min with 20% piperidine in 
dimethylformamide (DMF). Coupling reactions (repeated twice) were performed for 45 
min by using the Fmoc-protected amino acids dissolved in N,N Dimethylformamide 
(DMF), in presence of a solution of 2M N,N-diisopropylethylamine (DIPEA) in N-
Methylpyrrolidone (NMP) and a 0.5 M solution of 2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate (TBTU) in DMF.  
Acetylation of peptides from 7 to 9 was performed with a solution of acetic anhydride 
(20 eq) in N-Methylmorpholine (NMM) and dichloromethane (DCM). 
Peptide cleavage from the resin and deprotection of the amino acid side chains were 
carried out in 3 h with TFA/TIS/H2O (95:2.5:2:5) (vol:vol:vol:). The resin was filtered off, 
and the solution was concentrated. The crude products were precipitated with cold 
Et2O, centrifuged, and lyophilized.  
Products were analyzed by analytical RP-HPLC (Alliance, model 2695 equipped with a 
diode array detector, Waters) using a Jupiter C18 (5 mm, 250x4.6 mm) column 
(Phenomenex) at 1 ml/min and interfaced to an ESI-MS source (Micromass ZQ).  
The solvent systems used were A (0.1% TFA in H2O) and B (0.1% TFA in acetonitrile). 
Products were purified by preparative RP-HPLC (model 600, Waters) on a Jupiter C18 
column (10 mm, 25 cmx10 mm) at 4 ml/min by using the same solvent systems 
reported above. Characterization of the products was performed with the LCQ 
Advantage liquid chromatography electrospray ionization mass spectrometer 
(ThermoFinnigan). 
 
In solution digestion 
15 µL of a solution of the protein mixture in TEAB 0.1 M was prepared in order to 
contain 50 µg of proteins. 1.3 µL  of 0.1 M DTT, 1.5 µL of 0.2 M IAA and again 0.25 µL 
of 0.1 M DTT were  subsequently added, leaving the mixture for 1h at 37° C, 1h at r.t. 
in dark, and 20m at 37° C respectively. The sample was digested over night at 37° C 
by adding 2 µL of trypsin (0.5 µg/µL) and was stopped with 2 µL of  1% TFA. 
 
Data bank search and quantitation 
LC-MS/MS data were processed using the package Mascot Distiller whose features 
has been previously described. Raw data were processed using the default processing 
options described. Databank searches were performed within the SwissProt database 
(released version: Sept2012; 537505 sequences, 190795142 residues) without any 
restriction except for the BSA samples search that was limited to “other mammalia” 
taxonomy. Precursor tolerance of 20 ppm and fragment tolerance of 0.1 Da were set. 
Cysteine carbamidomethylation was set as fixed modification and methionine oxidation 
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as variable; according to the sample the specific modifications induced by the labeling 
strategy were considered as variable. Dimethyl (K), dimethyl (N-term), dimethyl:2H(4) 
(K), dimethyl:2H(4) (N-term), diethyl (K), diethyl (N-term), diethyl:2H(8) (K); 
diethyl:2H(8) (N-term) where selected among the Mascot Server panel. Four more 
modifications regarding the imidazolidinone derivatives where edited using the 
configuration editor of the Mascot Server: imidazol-methyl L, imidazol-methyl H, 
imidazol-ethyl L and imidazol-ethyl H. 
  
Relative quantitative analysis has been made by measuring the ratio between the 
signals of the light and heavy labeled peptides (L/H) in the mass spectra, using the 
Quantitation Tool of Mascot Distiller. Dimethylation [MD] and diethylation [MD] were 
pre-existing quantitation methods while one further method was edited to perform the 
quantitation of the imidazolidinone in methylation reactions. 
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CHAPTER 3 
 
 
 
 
Alpha actinin is specifically recognized  
 
by multiple sclerosis autoantibodies isolated  
 
using an N-glucosylated peptide epitope
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3.1 INTRODUCTION 
 
 
3.1.1 Multiple Sclerosis 
Multiple Sclerosis (MuS) is an autoimmune neurodegenerative disease characterized 
by a progressive loss of the myelin sheath of nerves and a consequent gradual 
reduction of motor, cognitive and sensorial skills. Neurons are able to communicate by 
sending electrical signals (action potentials) that travel along the myelin-isolated 
nervous fibers. Whenever these are subjected to anatomic damages severe 
backlashes are recorded in the organism. 
The degenerative process can potentially target any cerebral region and the 
neurological symptoms can vary among patients as well as the progression of the 
disease. Common features shared with other autoimmune diseases are the alternating 
remitting and relapsing phases which show unpredictable onset, duration and 
disappearance. In the late phase of the disease patients enter a sort of irreversible 
stadium characterized by a progressive worsening of the systemic conditions. 
An evident clinical symptom of MuS concerns the occurrence of neuroglial hypertrophic 
plaques and focuses of demyelination among the central nervous system (CNS), which 
account for the name of the disease. Demyelination has been proved to be largely 
mediated by immunocompetent factors thus suggesting a strong autoimmune 
component.107 
MuS shows a multifactorial pathogenesis characterized by a significant activation of the 
immune system and a strong inclination to develop in genetically predisposed subjects 
exposed to environmental factors such as bacterial/viral infections or toxic agents. 
Several hypothesis have been proposed to explain the trigger of the autoimmune 
response; both autoreactive T cells and demyelinating antibodies risen outside the 
CNS are thought to enter the hematoencephalic barrier. Adhesion molecules over-
expressed by endothelial cells would allow T lymphocytes’ entry thus promoting the 
activation of other immunocompetent cells (i.e. antigen presenting cells, APCs) after 
the release of pro-inflammatory cytokines. Activation of this choral immune response 
might result in the development of a local inflammatory reaction with a progressive 
myelinic and oligodendrocyte impairment (Figure 3.1). 
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Figure 3.1 Hypothetical mechanism of neuronal damage in MuS 
 
Four different patterns of MuS pathology have been proposed:108 
• Cell-mediated demyelinization;  
• Antibody-mediated demyelination; 
• Active myelin destruction; 
• Oligodendrogliopathy or oligodendrocyte dystrophy. 
Rather than a single pathology MuS is, thus, considered as a set of diseases exhibiting 
different onsets but sharing a strong inflammatory reaction and a progressive disability 
in afflicted patients. Four internationally recognized clinical forms of MuS have been 
described: relapsing remitting (RR), secondary progressive (SP), primary progressive 
(PP) and progressive relapsing (RP). 
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Like other autoimmune diseases, as already described in the case of rheumatoid 
arthritis, the possibility to perform an early diagnosis is of mandatory importance to 
develop appropriate therapies. Moreover the disease has a large social impact, with 
spiraling costs increasing with the progression of disability.109 If progression can be 
delayed, the quality of life and independence of MuS patients will improve and the cost 
to health care system and society will decrease accordingly.110 
Up to now, the drugs used to treat MuS are able to manage only the symptoms by 
reducing the severity and the frequency of exacerbation. Corticosteroid, interferons 
(Betaseron and Avonex) and Copaxone are the therapeutic approaches most 
frequently employed in the management of the disease. 
On the contrary, targeted treatments are not still available since the pathogenetic 
mechanisms involved in the establishment of MuS have not been unraveled, as well as 
the CNS myelin antigens responsible of the triggering of the autoimmune response. 
Most of the putative antigens belong to the myelin family (myelin basic protein, 
proteolipid lipoprotein, and myelin oligodendrocyte glycoprotein). 
However disappointing results have been obtained in extensive studies attempting to 
develop immunological assays employing these antigens. These assays showed only a 
limited clinical value, due to low sensitivity that compromises their ability to discriminate 
between various inflammatory CNS diseases.111 In fact, the recently revised criteria for 
the diagnosis of MuS (issued by the International Panel on Diagnosis of MuS) are 
essentially based on neurologist’s clinical observation, supported by magnetic 
resonance imaging (MRI), and do not include any confirmation derived from 
immunological assay.112 
Recently, a number of non-myelin antigens have been reported as putative biomarkers 
of MuS. These findings highlighted the complexity of the disease and were instrumental 
in the advancement of novel interpretations of this pathology. For example, by applying 
a proteomic approach, Mathey et al identified neurofascin and contactin-2 as candidate 
antigens for MuS, demonstrating that antibodies against each of these proteins cause 
axonal injury and demyelinating lesions in the cortex.113,114 Since high neurofascin 
expression occurs predominantly in the brain of MuS patients characterized by chronic 
progressive disease, it appears that these antigens might be implicated mainly in the 
degenerative phase of the pathology. Similarly, an exhaustive search for antigens 
recognized by IgG autoantibodies derived either from sera or cerebrospinal fluid of 
MuS patients, revealed the presence of both oligodendroglia (transketolase, CNPase) 
and cytoskeletal proteins (radixin, actin interactin protein 1) in human brain.115 
Due to the ambiguous identification of the antigens implicated in the disease the 
development of serum biomarkers to employ for the diagnosis, monitoring, and 
prognosis of MuS remains a challenging issue. 
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3.1.2 An N-glucosy lated peptide detect ing disease-specific  
autoantibodies, biomarkers of multiple sclerosis  
The heterogeneous clinical spectrum of MuS has suggested that a single diagnostic 
probe is unlikely to serve as a general prognostic tool. Therefore, the development of a 
number of biomarkers, each one specific for different pathophysiological mechanisms, 
will be important for better understanding disease pathogenesis and for future drug 
development in MuS.116 The role of autoantibodies as potential biomarkers of 
autoimmune diseases arise from several studies such as those regarding the role of 
IgM autoantibodies against myelin oligodendrocyte glycoprotein (MOG), reported to be 
elevated during the first demyelinating event.117,118  
Taking into account these considerations, at the Interdepartmental Laboratory of 
Peptide and Protein Chemistry and Biology of the University of Florence an approach 
has been pursued to develop a specific antigenic probe able to identify a population of 
MuS patients in which the presence of autoantibodies, recognizing the antigenic probe, 
was correlated with disease activity.119 
A “chemical reverse approach” based on the use of synthetic peptides as antigenic 
probes was employed for the identification of autoantibodies as biomarkers of 
autoimmune diseases. It was called "reverse" because the autoantibodies circulating in 
biological fluids of patients guided the selection of the probes. “Chemical” because 
autoantibodies recognition drived selection and optimization of the best “chemical” 
structure among defined peptide libraries. Thus, antibodies provided the model for the 
chemical structure of peptides, that mimicked native epitopes of the antigens involved 
in the disease pathogenesis. At variance, conventional methods are based on 
preselected myelin components, which displayed variable efficiency in the recognition 
properties for autoantibodies.  
This strategy is particularly promising when post-translational modifications of proteins 
are involved in antibody recognition. In fact, the use of synthetic peptides allows the 
introduction of specific chemical modifications to reproduce the structures that trigger 
the autoimmune response, in contrast to extracted or recombinant proteins. 
Post-translational modifications can play a crucial role in the autoimmunity mechanisms 
by creating new antigens no longer recognized by the immune system; in particular, 
aberrant glycosylation can affect the immune response and profoundly influence 
immune tolerance.120 
Using this approach the efficient detection of autoantibodies in a large group of MuS 
patients guided the selection of an optimized synthetic glucopeptide antigen called 
CSF114(Glc). 
Synthetic libraries of peptides bearing unmodified residues or glycosylated residues 
were analyzed through ELISA assays using MuS patients’ sera to check their capacity 
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to recognize autoantibodies. Peptides were designed to bear small variations of amino 
acid sequence or sugar moiety in order to rationally achieve optimal conformation of 
the epitope recognized by antibodies.  
The screening of this peptide collection enabled the selection of the sequence of 
CSF114(Glc), characterized by a N-linked glucose moiety, as the best ligand for 
antibody binding thus proving that the key feature for antibodies recognition was the 
glucosylated asparagine residue assembled on the top of a β–hairpin structure. Results 
were validated on a relevant number of MuS patients confirming that CSG114(Glc) 
detects serum autoantibodies in a subset of approximately 30% of patients and exhibits 
an immunoreactive response correlated with the relapsing remitting trend of the 
disease.121 Subsequently, the value of the glucopeptide was proved at cellular level by 
means of immunohistochemistry experiments that revealed CSF114(Glc) specific 
antibodies to be able to recognize myelin and oligodendrocyte autoantigens in brain 
tissue. 
Therefore CSF114(Glc) acts as a simple, reliable, and an efficient antigenic probe able 
to detect, isolate, and characterize antibodies as biomarkers of MuS. 
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3.2 OBJECTIVES 
 
Sophisticated approaches have recently led to the identification of novel autoantigens 
associated with MuS, e.g. neurofascin, contactin, CNPase and other T cell receptor 
membrane anchored proteins. These putative antigens, although differing from the 
conventional myelin derivatives, are conceptually based on an animal model of 
experimental autoimmune encephalomyelitis. A novel approach, which has shown 
promising results in terms of predictive value for the MuS pathology, is based on the 
documented post-translational modifications of native antigens present in the CNS. 
Pathophysiological post-translational glycosylation of native antigens generates 
neoantigens that trigger the immune system to generate autoantibodies which escape 
conventional diagnostic procedures. Previous studies has shown that glycosylated 
molecules can act as neo antigens surrogates that serve as probes for the detection of 
disease-related autoantibodies present in the serum of MuS patients.,122,123 
The glucopeptide CSF114(Glc), developed by our group, is capable of identifying and 
measuring MuS-related autoantibodies whose levels are correlated with clinical 
assessment of MuS activity and MRI profile of brain lesions. Furthermore, CSF114(Glc) 
affinity-purified autoantibodies from MuS serum specifically stains myelin and 
oligodendrocytes antigens in human brain histological specimens. 
The CSF114(Glc) peptide represents an unconventional approach since its structure is 
completely unrelated to myelin oligodendrocyte glycoprotein or any other myelin 
derivative and is not linked to any particular pathogenetic hypothesis. The main 
characteristic of CSF114(Glc) is its conformational propensity to form a β-turn that 
exposes the sugar moiety, perhaps the key element, for recognition by the MuS-
relevant autoantibodies.124,125 
Given this background we wondered whether CSF114(Glc) affinity-purified antibodies 
from MuS patients’ sera, could be useful in back-tracking CNS antigens implicated in 
the MuS-related autoimmune response. An immunoproteomic approach was followed 
to identify putative antigens from rat brain tissues using serum MuS autoantibodies 
purified through CSF114(Glc) affinity columns, hereafter termed “CSF114(Glc) 
antibodies”. MALDI mass spectrometry analysis of the isolated antigens were 
performed to achieve the protein identifications and further validation experiments were 
conducted to confirm the recognition. 
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3.2.1 Scheme of the work  
 
• CSF114(Glc) was covalently immobilized on sepharose columns using a cyanogen-
bromide activated resin and used to isolate reactive antibodies from MuS patients’ 
sera and from healthy subjects as negative control. 
• Rat brain proteins were extracted using a protocol based on alternating extraction 
phases and centrifugation steps; the yield of the extraction was checked through 
SDS-PAGE. 
• Protein extract was run on a monodimensional SDS-PAGE to be subsequently 
immunoblotted with anti-CSF114(Glc)-antibodies; reactive bands from 
corresponding gel were excised and submitted to trypsin digestion for the MALDI-
MS analysis. 
• Commercial standard proteins corresponding to the identified ones where run and 
immunodetected by the same isolated antibodies to confirm the previous 
recognitions. 
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3.3 RESULTS AND DISCUSSION 
 
 
3.3.1 Detection of immunoreact ive proteins in rat brain 
homogenate using anti-CSF114(Glc) antibodies  
As the primary aim of this study was to investigate whether antibodies detected by 
CSF114(Glc) glycopeptide might reveal specific antigens present in brain tissue, the 
first step of the research concerned the purification of the antibodies. To achieve this 
goal an affinity chromatography system was prepared immobilizing CSF114(Glc) to a 
solid support and then sera of MuS patients positive to CSF114(Glc) were pushed 
through the column to specifically isolate reactive antibodies. 
The chromatographic bed was assembled using CNBr activated sepharose beads able 
to covalently block the peptide. The coupling reaction was performed in presence of an 
amine-free basic buffer so that only the primary amines of the peptide could react with 
both the cyanate esters and imidocarbonates groups exhibited by the resin. After an 
overnight incubation the net result was a covalent coupling of the ligand to the 
sepharose matrix. Substituted imidocarbonate derivatives compared to charged 
isourea derivatives are the preferred resultant structures (Figure 3.2). 
 
 
Figure 3.2. Reaction scheme of the peptide coupling to the CNBr-activated Sepharose beads 
 
Autoantibodies responding to CSF114(Glc) were isolated from MuS patients’ sera and 
from normal blood donors’ sera, the latter used as negative control. In particular six 
MuS sera were taken among the 250 previously analyzed for autoantibodies by ELISA 
with the glycopeptide and belonged to patients in the relapsing-remitting disease 
stage.119 
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Isolation and purification of antibodies were performed loading each filtered serum onto 
the column and incubating it for one hour at room temperature; non-specific antibodies 
were removed with several washes while specific antibodies retained by the column 
were eluted with an acidic buffer, neutralized with a basic medium and finally 
concentrated in a small volume. The purified antibody titer of each serum was 
evaluated by means of ELISA test on CSF114(Glc) coated plates. Results indicated a 
wide range of antibody levels, from 4- to 20-fold that present in the pooled control 
serum, taken from blood donors of matching age (Figure 3.3). 
 
 
Figure 3.3. ELISA absorbance at 405 nm of autoantibodies purified by affinity column 
functionalized with CSF114(Glc) glycopeptide (MuS patients and pool of normal blood donor’s 
sera) 
 
The second step of the research concerned the extraction of proteins from brain 
tissues. As a source of putative antigens the brain was chosen from adult rats, a 
species in which the above mentioned proteins are conserved as compared to human, 
and which for its availability, avoids problems of protein degradation. In addition, brain 
homogenization might disclose proteins (putative autoantigens), which are hidden by 
the integrity of brain tissue. Rat brain homogenate was obtained after sonication of the 
tissue, previously minced into small pieces; after a slow centrifugation cellular debris 
were removed and supernatant re-centrifugated for a longer time. The final pellet was 
re-suspended in a specific buffer and incubated for one hour; soluble proteins were 
recovered, the concentration measured by spectrophotometry and the protein profile 
was examined on SDS-PAGE. 
Affinity purified anti-CSF114(Glc)-IgGs from each MuS patient were challenged through 
western blot against the separated rat brain proteins and three major bands were 
revealed (Figure 3.4). 
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Figure 3.4. Rat brain proteins are selectively recognized by CSF114(Glc) specific IgGs from MuS 
patients 
 
The bands were characterized by different Mr: 130 kDa, 98 kDa and two close bands at 
47kDa. The 98 kDa band was recognized by antibodies purified from all patients 
examined (6/6), while recognition of the other bands occurred only in 3 patients sera. 
The finding of these reactivities was in agreement with the mentioned 
immunoistochemistry results performed on neurological tissues with CSF114(Glc) 
purified antibodies that had highlighted a diffuse reactivity throughout the white matter. 
 
 
3.3.2 Identificat ion o f antigens through proteom ic approach 
A thorough proteomic approach was applied to the immunoreactive bands above 
described to identify the nature of proteins present in rat brain homogenate detected by 
CSF114(Glc) antibodies. 
After excision and trypsinization of individual bands, MALDI analyses were performed 
obtaining PMFs data for each protein (Figure 3.5). 
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Figure 3.5. MALDI-TOF MS analyses of the four trypsin-digested bands excised from the SDS-
PAGE 
 
The search for these fingerprint signatures in the SwissProt rattus database, enabled 
the identification of the rat brain proteins sensitive to recognition by human antibodies: 
• Alpha fodrin corresponding to the 130kDa band, 
• Alpha actinin 1 corresponding to the 98 kDa band; 
• 2’,3’-cyclic-nucleotide 3’-phosphodiesterase and creatine kinase for the two 47 
kDa bands. 
Results of databank searches follow (Figure 3.6). 
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Figure 3.6. Databank searches of the four digested bands starting from the one at 130kDa, 98 kDa 
and the two at 47 kDa 
 
Identifications were confirmed by MS/MS analyses of selected peptides for each 
protein (Table 3-I). 
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Table 3-I. Identification of putative autoantigens following peptide mass fingerprint search on 
Mascot engine and MS/MS analyses of selected signals for each protein 
 
One MS/MS spectra for each identified protein is reported consecutively (Figure 3.7).  
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Figure 3.7. MS/MS spectra of precursor at 2147 m/z from alpha fodrin, precursor at 1215 m/z from 
alpha actinin, precursor at 1672 m/z from cretin kinase and precursor at 1536 m/z from CNPase 
 
Mass spectrometric analyses had revealed two proteins, namely alpha fodrin and alpha 
actinin, that belong to the spectrin family and are associated with the cytoskeleton. The 
other two proteins, CNPase and creatine kinase, are, instead, enzymes involved in 
cellular metabolic processes. 
 
 
3.3.3 Validation o f the ident if ied rat brain antigens  
To rule out the possibility that the mass spectrometry analysis might have identified 
proteins of similar Mr co-localizing in the same band (false positive) the proteins 
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identified required a further validation. With the use of monodimensional 
electrophoresis as a protein separation technique, indeed, protein co-localization is 
unavoidable. At the same time the use of more powerful separation techniques, such 
as 2D electrophoresis, was hampered by the limited quantity of CSF114(Glc) 
antibodies available, due to the low yield of the purification procedure from MuS 
patients’ sera. 
For this reason the four identified bands, (i.e. alpha fodrin, alpha actinin 1, CNPase and 
creatine kinase) and their standard counterparts were compared side by side against 
both IgGs monoclonal antibodies and CSF114(Glc) antibodies. A sequence homology 
analysis indicated that each standard protein exhibits a significant level of sequence 
overlapping with the corresponding rat sequence (86.6% – 95.4%), and in the case of 
alpha actinin, with the corresponding human form (96.9%). 
Monoclonal antibodies recognized all standard proteins except alpha fodrin, possibly 
due to a faulty protein, demonstrating the immunogenicity of the commercial proteins. 
Similarly monoclonal antibodies also recognized all extracted proteins in similar fashion 
as CSF114(Glc) antibodies previously did, confirming the presence of the MS-identified 
proteins in the brain extract. The most interesting results came from the standard 
proteins challenged by CSF114(Glc) antibodies because only alpha actinin provided a 
positive band, while all other proteins failed to respond to the antibodies (Figure 3.8). 
 
 
Figure 3.8. Western blot of rat brain proteins with CSF114(Glc) specific IgGs from MuS patients 
(panel A); authentic proteins challenged with commercially available monoclonal antibodies (panel 
B) and with anti-CSF114(Glc) antibodies (panel C) 
 
The positive response obtained with alpha actinin was consistent with initial results, 
showing the presence of specific autoantibodies against this protein in all patient sera. 
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3.4 CONCLUSIONS 
 
CSF114(Glc) is a glycopeptide developed by the Laboratory of Peptide and Protein 
Chemistry and Biology (PeptLab) as specific probe for detection of autoantibodies of 
relapsing remitting subtype of MuS. It was selected by means of a “chemical reverse 
approach” that allowed autoantibodies response to guide the design and the 
optimization of its chemical structure. This peptide, bearing a N-glucosylated moiety, 
revealed to be the most efficient probe in recognizing specific autoantibodies in 
approximately the 30% of MuS patients’ population. 
The usefulness of CSF114(Glc) not only resides in the employment as antigenic probe 
for the detection of antibodies possibly biomarkers of MuS but also as investigative tool 
to help in delineating the pathogenetic mechanisms of the disease. Indeed serum 
autoantibodies ought to reflect the presence of corresponding antigens and peptides 
recognized by those autoantibodies might mimic structural features of neo-epitopes. 
Therefore an autoantibodies population proven to be relevant for the MuS pathology 
might be used to look for the proteins that originally could have primed its release, 
namely the native autoantigens. Since immunohistochemistry experiments had clearly 
proved the CNS specificity of anti-CSF114(Glc) antibodies, possible reactive proteins 
were searched among the brain tissue of rats. 
Experiments were designed to include four sequential stages: (a) purification of 
autoantibodies from MuS sera; (b) detection of antigens displaying immunoreactivity 
toward the autoantibodies; (c) MALDI identification of putative antigens; (d) 
assessment of immunoreactivity of putative antigens and their authentic protein 
counterparts against either specific monoclonal antibodies or the purified 
autoantibodies. 
The CSF114(Glc) antibodies, purified and enriched through affinity chromatography, 
were able to detect three distinct protein bands in the rat brain, which upon MALDI-
PMF and MS/MS analyses led to the identification of four proteins, i.e. alpha fodrin, 
alpha actinin 1, CNPase and creatine kinase. However, with the exception of alpha 
actinin 1, CNPase, alpha fodrin and creatin kinase, in their authentic form, failed to be 
recognized by CSF114(Glc) antibodies. They consistently provided a negative 
immunoreactive response when challenged with the MuS patient derived 
autoantibodies against the glycosylated probe. This failure might be attributed to post-
translational modifications of antigens, well documented particularly for CNPase.126  
The salient finding of this work was the identification of alpha actinin 1 as the only 
molecule, which provided immunoreactive responses to the CSF114(Glc) antibodies for 
both the extracted rat brain protein and the reference standard forms. 
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Alpha actinin 1 is an ubiquitous cytoskeletal protein, which in its isoforms 1 and 4, both 
termed non-muscle, has been reported to be involved in autoimmune diseases such as 
systemic lupus erythematosus and autoimmune hepatitis.127 To our knowledge, this is 
the first time that alpha actinin 1 has been identified as one of the targets recognized 
by specific autoantibodies associated with MuS. 
Alpha actinin 1 appears to be implicated in the organization of the cytoskeleton and 
through its proximity to adherens junctions, might be involved in T-cells migration. As 
component of adherence and tight junctions, it also modulates blood brain barrier 
functions.  
Anti alpha actinin 1 autoantibodies have been found in lupus nephritis and in 
autoimmune hepatitis (AIH), and their detection in the latter pathology is an important 
diagnostic tool. Because these diseases are characterized by inflammatory and 
degenerative components, prevailing features also of MuS, the identification of alpha 
actinin 1 as a major autoantibodies in MuS suggests that the underlying mechanisms 
producing these derangements are similar for a number of autoimmune pathologies. Its 
detection by autoantibodies from MuS patients, besides signaling its involvement in the 
pathology, implies a derangement of the barrier shield, leading to exposure of the 
neurovascular niche to further degenerative injuries. 
It is of interest that the use of CSF114(Glc) antibodies approach, which is not linked to 
any particular pathogenetic mechanism, discloses antigens undetected by conventional 
approaches, e.g. alpha actinin 1. It appears that the “a priori” designation of a specific 
pathogenetic autoimmune model for MuS, poses limitations as it reveals antigens 
confined to that specific mechanism. Recent reports have described an approach for 
the identification of diagnostically useful antibodies, which bears similarities with our 
approach that is not based on predefined knowledge of antigens.128,129 Both studies 
successfully employ peptide libraries, either synthetic or phage displayed, for capturing 
autoantibodies involved in immune mediated disorders of the CNS. 
 
In conclusion the distinct advantage of this study lies in the use of purified 
autoantibodies specific for the N-glucosylated peptide CSF114(Glc), which recognize a 
limited repertoire of relevant antigens. In contrast, the extensive use in other studies of 
unselected Ig fractions had accounted for the detection of antigens having remote 
relevance for the disease. 
In our view the observed cross-reactivity between the N-glucosylated peptide and 
alpha actinin 1 fits the well-known hypothesis that common pathogens are associated 
with the onset of MuS, suggesting that molecular mimicry may cooperate with the 
adaptive immune system leading to recognition of brain antigens.130 In addition the 
finding of the double reactivity of specific MuS autoantibodies toward a synthetic 
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peptide, CSF114(Glc), and a specific protein, alpha actinin 1, constitute a further 
validation of CSF114(Glc) as antigenic probe able to detect antibodies as biomarkers 
of MuS. 
Our findings support, also, the hypothesis that alpha actinin 1, a cytoskeleton protein 
implicated in inflammatory/ degenerative autoimmune diseases (lupus nephritis and 
autoimmune hepatitis), might be regarded as a novel MuS autoantigen, perhaps a 
prototypic biomarker for the inflammatory/degenerative process typical of the disease. 
Although it is difficult to assess, at this point, what is the role of alpha actinin 1 in the 
pathogenesis of MuS, its detection in several autoimmune diseases, which 
underscores its involvement in inflammatory/degenerative pathologies, warrants further 
investigations.
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3.4 EXPERIMENTAL PART 
 
 
CSF114(Glc)-Sepharose Coupling 
CSF114(Glc)-Sepharose column was prepared by using Cyanogen-Bromide Activated 
resin (CNBr-Sepharose® 4B, Sigma). CNBr-Sepharose beads (60 mg, coupling 
capacity 30-40 mg of ligand per ml) were washed thoroughly with 1 mM HCl, 
equilibrated with coupling buffer (0.1 M NaHCO3 containing 0.5 M NaCl, pH 8.3) and 
coupled to 1 mg of glycopeptide CSF114(Glc). Unreacted ligand was washed and 
unreacted sites were blocked with 0.2 M glycine (pH 8). Column was washed 
thoroughly and equilibrated with PBS.119 
 
Affinity Purification  
Multiple Sclerosis patients’ serum from six individual patients (MuS1 – MuS6) was 
diluted in PBS (1:10) and filtered through 0.22 µm filter (MILLEX®, GS). The study was 
approved by the institutional ethic committee. All patient included corresponded to 
relapsing-remitting MuS and had no comorbidities. Filtered serum was loaded onto the 
column and incubated for one h at room temperature. Column was washed with PBS 
buffer to remove non-specific antibodies, after washing specific antibodies were eluted 
with 0.1 M glycine buffer, pH 2.6. Eluted fractions were neutralized with 0.1 M NaHCO3 
pH 8.3 and concentrated on Amicon Ultra-0.5 ml, 50K (Millipore). Immunoreactivity of 
anti-CSF114(Glc) IgGs was examined by ELISA on CSF114(Glc) coated plates.121 
 
Extraction of Brain Proteins from Rat 
120 mg of frozen rat brain was excised and minced into small pieces. Sample was 
dissolved in 1 ml PBS and sonicated (Brandelin SONOPLUS Probe KE-76, Sigma) for 
2 min in ice. Homogenate was centrifuged at 10,000 g for 15 min and debris were 
removed. Supernatant was re-centrifuged at 31,870 x g for 90 min at 4°C. Pellet was 
solubilized in 0.01% Triton X-100 buffer containing a cocktail of protease inhibitors 
(Complete™ Mini tablets, Roche Applied Science) and NaN3 (0.05%) at 37°C for one 
h. Total protein concentration was 17.9 mg/ml, measured by spectrophotometry 
(NanoDrop 1000, Thermo Scientifics). 10 µl of sample were loaded and examined on 
SDS-PAGE 12%.  
 
SDS-PAGE and Western Blot Analysis 
Protein samples were subjected to SDS-PAGE 12% under reducing condition (2% v/v 
β-mercaptoethanol). The following standard proteins were obtained from commercial 
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GmbH, Germany), alpha actinin isoform 1 (brain), extracted from chicken gizzard 
(Sigma, Italy), recombinant human CNPase expressed in E. coli (Abcam, USA), 
recombinant human creatine kinase expressed in Pichia pastoris (Sigma, Italy). Gels 
were either stained with Coomassie blue or used to transfer onto nitro cellulose 
membrane (0.45 µm; BIO-RAD) at 220 mA for two h at room temperature. Membrane 
was blocked with milk powder 2% in TBST (0.1%) and incubated with affinity purified 
anti-CSF114(Glc)-IgGs (MuS patients and normal blood donors) for 1 h at room 
temperature. Membrane was washed thoroughly with TBST (0.1%) and incubated with 
alkaline phosphatase conjugated anti-IgGs (1:500; Sigma) for 1 h at room temperature. 
Membrane was washed as above with TSBT (0.1%) and blots were developed using 
AP conjugated substrate kit (BIO-RAD). 
 
Excision and digestion  
The samples were obtained by excision and digestion of the bands from SDS-PAGE 
12% of rat brain homogenate, after comparison with the Western blot results to identify 
the bands of interest. The bands were excised and minced into small pieces, washed 
with NH4HCO3 50 mM and shrunk with acetonitrile. Reduction and alkylation were 
performed with βME 20 mM (56°C, 30 min) followed by 2-iodoacetamide 55 mM (20°C, 
20 min, in the dark). Proteins were digested in a buffer containing 25 mM NH4HCO3, 5 
mM CaCl2 and ~20 ng/µl of trypsin (37°C, overnight). Peptides were extracted from gel 
in two steps by adding 25 mM NH4HCO3 and 5% formic acid; each step was followed 
by addition of acetonitrile to shrink the gel and maximize the peptide recovery. 
 
MALDI Analysis 
MALDI-MS measurements were performed using an Ultraflex II I TOF-TOF instrument 
(Bruker Daltonics, Bremen, Germany), operating in reflectron positive ion mode. Ions 
were formed by a pulsed UV laser (λ = 337 nm) beam. The instrumental conditions 
were: UIS1 = 25 kV; UIS2 = 21.65 kV; reflectron potential: 26.3 kV; delay time = 0 
nsec. The samples were dried, re-suspended in acetonitrile and desalted by Zip-Tip 
C18 pipette tips (Millipore). Zip-tipped samples were spotted on the stainless steel 
sample plate with α-cyano-4-hydroxycinnamic acid matrix (5 mg in 
H2O/Acetonitrile/0.1% TFA). 1µL of the peptide eluted solution was deposited on the 
stainless steel sample holder, and allowed to dry before introduction into the mass 
spectrometer. External mass calibration was done using the Peptide Calibration 
Standard, basing on the monoisotopic values of [M+H]+ of Angiotensin II, Angiotensin I, 
Substance P, Bombesin, ACTH clip (1-17), ACTH clip (18-39), Somatostatin 28 at m/z 
1046.542, 1296.685, 1347.736, 1619.823, 2093.087, 2465.199 and 3147.471, 
respectively. MALDI-TOF-TOF experiments were carried out using the LIFT device. 
The instrumental parameters were: UIS1=8 kV; UIS2=7.2 kV; ULIFT1= 19 kV. 
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The resulting data were processed using the FlexAnalysis 2.4 software (Bruker 
Daltonics) and optimized for databank search. Searches were performed using the 
Mascot Server 2.3 search engine against the Swiss-Prot database (release 2012_8, 
subset Rattus, 7800 entries) considering up to one missed tryptic cleavage, 
monoisotopic peptide mass tolerance of 500 ppm, and fragment ion mass tolerance of 
0.3 Da. Carbamidomethyl modification of cysteine and oxidation of methionine were 
considered as appropriate. 
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